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Abstract 
Multi-level analysis of regulation of regulation of EGFR signalling during Drosophila melanogaster 
leg proximal-distal axis patterning 
 
Susan E. Newcomb 
 
 A major pursuit of Developmental Biology is to determine how organisms composed of cells 
containing a single genome generate stereotyped body plans with diverse, complex morphologies. The 
development of these patterns is often determined by gradients of secreted factors known as 
morphogens, which activate cascades of gene expression to subdivide fields of cells into increasingly 
complex patterns. In many animals, including Drosophila, a rudimentary anterior-posterior (A-P) and 
dorsal-ventral (D-V) axes of the body plan are already established in the zygote, but the proximal-distal 
(P-D) axis of any appendages must be generated and patterned seperately. The spatio-temporal 
information responsible for activating gene expression and cell signalling that establishes this new axis is 
integrated at DNA regulatory elements often referred to as enhancers.  
 The segmented leg of the insect Drosophila melanogaster offers an ideal system for studying 
how signalling pathways control P-D axis establishment and patterning. In addition to the fact that flies 
are a particularly genetically tractable model organism, many of the signals required for leg patterning 
have already been identified. A number of signalling pathways, including Wingless (Wg), 
Decapentaplegic (Dpp) and Epidermal Growth Factor Receptor (EGFR), are important for proper P-D 
axis patterning in a dynamic fashion during embryonic and larval development. The leg primordia are fist 
specified in the embryo and then patterned throughout development as intercalated circles and rings of 
gene expression are established in the leg imaginal disc. The radius of these domains corresponds to 
the P-D axis of the adult appendage. 
 
 A rudimentary P-D axis is established in the embryo and the larval leg imaginal disc by the 
expression of the transcription factors Distalless, Dachshund and Homothorax in distal, medial and 
proximal domains, respectively. The P-D axis is further refined by activation of EGFR signalling in the 
presumptive tarsus, the distal-most portion of the fly leg, during the early third larval instar. As well as 
slightly later, in medial and proximal rings. EGFR signalling is a ubiquitous pathway with numerous roles 
throughout fly development as well as across metazoan taxa. Its activation produces diverse cellular 
outcomes such as growth, differentiation, or regulation of apoptosis depending on the precise regulation 
of its inputs and modulation of intracellular signalling components in a tissue-specific manner. The 
precise mechanism by which EGFR signalling is activated during tarsal patterning is the focus of this 
dissertation.  
As a crucial first step in the detailed characterization of EGFR activation in the leg, we have 
identified leg-specific enhancers of the genes encoding the neuregulin-like EGF ligand Vein and the 
ligand-activating protease Rhomboid and performed genetic and site-specific mutagenesis experiments 
to characterize the factors necessary to activate expression of vein and rho in the distal leg. While the 
enhancers of vein and rho (vnE and rhoE, respectively) employ similar transcriptional programs to 
activate target gene expression, there are some key differences. Both enhancers require Dll for their 
expression throughout leg development, however vnE requires Wg and Dpp only early and later 
becomes independent from these signals while rhoE requires them until much later in development. 
Further, vnE requires Sp1 while rhoE does not. These differences may be important for the precise 
timing of expression of these genes, with vn expression coming on several hours earlier than that of rho. 
It has been proposed that the distal source of EGFR ligand may act as a long-range morphogen 
to pattern the entire tarsus in a graded manner (Campbell, 2002; Galindo et al., 2005). Our analysis 
indicates that vnE and rhoE represent the only sources of EGFR ligand in the distal leg. Therefore, in 
order to determine the importance of distal of EGFR signalling for tarsal patterning we carried out 
CRISPR targeting to delete vnE and rhoE. Because these deletions produce only mild distal leg 
truncations and cannot be worsened by removal of other candidate EGFR inputs (for example the Rho 
homolog, Roughoid) we conclude that the long-range distal gradient model for P-D patterning by EGFR 
 
must be revised. Instead we propose that the tarsal segments are patterned by the combined action of a 
local, distal gradient of EGFR supplied by vnE and rhoE combined with secondary, more medial sources 
of EGFR signal.  
Our analysis of the mechanism by which EGFR patterns the distal leg segments improves our 
understanding not only of leg development, but also of how the EGFR pathway is regulated in general. 
Our conclusions have important evolutionary implications, as receptor tyrosine kinase signalling, of 
which EGFR is an example, is involved in limb patterning in taxa whose limbs themselves are not 
thought to be structurally homologous to fly legs (Panganiban et al., 1997; Pires-daSilva and Sommer, 
2003). Further, the components of the EGFR pathway assessed in this work are highly conserved 
signalling molecules, involved in cell proliferation and are therefore often misregulated in tumors. A 
nuanced understanding of the ways in which EGFR signalling is activated, particularly via regulation at 
non-protein-coding loci, could motivate new therapeutic approaches. 
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 1 
CHAPTER 1: General Introduction 
 The work presented in this dissertation is focused on how expression of key inputs of the EGFR 
signalling pathway that are required for proper leg development in Drosophila melanogaster are 
activated via cis-regulatory DNA modules. In this introduction I will summarize our current understanding 
of these three fields: appendage development and patterning, EGFR signalling, and cis-regulation of 
gene expression. 
 
1.1: Leg Development 
 A fundamental pursuit in developmental biology is to uncover how cells with a single genome 
gain distinct and diverse identities within the larger organism. In some cases, positional information 
exists during all stages of life, as with the anterior-posterior and dorsal-ventral axes of the zygote laid out 
by distributions of maternal factors. For the development of appendages, positional information must be 
derived later, as the patterns that prefigure outgrowths are not apparent in the early embryo. Much of the 
work to understand leg development has been done in arthropods and specifically in the genetically 
tractable model organism Drosophila melanogaster. Initial models of appendage development relied on a 
polar coordinate model to conceptualize the source of a third orthogonal axis developing from the 
existing anterior-posterior (A-P) and dorsal-ventral (D-V) axes (French and Daniels, 1994). Eventually, a 
clearer understanding of patterning within compartments of insects allowed investigation of the 
molecular mechanisms at play in limb specification and patterning (Basler and Struhl, 1994; Campbell 
and Tomlinson, 1998; 1995; Cohen and Jürgens, 1989; Diaz-Benjumea et al., 1994; Lecuit and Cohen, 
1997; reviewed in Baker, 2011). The major signalling pathways required to pattern limbs and the 
interplay between them became a major focus of study with important advances in our understanding of 
the molecular mechanisms that govern regulation of gene expression via regulatory DNA elements that 
integrate tissue-specific cell signalling cues.  
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From specification to axis patterning of the Drosophila melanogaster leg  
The six legs of Drosophila melanogaster are each composed of ten jointed segments extending 
in pairs from the ventral body wall in all three thoracic segments. From proximal to distal this includes 
the coxa, trochanter, femur, tibia, tarsal segments I-V and a pretarsus, which is comprised of the claw, 
empodium and pulvillus (Fig. 1.1B). Additionally, a portion of the thoracic body wall also shares a 
developmental lineage with the leg structures (reviewed in Estella et al., 2012). This ventral 
appendage,primordium as well as many other adult organs and structures, is established in the embryo 
and is further patterned during larval development as an imaginal disc; a sheet of cells that invaginate 
from the larval epithelium (Milner et al., 1984). The imaginal discs are the precursors of the adult fly 
structures, which develop within the larval cuticle until metamorphosis when they evert in preparation for 
eclosion (Fig. 1.1A). Interestingly, the peripodial membrane, a sac that encloses the imaginal discs, has 
been shown to influence development and patterning in eye and wing imaginal discs, but its role remains 
relatively unexplored in leg patterning (Gibson and Schubiger, 2000). 
The proximal and distal domains of the leg, the coxpodite and telopodite, respectively are 
distinct in terms of the molecular mechanisms of their specification. The coxopodite, composed of the 
coxa and trochanter, requires nuclear localization of the Hox cofactor Extradenticle (Exd) and is 
unaffected when Hedgehog (Hh) signalling is absent. The telopodite, comprising the femur, tibia and 
tarsus requires Hh signalling to activate the Wingless (Wg) and Decapentaplegic (Dpp) signalling 
pathways. Exd nuclear localization is repressed by Wg/Dpp targets and thus the coxopodite and 
telopodite are maintained by mutually antagonistic molecular programs (Fig. 1.2, Abu-Shaar and Mann, 
1998; González-Crespo et al., 1998). There are also evolutionary distinctions along the leg’s P-D axis. 
Experiments that remove Hox contributions to leg development result in a relatively normally patterned 
tarsus indicating that the distal leg is the more evolutionarily ancient arthropod limb, which was later 
elaborated upon to produce the extant fully segmented fly leg (Casares and Mann, 2001).  
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Figure 1.1: How Drosophila legs develop 
 
 
modified from Cohen et al., 1993 &  Kojima, 2005 with illustrations by Brian Staveley 
(A) Leg imaginal discs develop within the larval cuticle in each pair of thoracic hemisegments. By the third instar, the imaginal disc 
is highly folded in concentric rings with central domains corresponding to the future distal leg. The disc then everts out of the 
peripodial membrane during pupation. Red fluorescent signal in bottom panel is Dll protein expression. 
(B) Concentric domains in the leg imaginal disc map to specific segments along the proximal-distal axis of the adult leg. 
 
 
The primordium of the Drosophila melanogaster leg is specified during embryonic development 
by the activation of expression of the transcription factors (TFs) Sp1 (and its paralog, Buttonhead) and 
Distal-less (Dll) in the ventral domain of the six thoracic hemisegments around stage 10 (Cohen et al., 
1993; Estella et al., 2003; McKay et al., 2009; see Figs. 2.1A and 4.4). Sp1 is thought to be a leg selector 
gene since its expression in the ventral primordia marks the entirety of the future adult leg and in its 
absence dorsal appendage fate can become de-repressed (Estella and Mann, 2010a; Panganiban and 
Rubenstein, 2002). This initial pool of Dll- and Sp1-expressing cells will also give rise to the dorsal 
appendages: the wing and haltere of the second and third thoracic segments, though Dll is required only 
for the development of the distal portion of the leg (Wieschaus and Gehring, 1976; Gorfinkiel et al., 1997; 
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Abu-Shaar and Mann, 1998; Bolinger and Boekhoff-Falk, 2005; Beira and Paro, 2016; Requena et al., 
2017). As to be expected for an important developmental factor with numerous patterning roles, the cis-
regulatory architecture of the Dll gene is highly complex in order to facilitate the integration of multiple 
and dynamic cell signals (McKay et al., 2009; Galindo et al., 2011;  reviewed in Estella et al., 2012). 
Maintenance of Dll expression throughout leg development relies on coordinated activity of multiple cis-
regulatory DNA modules that interact additively or redundantly to produce the final gene expression 
pattern (see Appendix 2 for a more detailed description of regulation at the Dll locus). 
A number of signalling inputs are required in a dynamic fashion throughout embryonic and larval 
development in order to set up and maintain domains of expression of key genes along the P-D axis of 
the adult leg. The Wingless (Wg) and Decapentaplegic (Dpp) signalling pathways are activated in the 
ventral and dorsal domains of the embryo, respectively, as a result of Hedgehog signalling from the 
posterior compartment and their distinct expression patterns are maintained by mutual repression 
(Basler and Struhl, 1994; Kubota et al., 2003). These signals play a dynamic role in directly activating 
expression of a number of genes throughout the course of P-D patterning and are also important for 
establishing and patterning D-V fates in the leg in a graded manner (Brook and Cohen, 1996; Brook et 
al., 1996; Jiang and Struhl, 1996; Theisen et al., 1996). Early in embryonic development Dll expression 
depends on activation from Wg and repression by Dpp and EGFR signalling, but by stage 14, Dll 
expression depends on the combined activity of Wg and Dpp signalling as well as Sp1 and Dll itself. By 
this point, its expression domain is constrained to the future telopodite of the adult leg and is encircled 
by domains of expression of the Hox TF, Homothorax, nuclear localization of the Hox cofactor 
Extradenticle and the Zn-finger TF, Teashirt (Wu and Cohen, 2000). Establishment of these nested rings 
of gene expression represents an elaboration from two-dimensional positional information laid down by 
the A-P and D-V axes of the fly body plan by adding an orthogonal P-D axis corresponding to the radius 
of these circular domains.  
This rudimentary P-D axis is established by the beginning of larval development when the leg 
primordia separate from the surrounding tissue to form the epithelial monolayer of the imaginal disc. At 
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this point, Dll activates expression of Dachshund (Dac), another homeodomain TF, in a medial domain 
proximal to that of Hth/Exd. Through complex feed-forward loops of activation and cross-repression 
combined with growth of the disc these expression domains come to roughly subdivide the telopodite 
along the P-D axis (Giorgianni and Mann, 2011; reviewed in Estella et al., 2012; Fig. 1.2). Although 
initially mutually exclusive, by the third larval instar, the Dll and Dac domains begin to overlap medially 
once the disc has grown sufficiently to allow Dac to escape repression by Wg and Dpp (Lecuit and 
Cohen, 1997). Further, Dll expression is repressed in the corresponding cells of the abdominal segments 
in order to prevent limb development there (Vachon et al., 1992).  
 
 
Figure 1.2: Overview of fly leg development 
 
from Estella et al., 2012 
 
 
Patterning along the P-D axis 
Although a rudimentary P-D axis comprising distal, medial and proximal domains is present by 
the beginning of larval development, not until the third larval instar does elaboration of the tarsal P-D 
domain occur. This is achieved by waves of Epidermal Growth Factor Receptor (EGFR) signalling 
activated as a result of the expression of multiple secreted EGFR ligands in the center of the leg disc. 
This leads to intercalation of a number of concentric circles and rings of expression of EGFR target 
genes whose domains fate map to the future tarsal segments (Campbell, 2002; Galindo, 2002; Natori et 
al., 2012). These genes display a complex timing and system of activation and cross repression along 
the P-D axis (Kojima et al., 2000; 2005; Kozu et al., 2006; Tajiri et al., 2007; Tsuji et al., 2000; reviewed in 
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Galindo and Couso, 2000; Kojima, 2005). Many specific aspects of the regulation of these EGFR target 
genes have been established, but the overall mechanism by which EGFR might coordinate this 
patterning along the length of the tarsus is not well understood (Mojica-Vazquez et al., 2017). See 
Appendix 1 for a detailed description of current understanding of the regulation of leg patterning genes 
downstream of EGFR. 
One model for the mechanism of activation of these EGFR target genes is based on the 
observation that patterning of the tarsus can be perturbed in a graded manner using a temperature-
sensitive Egfr allele (Campbell, 2002). It has been proposed that the tarsal patterning genes are activated 
in response to a long-range gradient of EGFR signal originating from a constrained organizing center 
(EOC) at the distal tip of the future adult leg (Campbell, 2002; Galindo, 2002). Indeed, the EGFR inputs 
Vein and Rhomboid are expressed in the distal leg (Campbell, 2002; Galindo et al., 2005; reviewed in 
Mann and Casares, 2002). However, it is also possible that EGFR is required only to activate distal 
patterning genes which in turn initiate a cascade of transcription factor expression along the P-D axis 
that does not directly depend on EGFR input. Further, medially and proximally expressed P-D genes 
may be activated directly by additional, non-EOC sources of EGFR ligand. 
By the late third instar and into pupal stages, EGFR inputs begin to be expressed in rings that 
abut Notch signalling activity at positions along the P-D axis that prefigure the joints of the adult leg  
(Bishop et al., 1999; Rauskolb and Irvine, 1999; Galindo et al., 2005; Córdoba and Estella, 2014). This 
Notch activity may be important for structural constriction necessary at the joints as has been shown in 
antennal development (Ku and Sun, 2017). One reason why the potential contribution of various EGFR 
signalling sources to leg P-D patterning is difficult to discern is that this pathway plays multiple roles 
during the course of leg development. However, some rings of EGFR activity may instead contribute to 
medial/proximal tarsal patterning as distinct from formation of the joints. The expression patterns of 
some tarsal genes are also regulated by Notch signalling during the third instar (de Celis Ibeas and Bray, 
2003; Campbell, 2005; Greenberg and Hatini, 2009).The possibility of contributions of multiple sources 
of EGFR to tarsal segment patterning is addressed in more detail in Chapter 3. 
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Conserved aspects of limb development and patterning in evolution 
Detailed molecular studies of limb development in arthropods have proven broadly applicable to 
our general understanding of appendage patterning. Hox family transcription factors are involved in the 
development of the proximal Drosophila leg as well as in repressing appendage fate in abdominal 
segments (Vachon et al., 1992). In other related phyla such as crustaceans, Hox proteins are important 
for limb specification and the evolution of diverse appendage morphologies in various invertebrates 
(Hannibal and Patel, 2013; Martin et al., 2016). Many other genes involved in leg development and 
patterning have been revealed to have conserved roles in other insects (Angelini et al., 2012). Further, 
despite a lack of strict evolutionary homology between the appendages of insects and vertebrates, many 
of the factors and signalling pathways identified in fly leg specification and development have found to 
be important for limb development in vertebrates (Panganiban et al., 1997; Shubin et al., 1997; reviewed 
in Pueyo and Couso, 2005). While the limbs of highly divergent taxa are not directly homologous, 
similarities in the signalling pathways responsible for their establishment may reflect conservation of 
those signalling relationships or even a rudimentary limb progenitor in some distant common ancestor 
(Shubin et al., 2009; Tschopp and Tabin, 2017).  
Of particular relevance to the work presented in  this dissertation, comparative studies reveal 
that homologs of the Dll/Dlx family of homeodomain proteins play an important role in limb specification 
not only throughout arthropods but also in a number of vertebrate taxa (Robledo et al., 2002; 
Panganiban and Rubenstein, 2002; Ishimaru et al., 2015; Chen et al., 2016). Sp1-family proteins have 
also been found to be important for limb development in mice (Giorgianni and Patel, 2004; Bell et al., 
2003; Kawakami et al., 2004; Córdoba et al., 2016). Also, receptor tyrosine kinases (RTKs), of which 
EGFR is an example, are active in limb bud development in many metazoan taxa (Martin, 1998). A 
number of factors important for Drosophila leg patterning are thought to regulate adhesion properties of 
cells and so may be generally important for the biophysical properties inherent in generating outgrowths 
(Campbell and Tomlinson, 1998; Panganiban and Rubenstein, 2002). Study of the nuances of gene 
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networks that pattern Drosophila legs have and will continue to contribute to our understanding of the 
evolution of morphological diversity in related and highly divergent taxa. 
 
 
1.2: EGFR signalling 
 In addition to playing a number of important roles in leg specification and patterning as 
described in the preceding section, the Epidermal Growth Factor Receptor (EGFR) is at the nexus of an 
essential, ubiquitous signalling pathway in flies and throughout metazoan taxa (Freeman, 1998; Shilo, 
2003; Citri and Yarden, 2006). It is one of the many Receptor Tyrosine Kinase signalling pathways 
present in animals and its activation can have diverse and potent effects on cell proliferation, growth, 
regulation of apoptosis and other homeostatic functions; reviewed in (Tan and Kim, 1999; Sopko and 
Perrimon, 2013). As a complex pathway involving numerous ligands, inputs and downstream effectors, 
EGFR signalling may be regulated at various levels in complex and nuanced ways. Identification of all 
key components in a given developmental context and characterization of their modes of regulation and 
interaction with other signals is crucial to understanding how this single pathway is capable of 
functioning in numerous cellular contexts to achieve diverse outcomes (Freeman, 1998). Further, 
misregulation of EGFR signalling is a common cause or contributor to cancers and other diseases 
(Normanno et al., 2006; Zandi et al., 2007; Casaletto and McClatchey, 2012). A detailed mechanistic 
understanding of how EGFR is activated and regulated, particularly via non-coding DNA elements, is a 
crucial pursuit for preventing and treating disease. 
 
 
Epidermal Growth Factor Receptor signalling in vertebrates and human disease 
 The Epidermal Growth Factor Receptor (EGFR or in humans, ErbB/HER) pathway is a ubiquitous 
Receptor Tyrosine Kinase (RTK) signalling cascade conserved throughout metazoans. Originally named 
for observations of the effect of growth factor in mice (Cohen, 1965), EGFR signalling plays important 
 9 
roles in human organogenesis and adult homeostasis with outcomes including growth, cell proliferation, 
differentiation, migration  and inhibition of apoptosis. (Burden and Yarden, 1997; Wee and Wang, 2017). 
Its ubiquity invites a central question of developmental biology: how are specific cellular outcomes 
achieved from a general signal (reviewed in Pires-daSilva and Sommer, 2003)? Work from model 
organisms like Drosophila melanogaster indicates that precise patterns of expression of combinations of 
partially redundant ligands that differ in potency lead to activation of varying levels of downstream 
signalling in different contexts, which in turn activates positive and negative feedback loops that serve to 
tightly regulate the timing, strength and spatial distribution of signalling. 
EGFR is one of 20 RTK families in humans; reviewed in (Lemmon and Schlessinger, 2010; Sopko 
and Perrimon, 2013). Study of RTKs in general and of EGFR signalling specifically has led to some 
important insights about how various combinations of receptor homologs, partially redundant ligands 
and integration of multiple intracellular signalling cascades within the cell can produce tissue specific 
outputs appropriate to the developmental or cellular context (reviewed in Yamaoka et al., 2017. This 
complexity underscores the importance of analyzing the regulation of this pathway under normal and 
pathological circumstances to reveal the importance of various components in driving disease or more 
nuanced aspects such as prognosis, susceptibility or potential for development of drug resistance 
(Webster et al., 2014; Yamaoka et al., 2017). However, the complexity and redundancy of EGFR 
signalling in vertebrates makes detailed genetic studies fraught and therefore much of our understanding 
stems from work in model systems such as Drosophila melanogaster and Caenorhabditis elegans. These 
species possess a more primitive linear signalling structure and a single receptor; C elegans express 
only one EGF ligand and one receptor homolog (Aroian et al., 1990), as compared to four ligands and 
one receptor gene encoding two isoforms in Drosophila (Yoo et al., 2004). 
 Vertebrates express a repertoire of four EGFR paralogs: EGFR/ErbB-1/HER-1, ErbB-2/HER-2, 
ErbB-3/HER-3, and ErbB-4/HER-4. The prototypical receptor, comprises an extracellular domain 
including ligand binding sites, a transmembrane region, and an intercellular domain which possesses the 
kinase activity (Fig. 1.3; (Garrett et al., 2002; Ogiso et al., 2002; reviewed in Citri and Yarden, 2006; Wee 
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and Wang, 2017). In the presence of growth factor ligand, formation of receptor homo- or heterodimers 
triggers conformational changes and reciprocal phosphorylation that initiates the recruitment of 
intracellular factors that can initiate a variety of downstream signalling cascades (reviewed in Doroquez 
and Rebay, 2006). Crosstalk between these cascades and other intracellular factors permit regulation of 
EGFR and feedback at multiple levels to determine the ultimate cellular outcome; reviewed in (Yarden 
and Sliwkowski, 2001). Receptor endocytosis then leads to downregulation of signal and recycling of 
upstream EGFR components; reviewed in (Sorkin and Goh, 2009). Interestingly however, recent reports 
have implicated nuclear translocation of the EGFR intercellular domain or whole receptor in non-
canonical downstream signalling events further expanding the potential downstream outputs of this 




Figure 1.3: Increasing EGFR upstream complexity from worms to humans 
 




There are more than a dozen EGFR ligands expressed in humans whose binding to EGFR 
facilitates receptor dimerization that initiates a signalling cascade within the cell (Citri and Yarden, 2006; 
Lemmon and Schlessinger, 2010; Riese and Stern, 1998; reviewed in Singh et al., 2016). These ligands 
are expressed as larger, transmembrane forms whose secretion depends on regulated proteolysis (Riese 
and Stern, 1998; Bang and Kintner, 2000; Urban and Dickey, 2011). However, many can also activate 
receptor without cleavage in a juxtacrine manner (Singh et al., 2016; Steinhauer et al., 2013). Regulation 
of this process depends to some extent on the apical-basal localization of receptor and ligand, as has 
shown to be important in the intestine (Singh and Coffey, 2014). Some ligands are specific to particular 
ERBb homologs and some are more general binders (Stortelers et al., 2002; Wee and Wang, 2017). This 
leads to a complex system of partial redundancy with respect to each ligand’s affinity for or ability to 
bind different receptors in various homo- or heterodimeric combinations which may be important to 
determine the downstream signalling outcome  (Jones et al., 1999). These outcomes may be further 
modulated by changes in the abundance or activity of intracellular components that can affect the 
strength of response to varying levels of activation by different ligands; reviewed in (Antebi et al., 2017). 
Studies in cell culture or other model systems have shown that EGFR activation can lead to thousands 
of downstream phosphorylation events on hundreds of targets and the differential expression of 
thousands of genes within receiving cells. The complexity and broad range of effects of downstream 
signalling cascades make it clear why EGFR is such a powerful driver of global changes that promote 
developmental differentiation as well as transformations that cause malignancies. 
Several aspects of EGFR activation are unique among Receptor Tyrosine Kinases. In many 
RTKs, ligand binding is “bivalent” in that a single ligand molecule makes contacts between two receptor 
domains. EGFR ligands are bivalent but instead make contacts between two extracellular subdomains 
on one EGFR monomer, rather than between monomers, thereby relieving autoinhibition and producing 
a conformational change in the receptor that favors dimerization (Garrett et al., 2002; Ogiso et al., 2002; 
reviewed in Burgess et al., 2003; Lemmon and Schlessinger, 2010). Further, autophosphorylation occurs 
between the two monomers, rather than autophosphorylation by each monomer on itself as a result of 
the conformational change. These features are useful in drug development as treatments that target 
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such idiosyncrasies would be specific to EGFR and avoid off-target effects on other RTKs. Dimerization 
is entirely receptor-mediated in that it requires no ligand-ligand contact or interaction between a ligand 
and the reciprocal receptor monomer (Lemmon and Schlessinger, 2010). The biochemical properties of 
both ligands and receptors that facilitate binding, dimerization and transautophosphorylation are 
commonly mutated in cancers because variants that undergo these processes in a constitutive manner 
will induce signalling in the absence of the proper upstream cues to promote tumorigenesis and cell 
survival (Freed et al., 2015). As such these are common targets for cancer treatments, however many 
EGFR-related cancers become resistant to drugs targeting upstream inputs indicating that multiple 
aspects of EGFR signalling can be modulated to evade downregulation. Further study of the 




EGFR signalling in Drosophila melanogaster: upstream components and regulation 
 Though the complex system of redundancy of multiple EGF ligands and receptor homologs and 
the branched signalling cascades they induce is pertinent to understanding the nuances of EGFR 
signalling in humans and in disease, it makes genetic studies challenging. Flies are a particularly 
attractive model in which to study the regulation of EGFR signalling since the Drosophila melanogaster 
genome contains only one EGF receptor gene (Livneh et al., 1985) and four EGF ligands. Further, the 
genetic toolkit available in flies makes assessment of regulation at multiple levels relatively 
straightforward compared to other animal models. For these reasons, significant work carried out in flies 
has helped to elucidate the nature of EGFR signalling, which, like in vertebrates, is involved in a growing 




Figure 1.4: Overview of EGFR signalling in Drosophila 
 




 In flies, EGFR signalling can be activated by any of four ligands: the neuregulin-like ligand Vein 
(Vn) and three Transforming Growth Factor-alpha (TGF-α) -like ligands: Spitz (Spi), Keren (Krn) and 
Gurken (Grk). There is also a secreted EGFR antagonist, Argos, originally thought to bind EGFR 
(Schweitzer et al., 1995a; Vinós and Freeman, 2000). Crystal structures have revealed that instead Aos 
may act by binding activating ligand directly to dampen EGFR signalling (Klein et al., 2004; 2008). Spi is 
the most commonly used EGFR ligand in flies and null mutations in this gene are embryonic lethal. 
Gurken is thought to be required only for ovary patterning (Shmueli et al., 2002). Keren was first 
predicted based on sequence homology to the other TGF-α ligands and has recently been implicated in 
EGFR signalling in vivo in the development of the eye and gut (Reich and Shilo, 2002; Brown et al., 2007; 
Jiang and Edgar, 2009). Animals deficient for either Krn or grk are viable as homozygotes and appear 
morphologically wild-type other than sterility of female grk mutants. As for EGFR ligands in vertebrates, 
these TGF-α ligands are expressed in a transmembrane pro-ligand form (m-TGF-α) requiring regulated 
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proteolysis and trafficking through the secretory pathway. This is carried out by the chaperone Star, 
which facilitates transport of transmembrane TGF-α from the ER to the Golgi. Then cleavage within the 
transmembrane domain is performed by a Rhomboid-family metalloprotease to produce free ligand 
(Guichard et al., 1999; Bang and Kintner, 2000; Lee et al., 2001; Tsruya et al., 2002; Urban et al., 2002a; 
Fig. 1.4). Krn has been shown to be cleaved at low levels in a Rho-independent manner, though the 
biological significance of this alternate secretory mechanism is not clear (Reich and Shilo, 2002). This 
represents a key distinction between EGFR signalling in flies and vertebrates as vertebrate m-TGF-α 
ligands can signal in a juxtacrine/paracrine manner in the transmembrane form. Recent work suggests 
that transmembrane Spi can signal without cleavage in cell culture or when ER retention is compromised 
thus its failure to signal in the context of the epithelium may depend on regulation of its sub-cellular 
localization in the plasma membrane (Reich and Shilo, 2002; Steinhauer et al., 2013). Because the 
Drosophila TGF-α ligands are expressed in an inactive form, their activity is constrained by the 
expression patterns of the required processing machinery. Indeed, Rho is sufficient to activate EGFR 
targets in diverse tissues and its expression is highly correlated with MAPK-dpERK phosphorylation 
patterns (Gabay et al., 1997). 
There are a number of important differences between the TGF-α ligands and Vein. Vein is 
secreted without cleavage and is involved in activating EGFR signalling either alone, or more commonly 
in concert with the TGF-α ligands (Buff et al., 1998; Yarnitzky et al., 1997; 1998). The Vein protein itself is 
complex and contains a number of domains important for regulation of its degradation and possibly for 
interaction with other EGFR inputs (Schnepp et al., 1996; Simcox et al., 1996; Schnepp et al., 1998; 
Wessells et al., 1999; Garratt et al., 2000; Donaldson et al., 2004). Interestingly, Vein is not capable of 
ectopically activating EGFR signalling in some tissues, except in the context of a vein null mutant (Zecca 
and Struhl, 2002b; 2002a). Taken together, these studies indicate that although Vein does not require 
cleavage in order to be secreted, there are some as yet unidentified modifiers, cofactors or other 
regulators necessary for Vein to be able to activate EGFR signalling under wild-type conditions. 
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In addition, Vein and Spitz differ in the range of their diffusion. There are a number of factors that 
may influence this, beyond the inherent nature of the protein, for example ligand perdurance or post-
translational modifications, which themselves may differ between developmental/cellular contexts. 
Ectopically expressed Vein can diffuse relatively long distances to activate receptor (Zecca and Struhl, 
2002b). Spitz appears to be comparatively limited in its range of diffusion and that is thought to be due 
in part to post-translational palmitoylation that serves to tether secreted ligand to the secreting cell 
(Miura et al., 2006). This tethering likely also serves to concentrate secreted Spitz at the source thereby 
increasing its potency. Interestingly, a recent screen for modulators of EGFR signalling point to heparin 
deposition in the extracellular matrix of receiving cells as an important condition for the ability of Vein to 
efficiently activate EGFR (Butchar et al., 2012). Thus, secretion and diffusion of EGF ligands can be 
modulated at multiple levels in order to generate appropriate cocktail of EGF inputs for a specific 
signalling context. 
Vein also has a lower affinity for binding the EGF receptor than Spi and this difference is likely 
mediated by the respective EGF domains (Schnepp et al., 1998; Yarnitzky et al., 1998). Additionally, 
EGFR dimerization is thought to follow a negative cooperativity model whereby binding of one ligand 
decreases the availability of the ligand-binding domain on the reciprocal receptor monomer (Alvarado et 
al., 2010). Interestingly, vein and rho are themselves targets of EGFR signalling in some tissues (Wessells 
et al., 1999). This may serve as a positive feedback mechanism for maintenance of signalling 
(Wasserman and Freeman, 1998; Golembo et al., 1999). However, the lower affinity of Vein for the 
receptor and potential for nuanced regulation of its ability to activate signalling make it possible that co-
expression of Vein and Spi may actually dampen signalling in some contexts (unpublished observations, 
see Chapter 3, Figure 3.1E-G). More research is necessary to understand how the differing affinities of 
various ligands combined with their available concentrations at the cell surface (a product of expression 





 Because EGFR itself is broadly expressed in most tissues, spatiotemporal regulation of Rho 
expression often serves to constrain EGFR activity (Zak et al., 1990) and is there for a crucial point of 
EGFR regulation in most tissues that require EGFR signalling. The Rhomboid family of proteins was 
discovered in flies; rhomboid was one mutant identified by the landmark Heidelberg genetic screen for 
mutants affecting Drosophila larval cuticle patterning (Jürgens et al., 1984; Mayer and Nüsslein-Volhard, 
1988) but have since been identified in taxa from all kingdoms and are now appreciated as one of three 
families of proteins capable of cleavage within the transmembrane domain of substrates (Urban et al., 
2001; Urban et al., 2002b; Kanaoka et al., 2005) This cleavage mechanism was a surprising discovery 
because hydrolysis, which requires water, was not thought likely to occur within the hydrophobic 
domain of transmembrane proteins (Lemberg et al., 2005; Urban, 2010) but has since been elucidated. 
Furthermore this form of cleavage shown to be broadly important in many forms of life as Rhomboid-
dependent cleavage has been implicated in a wide array of biological processes including cholesterol 
metabolism, chloroplast and flower development, and bacterial quorum sensing (Brown et al., 2000; 
Gallio et al., 2002; Thompson et al., 2012; Adam, 2013).  
The prototypical Drosophila Rhomboid (Rho-1) is a seven-pass transmembrane serine 
metalloprotease which localizes to the Golgi membrane (Lee et al., 2001). Rhomboid functions in EGFR 
signalling by cleaving the TGF-α ligands to promote their secretion. Rhomboid is also thought to cleave 
other substrates, including the TGF-α chaperone Star in an apparent negative regulatory role (Tsruya et 
al., 2007). rho is also commonly upregulated by EGFR signalling in one of several feedback loops 
important for regulating this pathway. However, involvement of Rhombiods in EGFR signalling 
represents an evolutionary cooption since EGFR is limited to metazoans but Rhomboids can be found in 
all kingdoms of life (Urban and Freeman, 2002; Urban and Dickey, 2011). Incorporation of Rho-
dependent ligand secretion into EGFR signalling during the course of evolution greatly expanded the 
mechanisms for fine regulation of EGFR output (Singh et al., 2016). Recently, the Rhomboid family of 
proteins has been upgraded to a super-family as the diverse roles of related proteins in many aspects of 
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cell biology across diverse taxa have come to be better understood (reviewed in (Freeman, 2014). 
Further, enzymatically inactive Rhomboids, or iRhoms, have been shown to function in downregulating 
EGFR signalling in flies and mammals by promoting endoplasmic reticulum-associated degradation 
(ERAD) of Rho catalytic substrates (Zettl et al., 2011).  
 There are at least seven Rho-like proteases encoded in the Drosophila genome and comparison 
of some of the more well-studied homologs provide some insights about potential modes of their 
regulation. Some rho homologs are known to function in EGFR signalling similarly to Rho-1, like the 
paralogous stet (brho, rho-2) thought to function exclusively in Gurken processing during ovary 
patterning (Guichard et al., 2000), or roughoid (ru, rho-3). Ru serves as the predominant TGF-α-
processing protease in some instances of EGFR signalling in Drosophila (Gallio et al., 2004; Yu et al., 
2010). However Rho and Ru have been observed to localize differently within cells indicating that they 
may not have entirely redundant functions in promoting ligand secretion (Yogev et al., 2008). Despite 
these key differences, Rhomboids play a crucial role in EGFR signalling by cleaving TGF-α ligand for 
secretion. There are human homologs of rho that can cleave TGF-α, however many other proteases are 
also involved in EGF ligand processing in humans (Nakagawa et al., 2005). 
 
 
Negative Feedback and Repression: 
Finally, the cast modulators of EGFR signalling includes a number of repressors that are 
expressed in response to EGFR activation as negative feedback. Upstream of the receptor the secreted 
repressor Argos (Aos) that likely acts by binding EGF ligands themselves thereby preventing them from 
activating the receptor and thus dampening signalling (Klein et al., 2004; 2008), Fig. 1.2). This is a 
common role for Argos as it is often a target of EGFR signalling and serves to prevent excess signalling 
by Spitz (Gabay et al., 1997; reviewed in Shilo, 2003). However, Aos is expressed in domains adjacent to 
vein expression in the wing and so may function there to sharpen the boundaries of signalling. This is 
just one of many examples of the flexibility of inputs and modulators that are used to regulate EGFR 
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signalling on a context-by-context basis. Interestingly, no secreted EGFR antagonists had been 
identified in humans until recently, when the cytokine Macrophage Migration Inhibitory Factor (MIF) was 
found to bind and inhibit EGFR (Zheng et al., 2015). Although this protein is not homologous to 
Drosophila Aos, it may function in a similar fashion and therefore represent an underappreciated 
component of wild-type EGFR regulation in mammals and an attractive therapeutic target.  
Two other negative inputs act in a cell-autonomous manner and are activated less commonly 
that Aos. The transmembrane repressor Kekkon represses EGFR signalling in a cell-autonomous manner 
by forming heterodimers with receptor monomers thus interfering with dimerization (Ghiglione et al., 
2003; Alvarado et al., 2004;  Fig. 1.4). An intracellular repressor, Sprouty, associates with the interior of 
the plasma membrane to repress components of the downstream EGFR signalling cascade as well as 
other RTK signalling components (Casci et al., 1999; Reich et al., 1999); Fig. 1.4), but may also serve to 
upregulate EGFR signalling in some instances by impeding receptor degradation (Wong et al., 2002). 
Further, rhomboid is itself a target of EGFR signalling in some cases (Sapir et al., 1998; Wasserman and 
Freeman, 1998) and this activation would serve as a positive feedback, however some Rho proteases 
and pseudoproteases (iRhoms) have been proposed to have repressive effects on signalling and so 
might represent another instance of a negative feedback loop in EGFR regulation (Tsruya et al., 2007; 
Zettl et al., 2011). 
Repressors are a necessary component to establish proper patterns and levels of EGFR 
signalling and to prevent oncogenic effects associated with high levels of EGFR ligand, particularly Spi. 
However, it is not clear how combinations of activating and repressing inputs might contribute to 
EGFR’s ability to act in a graded manner as has been proposed for EGFR’s role in leg patterning. EGFR 
signalling usually functions as a binary switch to activate downstream targets and acts via a morphogen 
in relatively few contexts (Golembo et al., 1996; Shmueli et al., 2002; Cheung et al., 2011). Negative 
feedback is generally thought to be important for the establishment of morphogen gradients so that the 
level of signal produced at the source does not increase beyond the dynamic range of the tissue (Rogers 
and Schier, 2011). However, the molecular mechanisms by which receiving cells might interpret levels of 
EGFR activity to direct differential transcriptional programs are not understood. 
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Downstream EGFR signalling, readouts & regulation 
 As opposed to multiple branched cascades initiated by EGFR signalling in humans, activation of 
the Drosophila EGF receptor by similar mechanisms of ligand binding and dimerization results in a linear 
phosphorylation cascade within the cell. This is implied by the fact that mutations in downstream 
components such as Ras phenocopy Egfr or ligand mutants (Diaz-Benjumea and Hafen, 1994). The core 
components of this canonical downstream Ras/Raf/MAPK phosphorylation cascade are well-conserved 
within metazoans and terminate in the phosphorylation of two ETS transcription factors PointedP2 (Pnt) 
and Yan (Gabay et al., 1996). The downstream effector of EGFR signalling in flies is PointedP2, one of 
two isoforms encoded by the pnt locus which, when phosphorylated, becomes a strong activator of RTK 
downstream targets (Klämbt, 1993; Brunner et al., 1994). Phosphorylation of Yan promotes its nuclear 
export and degradation resulting in de-repression of RTK targets. This reciprocal relationship suggests a 
model by which these two factors function as a bistable switch between high and low RTK signalling 
states (O'Neill et al., 1994; Rebay and Rubin, 1995; Graham et al., 2010).  
According to a recent study, Pnt and Yan have mutually exclusive expression patterns in many 
tissues which correspond to the patterns of RTK activation. However, these patterns overlap in some 
tissues indicating that there is more complexity to the relationship between these TFs. It is unclear how 
spatiotemporal regulation of expression and MAPK-dependent localization or activity of these TFs 
contribute to their antagonistic effects on target gene activation in different tissues. Additionally, Yan 
does not appear to be expressed in many tissues that depend on precise patterns of RTK signalling, 
such as the leg, antenna or wing imaginal discs (Boisclair Lachance et al., 2014). Yan is also capable of 
polymerization and has been shown to spread across many kilobases to silence expression. These 
nucleation sites occur often at highly conserved and developmentally important loci, however the 
precise relevance of this property of Yan has not been established (Webber et al., 2013). It may function 
to silence sets of linked loci, or to facilitate long-range physical interactions in the genome and these 
functions may or may not relate to its role as a repressor of RTK targets, specifically. 
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Activation of EGFR target genes in the leg requires Pnt (Galindo et al., 2005) but additional 
factors must be responsible for repressing these targets outside of the proper domain since Yan 
expression cannot be detected there (Boisclair Lachance et al., 2014), unpublished observations). An 
attractive candidate to function as an antagonistic repressor to Pnt is the HMG-box TF Capicua (Cic) ( 
O'Neill et al., 1994; Boisclair Lachance et al., 2014) cic is expressed in imaginal discs and loss of 
function mutants show de-repression of RTK targets in those tissues (Roch et al., 2002). Tight regulation 
of expression, activity and nuclear localization of downstream effectors and repressors of EGFR targets 
is clearly an important control mechanism for coordinating spatiotemporal signalling patterns. The leg 
disc offers an interesting system in which to study this phenomenon as both pnt and cic are broadly 
expressed, the canonical repressor Yan is absent, and yet EGFR target genes are activated in tightly 
spatiotemporally controlled domains throughout development. 
Although the linear EGFR pathway present in flies is simpler than the branched cascade found in 
humans, it is nevertheless capable of directing diverse cellular outcomes during fly development. This is 
representative of a general observation that relatively few signalling pathways in metazoans are 
responsible for the multitude of cell fates we observe in animals (Ammeux et al., 2016). In addition to the 
ways in which levels of individual pathways can be modulated by regulation of their intercellular inputs, 
the transcriptional and cellular outcomes a single pathway produces are also a product of regulation and 
crosstalk between pathways within a given cell. The multitude of ways in which different signalling 
pathways may interact, by synergistic or antagonistic regulation of transcriptional targets or by 
convergence on shared intracellular components serve to produce a unique signalling state within a 
given cell type; reviewed in (Housden and Perrimon, 2014). For example, modulation of the abundance 
of intracellular components of the EGFR pathway have been shown to influence its downstream effects 
(O'Shaughnessy et al., 2011; reviewed in Antebi et al., 2017). In flies, multiple RTK signalling pathways 
may converge on shared intracellular components such as Ras or Pnt to cross-regulate downstream 
signalling outcomes (reviewed in Housden and Perrimon, 2014).  
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Co-occurrence of multiple signalling pathways within a cell may lead to additive, competitive or 
otherwise emergent transcriptional or cellular outcomes for which a single pathway is insufficient, as has 
been observed for EGFR and Notch in the Drosophila eye (Flores et al., 2000). Indeed, Notch and RTK 
signalling pathways have been found to interact in multiple developmental contexts in flies, worms and 
other higher organisms (Yoo et al., 2004; reviewed in Doroquez and Rebay, 2006) and to have a large 
number of shared transcriptional targets (Hurlbut et al., 2009). The fact that both EGFR and Notch are 
highly conserved pathways means that these highly regulated interactions are to the study of vertebrate 
development and human disease (Sundaram, 2005). Interactions between such highly dynamic 
pathways with context-specific outcomes can be challenging to assess because precise timing and 
spatial information can be difficult to capture with reporter assays or ectopic experiments. The specificity 
with which these interactions can be studied in higher resolution thanks to ongoing advances in genome 
editing and single-cell profiling techniques. These techniques can be applied to leg patterning where 
EGFR and Notch are activated in highly spatiotemporally dynamic and interrelated patterns, but their 




1.3: cis-regulation of gene expression 
As organisms grow and develop from one cell to many those cells must take on new identities 
that differ from other groups of cells in order to carry out specialized functions. Spatiotemporal 
regulation of gene expression is crucial for this differentiation as well as for a cells ability to sense and 
respond to their environments in order to maintain homeostasis. Enhancers, the best studied class of 
non-protein-coding DNA cis-regulatory elements, are the components of the genome that integrate the 
signals that drive this differentiation. In response to developmental or environmental cues, trans-acting 
factors interact with these cis-regulatory modules (CRMs) to influence expression of target genes in a 
context-specific manner. This is thought to be achieved by formation of short- and long-range physical 
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contacts between CRMs and gene promoters that facilitate assembly of the protein machinery required 
for transcription. As this occurs in a coordinated fashion throughout the genome, a cell acquires its 
unique transcriptome and proteome, which determine its fate. While their importance has long been 
appreciated, the pervasiveness of enhancers in regulating biological functions has become clear since 
the complete sequencing of the human genome revealed just how little of our DNA is comprised of 
genes and just how much seemed to be “junk” (Pennisi, 2012). Yet, despite widespread appreciation for 




Enhancer Basics and Beyond 
cis-regulatory modular DNA elements (CRMs) are crucial for an organism’s ability to properly 
regulate expression of genes in response to developmental or environmental cues. Although they drive 
differentiation of cell types and are thus the basis for multicellular life, CRMs are present and important 
in all kingdoms and have been a key force in driving the evolution of the morphological diversity of life on 
Earth. Even in prokaryotes and other single-celled organisms where cell-specific regulation of gene 
expression is not relevant, enhancer elements may function to increase the occupancy of promoters by 
Pol II (Ptashne, 1986). These non-protein-coding portions of DNA generally function to increase 
(enhance) or inhibit expression of a target gene or genes in cis by facilitating long-range interactions with 
target gene promoters and transcriptional machinery including RNA polymerase and proteins of the 
Mediator complex (Wildeman et al., 1984; Kadonaga, 2004). This is achieved by sequence-specific DNA 
binding of transcription factors that form a physical bridge between linearly distant genomic loci. In 
practice, the mechanisms by which CRMs regulate expression have proven to be highly varied and 
nuanced and these elements are quite resistant to having overarching rules applied to their function. 
CRMs have therefore been difficult to reliably detect in an unbiased yet efficient manner. 
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Enhancers are the most well-studied class of regulatory element because their action is 
theoretically straightforward to detect. However, CRMs can and do participate in various other modes of 
regulation that have been more difficult to observe and readily characterize with standard assays. A DNA 
element may act in cis to repress gene expression. It may drive weak expression or act redundantly with 
other CRMs in a manner that is not readily observable from reporter assays. Further, CRMs may contact 
other non-coding DNA in order to stabilize interactions or to assemble important regulatory factors and 
need not necessarily contact the promoter. Indeed, so-called enhancers may only act as such in certain 
developmental contexts and instead perform many regulatory roles in different cells at different time 
points (Webber and Rebay, 2014). Enhancers can also be counted as a class of non-coding RNA as 
many regulatory loci have been found to be transcribed in vivo; however, other than being positively 
correlated with highly expressed loci, the functional importance of eRNA transcript itself is still an open 
question (Li et al., 2016). We still have much to learn about the mechanisms by which non-coding DNA 
regulates gene expression, particularly in the context of endogenous genomic loci, but some key 
features are common among CRMs.   
Enhancers appear to be able to function regardless of distance from or orientation with respect 
to the target gene (Ptashne, 1986; reviewed in Smallwood and Ren, 2013) and have been found to occur 
tens or even hundreds of kilobases away from the promoter or even on different chromosomes, although 
this is relatively rare (Spitz and Furlong, 2012). Further, while chromatin state can influence the ability of 
enhancers to drive expression, CRMs can regulate expression independent of the target promoter or 
local sequence context. Indeed, this has been considered a kind of gold standard for functional 
characterization of a given sequence as an enhancer: its ability to drive expression of a reporter gene 
(reviewed in Shlyueva et al., 2014). However, some recent studies indicate that ability to drive gene 
expression may be strongly affected by the 5’ or 3’ orientation of an enhancer with respect to the coding 
sequence of its target gene or by other aspects of its endogenous genomic locus which may necessitate 
reevaluation of the utility of reporter assays to identify enhancers (Galindo et al., 2011; this study). 
 
 24 
Finally, enhancers act as “modules”. Individual stretches of DNA function as one unit in a 
specific context that interacts, often in complex ways (additively, redundantly or in competition), with 
promoters or other CRMs in order to influence expression at a given locus (Figs. 1.5 & 1.6). Modularity of 
an enhancer element likely depends on its ability to be bound by specific combinations of transcription 
factors that, as a complex, permit its regulation of gene expression. Mutagenesis experiments have 
demonstrated that disruption of TF binding at enhancers can dramatically affect ability to drive gene 
expression (see Chapter 2). This modularity is what permits enhancers to function as so-called “drivers” 
of tissue-specific expression patterns out of their endogenous genomic context and has served as an 
invaluable tool exploited for genetic studies in model organisms using binary systems such as UAS-
GAL4; reviewed in (Shlyueva et al., 2014).  
The nature of this modularity can be explored in detail now that precise and highly specific 
modification of the genome is feasible. An enhancer’s endogenous locus with respect to its target gene, 
neighboring CRMs or other genomic features is a far more nuanced and complex context than reporter 
assays which, while crucial for identifying and characterizing individual enhancers, remove the 
complexity inherent in a multiple-CRM system. Examination of a CRM in an exogenous context may 
preclude discovery of crucial regulatory mechanisms that can only be appreciated in an intact genome. 
For example, the incidence of clusters of CRMs at dynamically expressed loci, sometimes referred to as 
super-enhancers, may represent a particularly conspicuous example of a more common regulatory 
phenomenon where multiple enhancers are necessary for proper gene function (Hnisz et al., 2013; 2015). 
Improving our understanding of enhancer function in situ is a necessary next step in discerning how 
animals develop and how cell and tissue homeostasis is maintained. 
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Figure 1.5: Features of enhancers 
 
 




Any given enhancer may or may not conform to the ideal characteristics described above and 
the variation inherent in the way real enhancers function has made reliable prediction and identification 
of functional enhancers challenging. The linear distance between a CRM and its target promoter makes 
assignment of a given enhancer to a gene difficult, particularly in large genomes or gene-rich regions. 
One cannot necessarily simply search near a gene of interest and expect to find its enhancers. Further, 
despite a requirement for specific binding by transcription factors, nucleotide sequence is far less 
constrained in regulatory DNA than in coding regions and thus conservation between divergent species 
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may not always correlate with functional CRMs. Additionally, ChIP studies have demonstrated that many 
transcription factors bind thousands of sites across the genome, yet a relatively small subset represent 
functional binding events in a given tissue (Grossman et al., 2017). Finally, histone modifications found to 
be enriched in enhancer and promoter regions may indicate a permissive chromatin state for the 
presence of an enhancer (Fig. 1.5) but are not necessarily strongly predictive as chromatin state is also 
thought to be highly dynamic during development (McKay and Lieb, 2013) and so high-resolution 
assessment would be necessary to predict enhancers thought to be equally dynamically regulated. 
Combination of multiple parameters can improve the predictive power of traditional sequence-gazing 
and enhancer bashing approaches which are often used in a low-throughput manner to identify 
enhancers in specific regulatory contexts, but the efficacy of such an approach is highly variable. 
Recent advances in functional genomic approaches such as ChIP, DNAse hypersensitivity and 
3C-based assays (in combination with next generation sequencing), targeted genome engineering, and 
high-resolution imaging have permitted high throughput identification of CRMs and investigations into 
the biophysical mechanisms of their function at and between loci as well as within the nucleus at large. 
These studies offer fascinating insights into the possible roles enhancers may play in regulating 
transcriptional programs at the level of the entire genome. The most prominent model for enhancer 
activity is that CRMs bound by appropriate transcription factors loop to form physical contact with 
transcriptional machinery at or near gene promoters (Fig. 1.5). A number of factors are thought to play 
important roles generally in facilitating or stabilizing looping such as CTCF and Cohesin (Sanyal et al., 
2012). There may be other, looping-independent functions for enhancer loci that serve as assembly 
areas for factors important to alter chromatin state and thereby permit transcription of nearby genes 
without necessarily forming physical interactions with distal loci (Bulger and Groudine, 2011). While the 
looping model is easy to picture for a simple, individual locus, it necessarily prompts the question of how 
distant loci find the correct partner to form physical interactions in a nucleus densely packed with DNA, 
proteins and other molecules.  
Several important mechanisms are thought to promote enhancer-promoter specificity in addition 
to transcription factor binding including chromatin state, the presence of insulators and the organization 
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of the genome into cell type-invariant topologically-associated domains (TADs). These physical 
constraints on genome arrangement and dynamics limit the available interaction partners for a given 
enhancer (Fig. 1.6; reviewed in Dekker et al., 2013; van Arensbergen et al., 2014). Beyond limiting 
potential interactions, tightly-regulated organization of the genome may also contribute significantly to 
the regulation of genes in differentiated cells. Co-regulated loci are often found to co-localize within the 
nucleus into so-called transcription “factories” or hubs (Schoenfelder et al., 2010a; 2010b). These 
regions of active gene expression are often located in the interior of the nucleus with the nuclear 
periphery as a comparatively transcriptionally inactive region (Kohwi et al., 2013). These genomic 
phenomena (chromatin composition, genome and sub-nuclear organization) certainly facilitate regulation 
of gene expression via enhancers but enhancers themselves may also play a role in establishing and 
regulating these mechanisms; reviewed in (Shlyueva et al., 2014). 
 
Figure 1.6: Distinct mechanisms can drive promoter–enhancer interaction specificity 
 
 
from van Arensbergen et al., 2014 
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Approaches for CRM Identification and Functional Characterization 
 The features of enhancers described in the preceding sections have been identified 
based on the study of functionally validated enhancers across taxa and a number of large databases are 
dedicated to collecting and annotating these regulatory elements: FlyLight (Jenett et al., 2012; Jory et 
al., 2012); ModENCODE (ENCODE Project Consortium, 2012); the Roadmap Epigenetics Project 
(Chadwick, 2012) and GeneHancer (Fishilevich et al., 2017) to name a few. The complete sequencing of 
the genomes of numerous divergent species has made comparisons of sequence conservation relatively 
simple and this can be instructive to a certain extent. Sequence conservation alone can be useful in 
identifying relatively evolutionarily static regulatory loci but because there is less sequence constraint on 
regulatory as compared to protein-coding loci, is biased against identification of more dynamic loci 
which may still be functionally important (Richards et al., 2005). Further, regulatory transcription factors 
may not require high-affinity binding sites as collections of relatively weak predicted motifs can achieve 
the necessary level of activator binding while still permitting this binding to be dynamic enough to 
respond to transient cell signalling that facilitates rapid and sensitive control of gene expression by 
enhancers in response to the environment ( Evans et al., 2012; Crocker et al., 2015). This contributes to 
the relative fluidity of nucleotide sequence found in regulatory elements as compared to coding DNA 
which has allowed enhancers to drive significant morphological evolution, but confounds attempts to 
identify CRMs based on sequence homology even when regulatory transcription factors are thought to 
be shared. Instead, functional genomic approaches, particularly when assessed in combinations, are 
more fruitful in identifying putative regulatory regions because they allow querying of enhancer features 
at multiple levels beyond sequence.  
Based on their crucial function in regulating gene expression the importance of identifying 
enhancer elements in the genome is clear. However, these functional characteristics, i.e. the ability to 
influence gene expression, did not initially permit any type of general or high throughput screening 
approach to identify large numbers of enhancers. Instead, a number of biochemical features of 
enhancers have been identified that permit enhancer prediction. Enhancers are marked by nucleosome 
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depletion (Sabo et al., 2006). Chromatin accessibility is a permissive characteristic of an enhancer locus 
because function relies on the ability of trans-acting factors to bind and facilitate contact between the 
CRM and its target gene promoter. Further, enhancer-adjacent loci are enriched for certain histone 
modifications that define not only open chromatin but also enhancer (or promoter) “state” (including 
H3K4me1 + H3K27ac) (Azuara et al., 2006; Bernstein et al., 2006; reviewed in Sakabe et al., 2012). 
However spatio-temporal regulation of chromatin accessibility in the context of development is an 
ongoing field and accessibility is thought to change rapidly as cell fate is specified (McKay and Lieb, 
2013).  
Open chromatin is important for enhancer function so that the DNA can be bound by key trans-
acting factors that facilitate its interaction with the target gene promoter and transcriptional machinery 
(Deng et al., 2012; Sanyal et al., 2012). There are a number of models for how transcription factor 
binding may determine enhancer activity and how the grammar of arrangement of binding motifs 
facilitates the assembly of this “enhancer-ome” (Arnosti and Kulkarni, 2005; van Arensbergen et al., 
2014). However, clusters of binding sites of key factors has proven to be a productive approach for de-
novo identification of enhancers (Markstein et al., 2004; Moorman et al., 2006; this study). Further, 
collections of enhancers identified in this way can also serve as a training set of sequences for 
identification of new or non-canonical binding motifs for unknown or poorly characterized transcription 
factors (Guo et al., 2012; Kheradpour and Kellis, 2014). ChIP data is a useful tool for assessing the 
binding landscape of known activators across the whole genome and generation and combination of 
many of these data sets can identify enhancers, however such data is prone to false positives, 
particularly in highly transcribed loci (Blow et al., 2010; Teytelman et al., 2013). A number of  high 
throughput approaches leverage enhancer-associated biochemical characteristics including chromatin 
state (enhancer/promoter epigenetic marks, methylation), chromatin openness (DNAseI hypersensitivity, 
ATAC-seq), pioneer or tissue-specific transcription factor binding (ChIP-seq), and more recently RNA-
seq to identify transcribed enhancer loci (eRNA transcription is positively correlated with active 
enhancers) to correlate marks of active enhancers with gene expression (Sanyal et al., 2012; Savic et al., 
2015; reviewed in Engel et al., 2016).  
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Many of these techniques are limited by the fact that they identify only putative regulatory 
elements which then must be functionally validated. Large sets of CRM sequence can be leveraged for 
unbiased bioinformatic identification of enriched features such as known or novel TF binding motifs. 
However, in order to use large sets of identified regulatory DNA elements to refine our understanding of 
the determinative characteristics of these elements we must avoid diluting such datasets with 
sequences that are merely correlated with characteristics of regulatory DNA yet are not functional in 
vivo. ChIP related approaches, for example, are confounded by the observation that although many 
transcription factors bind thousands of sites throughout the genome, few appear to be functionally 
relevant in a specific cell type. Further, open chromatin may represent a permissive state rather than an 
indicator of active enhancers as distinct tissues may have highly similar patterns of open chromatin at 
the same developmental time point (McKay and Lieb, 2013). This issue could be resolved by refining 
single-cell versions of many high-throughput functional genomic approaches as many enhancers have 
highly dynamic and constrained spatiotemporal activity. Still, functional genomic approaches used in 
combination can reliably identify large numbers of likely regulatory elements for downstream functional 
analysis. 
Recently, approaches that leverage the 3-dimensional structure of loci and organization of the 
entire genome within the nucleus have been used to identify CRMs in an unbiased manner. These so-
called chromatin-conformation capture (3C) techniques rely on cross-linking of physically interacting loci 
and subsequent sequencing in order to map long-range genomic interactions (Dekker et al., 2013; 
Dekker and Misteli, 2015). Combination of functional genomic assays that identify sequences based on 
enhancer-associated properties of loci with variants on 3C (reviewed in de Wit and de Laat, 2012) can 
help to distinguish passive or stochastic interactions from active enhancers that are likely to influence 
gene expression (reviewed in van Arensbergen et al., 2014). Still, many of these high-throughput 
approaches rely on properties of enhancers other than their defining characteristic, the ability to 
influence target gene expression, and so may generate false positives. 
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Recently, the desire to identify regulatory elements on a large scale based on their ability to 
enhance or suppress the expression of a target gene has driven the development of high-throughput 
reporter techniques like enhancer/suppressor-FACs-seq (Gisselbrecht et al., 2013), CRE-seq 
(Kwasnieski et al., 2012) and STARR-seq (Arnold et al., 2013). These techniques permit assessment of 
the expression of large libraries of identifiable DNA fragments and so are inherently more effective at 
identification of functional CRMs than techniques that rely on biochemical qualities of candidate 
fragments. However, these high-throughput reporter approaches are still limited because it is difficult to 
assess an enhancer’s ability to affect gene expression in the endogenous locus and in a biologically 
relevant tissue-specific spatio-temporal manner. Although techniques exist to improve the efficiency of 
traditional locus scanning and cloning techniques that are traditionally used to identify tissue-specific 
functional enhancers (see Voutev and Mann, 2016), most are still relatively time-consuming, expensive or 
unreliable. 
There are advantages and limitations to the use of individual CRM characteristics to predict 
functional enhancers in an unbiased fashion. Although biochemical properties common to regulatory 
DNA can be used to identify putative enhancers these are necessarily distinct from CRMs that have 
been validated by testing their ability to drive expression. Recently, the improvement of approaches to 
assay genomic interactions allows the integration of biochemical and physical/functional characteristics 
of enhancers to improve the reliability of predictive methods. A number of approaches described in this 
section have been developed and refined in the past several decades to identify enhancers; however, 
despite their ubiquity in all forms of life (Banerji et al., 1981; 1983) and their importance for proper 
cellular and organismal function, enhancers are still difficult to reliably find. Also, other than the basic 
characteristics listed above, we still fall short of being able to describe overarching mechanistic 





Enhancers in Evolution and Disease 
 Enhancer-like features of the genome are not limited to multicellular life. In fact, the first CRM 
elements described were in viruses (Banerji et al., 1981). As life has evolved, so have the applications of 
enhancers for regulating gene expression during development and maintenance of homeostasis and 
they have been utilized to great effect by multicellular organisms to drive differentiation that produced 
the variety of developmental forms we see represented across taxa (Rubinstein and de Souza, 2013). 
Indeed, the number of annotated enhancers in the human genome far exceeds the number of protein-
coding genes. The number of genes identified as a result of the Human Genome Project was surprisingly 
small to many scientists interested in cataloging the landscape of the newly sequenced genome or in the 
genetic basis for the diversity of life on Earth (Pennisi, 2007; Science2003). The dynamic regulation of 
gene expression made possible by context-responsive CRMs greatly expands the number of diverse 
combinations of gene products that allow cells to take on new roles and identities within organisms or in 
response to stresses, thus driving evolution. 
Drosophila are an excellent system in which to study enhancer function because, while flies have 
many of the attractive qualities of more primitive model organisms (cheap, easy to maintain and a 
relatively short lifespan) they also display complex body plans and behaviors which gives rich output for 
assaying the tissue specific and dynamic nature of enhancers. In addition, there is an extensive genetic 
toolkit available for use in flies that makes transgenics easy and reliable. Although mechanisms of 
enhancer function appear to be well-conserved across diverse taxa, there are some key differences in 
how enhancers regulate gene expression in different systems. Particularly in flies, cis-regulation might 
not always be so. Drosophila CRMs can sometimes act not only on the target gene promoter in cis but 
also on the homologous promoter; a phenomenon referred to as transvection (Lewis, 2015; Fukaya and 
Levine, 2017). And while the frequency of occurrence of transvection differs between loci in the 
Drosophila genome it is fairly widespread. However, this phenomenon is not common in higher 
organisms (Chen et al., 2002). The chromosomal kinetics involved in transvection may be important in 
certain X-chromosome inactivation contexts in higher organisms or in the looping dynamics that 
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insulators undergo in the formation of TADs (Fujioka et al., 2016; reviewed in Fukaya and Levine, 2017). 
The relevance of CRMs acting in trans for gene expression and development as a general mechanism in 
animals is yet to be determined, however it is important to consider differences in the regulatory biology 
of various model organisms when drawing broad conclusions about enhancer function. 
For some of the same reasons that enhancers have been a powerful substrate for driving 
evolutionary change, these sequences can be equally powerful for affecting gene expression and the 
functions in biological systems to cause disease. Mutations affecting the coding sequence of genes can 
prevent the production of functional gene products and so it is easy to appreciate the role such variants 
might play in in causing or increasing susceptibility to genetic disease. Discoveries about the importance 
of non-coding DNA in regulating gene expression and thus developmental and homeostatic processes 
has coincided with observation of and increased appreciation for the relationship of these sequences to 
biological dysfunction. The concurrent rise of functional genomic approaches has permitted high-
throughput investigations of a number of relevant aspects of the genome in both wild-type and disease 
states. Integration of such data-sets has permitted identification of correlations between known or 
predicted enhancers and disease-associated variants or genes (Oki et al., 2013). 
Specifically, recent work has shown that single-nucleotide polymorphisms (SNPs) that are 
associated with risk for various diseases in genome-wide association studies often lie within promoters 
or tissue specific enhancers (Huang et al., 2013; Sur et al., 2012; Sur and Taipale, 2016; Wang et al., 
2018; reviewed in Corradin and Scacheri, 2014; Sur and Taipale, 2016; Wang et al., 2018). Beyond 
causal variants, variations in enhancer sequence that permit function under normal circumstances but 
contribute to sub-optimal function in response to stress conditions are particularly relevant for prediction 
of predisposition to disease or drug resistance (Webster et al., 2014; Yashiro-Ohtani et al., 2014). Such 
variants that affect an individual patient’s prognosis or that could inform decisions about therapeutic 
interventions will be of interest as the field of personalized medicine expands (reviewed in Sakabe et al., 
2012). 
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Also, despite limited evidence about the biological relevance of eRNA, this type of ncRNA has 
recently been implicated in human disease (reviewed in Ren et al., 2017). One proposed explanation for 
the prevalence of expressed enhancer loci transcription is that transcription itself contributes to 
maintaining enhancer function or chromatin state and the transcript itself may be dispensable at some 
loci (Kaikkonen et al., 2013; Mikhaylichenko et al., 2018). However, recent studies find that some eRNAs 
appear to contribute to genome instability through the formation of RNA-DNA complexes known as R-
loops (reviewed in (Li et al., 2016). This function may play a role in generating antibody diversity in 
healthy cells but could contribute to malignancy when improperly regulated (Qiu et al., 2018). Far from 
“junk” DNA, cis-acting and transcribed non-protein-coding genomic elements are now at the forefront of 
research aimed at understanding the regulatory mechanisms of the cell in developmental, homeostatic 
and disease contexts (Feeley and Edmonds, 2018). 
 
 
1.4: Concluding remarks 
 This project represents the synthesis of the three fields summarized in this introduction. We 
aimed to uncover how an important signalling pathway was regulated via cis-acting DNA elements in 
order to pattern a functional, segmented fly leg. In Chapter 2, we identify leg-specific enhancers 
upstream of two key EGFR inputs and describe the molecular mechanisms by which these CRMs are 
regulated in the developing leg. In Chapter 3, based on foundational work from the Campbell and Couso 
groups (Campbell, 2002; Galindo et al., 2005), we describe our efforts to further characterize the specific 
components of the EGFR signalling pathway active in the leg imaginal disc and propose a revised model 
for its role in tarsal patterning. Taken together, these chapters expand on existing models of leg 
patterning and provide interesting insights into how tissue-specific enhancers are regulated by 
transcription factors. The Appendices present the results of additional experiments to identify or 
characterize cis-regulatory elements of Distal-less and other genes downstream of EGFR signalling in 
the leg. 
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CHAPTER 2: cis-regulatory architecture of a local 
EGFR organizing center in the Drosophila 
melanogaster leg 
 
Note: Chapters 2 and 3 of this dissertation are derived from a manuscript that has been submitted for 
publication. Specifically, the data presented in Figures 2.1 – 2.4 and 2.6 – 2.7 were included in the 
manuscript. I have written new introductions and discussions for each chapter and have included 
additional information in the results and materials/methods sections where appropriate. Supplementary 
tables and figures can be found in Appendices 3 & 4. 
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Animal development relies on the establishment of organizing centers that control growth and 
patterning by regulating the expression of secreted signalling molecules. We elucidated the molecular 
mechanism that establishes an Epidermal Growth Factor Receptor (EGFR) organizing center (EOC) in the 
distal leg imaginal disc during larval development in Drosophila melanogaster. Initial EGFR activation 
occurs by expression of the EGFR ligand Vein (Vn) and the EGFR ligand-processing protease Rhomboid 
(Rho), each through single enhancers, vnE and rhoE, that integrate independent inputs from Wingless 
(Wg), Decapentaplegic (Dpp), Distal-less (Dll) and/or Sp1. These activators or their downstream effectors 
act directly by binding these enhancer elements, as mutations that disrupt binding abolish vnE and rhoE 
reporter expression. The set of regulators that activate expression via these enhancers is highly similar 
to the mechanism that activates Dll expression via the Dll-LT CRM and may represent a common 
regulatory logic among genes expressed during leg development. 
 
2.2: Introduction 
 The development of multicellular organisms relies on regulation of gene expression in a tissue-
specific manner by cis-regulatory modules (CRMs). These non-protein coding DNA elements integrate 
developmental and environmental cues when specific sets of transcription factors bind and facilitate 
transcription of target genes. This transcriptional program gives a cell or tissue its specific identity 
(reviewed in Levine, 2010). As heritable factors that govern and modulate the combinations and levels of 
gene products that are expressed in specific cells, enhancers have been crucial in driving the evolution 
of morphological diversity of living things. 
 The segmented leg of the fruit fly Drosophila melanogaster offers an excellent model in which to 
study the way in which regulation of gene expression by CRMs can affect patterning in animal 
development. Many of the signalling pathways important for leg development and patterning have been 
identified and their regulatory relationships have been characterized in detail providing a system in which 
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to evaluate the importance of these signals for activating leg patterning genes via CRMs (reviewed in 
Estella et al., 2012). The fly leg is specified during embryonic development when the expression of 
transcription factors Distal-less and Sp1 is activated in a small circular patch of cells in each of the six 
thoracic hemisegments (Cohen, 1990; Estella et al., 2003; Estella and Mann, 2010b). The radius of this 
patch of cells corresponds to the proximal-distal (P-D) axis of the future adult leg (Fig. 2.1A). 
The developing leg continues to be patterned in the larva where Dll expression is maintained in 
the distal domain via the Dll-LT CRM by combined activation of Wingless (Wg) and Decapentaplegic 
(Dpp) signalling as well as Dll and Sp1 (Figure 2.1A; (Campbell et al., 1993; Diaz-Benjumea et al., 1994; 
Lecuit and Cohen, 1997; Estella and Mann, 2008). Expression of the transcription factor Dachshund 
(Dac) is then activated by Dll in a medial ring domain which is encircled proximally by expression of the 
transcription factor Homothorax thereby establishing a rudimentary P-D axis along the entire length of 
the future leg (reviewed in Giorgianni and Mann, 2011; Estella et al., 2012). After the subsequent 
proliferation and growth in the leg disc the Dll and Dac domains come to overlap medially, further 
subdividing the future distal leg (Figure 2.1A).  
This initial P-D axis is established at the beginning of larval development. Not until the beginning 
of the third larval instar is the distal leg further patterned by activation of the Epidermal Growth Factor 
Receptor (EGFR) pathway resulting from the expression of two EGFR inputs: the ligand Vein (Vn) and the 
ligand-processing protease Rhomboid (Rho). EGFR activation is triggered by Wg and Dpp (Campbell, 
2002; Galindo, 2002). However, the molecular mechanisms that govern the activation of expression of 
individual EGFR inputs in the distal leg is not understood. We identified leg enhancers of the genes 
encoding vn and rho, vnE and rhoE, respectively and demonstrate that these CRMs are both necessary 
and sufficient for their target gene expression in the distal leg. We then performed extensive genetic and 
biochemical characterization of these enhancers and establish that they are directly regulated by Wg, 
Dpp, and Dll (and Sp1, in the case of vnE). Interestingly, this is the same set of regulators required to 
activate Dll expression earlier in leg development and may represent a common regulatory logic for the 




Identification and genomic manipulation of the vn and rho EOC enhancers 
To understand the molecular mechanism by which the EGFR signalling pathway is activated in 
the center of leg imaginal discs during larval stages, we searched for leg disc enhancer elements 
controlling the expression of EGFR ligands and ligand-processing proteases implicated to function in 
this process (Campbell, 2002; Galindo, 2005). We scanned the genomic regions of vn and rho using in 
vivo lacZ reporter assays (Fig.2.1B, G and Tables A1 and A2) and defined minimal enhancers (vnE – 654 
bp and rhoE – 544 bp) that recapitulate the expression pattern of these genes in the center of leg discs 
during development (Fig. 2.1C, H), as well as in the serially homologous antennal discs (Fig. 3.3A, B). 
The vnE- and rhoE-lacZ transgenes exhibited earlier expression (starting at ~71h PEL for vnE and ~82h 
PEL for rhoE; Fig. 2.1C, H) than detected by in situ for vn and rho (Fig. 2.1D, I), perhaps because of the 
greater sensitivity of the anti-ßgal staining, and suggest that the genes might be expressed earlier than 
previously thought (Campbell, 2002; Galindo, 2002; Campbell, 2005; Galindo, 2005).   
To assess the requirement of the vnE and rhoE CRMs for vn and rho expression, we deleted 
them from their native genomic loci using CRISPR/Cas9-mediated genome editing (Gratz et al., 2013; 
Kondo and Ueda, 2013; Port et al., 2014; see Methods) and assessed the phenotypes of these alleles 
(vnvnE-Df and rhorhoE-Df). We found that these deficiencies abolished the expression of these genes, 
respectively, only in the EOC of the legs and antennae (Fig. 2.1E, J and data not shown). The lack of 
expression in the enhancer deletion alleles was restored when the wild type enhancers were resupplied 
in their native genomic positions (Fig. 2.1F, K). Therefore, we conclude that vnE and rhoE are necessary 
and sufficient for vn and rho expression in the EOC, respectively.  
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(A) Schematic representation of the establishment of an initial PD axis, EOC and medial EGFR activiity in the leg, and target gene 
expression domains 
(B) Schematic representation of the vn genomic locus on chromosome 3L; enhancer bashing fragments for identification of vnE 
represented in tan did not drive expression in leg discs, dark red drove expression in leg discs and bright red designates the 
minimal enhancer used for further analysis; the vnvnE-Df CRISPR deletion is represented by red bracketed bar.  
(C) Time-course analysis of the expression pattern of vnE-lacZ reporter gene. In young discs, expression is limited to the EOC, 
while in late L3 additional expression appears in medial rings. 
(D-F) In situ analysis of vn expression in 3rd instar leg discs with genotypes: WT (D), vnvnE-Df (E; a wing disc from the same genotype 
serves as a positive control). vnvnE-WT, in which RMCE was used to re-introduce the wild type CRM (F). Arrowheads indicate the 
presence (filled) or absence (open) of EOC vn expression, arrows indicate non-EOC medial expression. 
(G) Schematic representation of the rho genomic locus on chromosome 3L; enhancer bashing fragments for identification of rhoE 
represented in tan did not drive expression in leg discs, dark red drove expression in leg discs and bright red designates the 
minimal enhancers used for further analysis; rhoEMIN was only used for enhancer mutagenesis; rhorhoE-Df CRISPR deletion is 
represented by the red bracketed bar.   
(H) Time-course analysis of the expression pattern of rhoE-lacZ reporter gene. In young discs, expression is limited to the EOC, 
while in late L3 additional expression appears in medial rings. 
(I-K) In situ analysis of the rho expression pattern in 3rd instar leg disc with genotype: WT (I), rhorhoE-Df (J, an eye disc from the same 
genotype serves as a positive control), rhorhoE-WT, in which RMCE was used to re-introduce the wild type CRM (K). Arrowheads 
indicate presence (filled) or absence (open) of EOC rho expression, arrows indicate medial expression and “C” indicates 
chordotonal organ precursor expression. Scale bar = 100µm in all figures. 
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Genetic regulation of vnE and rhoE  
 Previous studies have underscored the importance of the Wg and Dpp pathways for EGFR 
activation in the center of leg discs (Campbell, 2002; Galindo, 2002). Using the vnE and rhoE enhancer 
elements, we have been able to address this question in greater detail. We generated mutant clones of 
arrow (arr), an obligate co-receptor in Wg signalling, and Mothers against dpp (Mad), a downstream 
effector of Dpp signalling, at different time points and assessed the requirement of these pathways for 
vnE and rhoE activation. Both Wg and Dpp pathways are necessary for the initiation of vnE-lacZ 
expression in late L2 larval stage (Fig. 2.2A, E), while clones made early in L3 stage did not affect vnE-
lacZ expression (Fig. 2.2B, F). rhoE-lacZ expression was lost when either Wg or Dpp activity was 
removed during L2 or early L3 (Fig. 2.2D, H) but became independent of these pathways later in mid-L3 
(Fig. 2.2C, G). 
 In addition to Wg and Dpp, at the early larval stages of leg disc development there are two other 
factors known to be crucial for leg specification and growth – the homeodomain transcription factor 
Distal-less (Dll) (Cohen and Jürgens, 1989) and the Zn-finger transcription factor Sp1 (Estella et al., 2003; 
Estella and Mann, 2010b). Dll mutant clones induced at any larval stage abolished vnE-lacZ expression 
(Fig. 2.2I and data not shown). In addition, ectopic expression of Dll activated vnE not only in leg discs 
but in other imaginal discs as long as Wg and Dpp were available in these tissues at the time of clone 
induction (Fig. 2.3A, B, C). These results suggest that Dll is required for vnE activity. Similarly, rhoE-lacZ 
expression also required Dll at all developmental times (Fig. 2.2K and data not shown).  
 We also examined the requirement of Sp1 for vnE and rhoE activation. We found that vnE 
activation requires Sp1, either when the entire animal was mutant or in clones (Fig. 2.2J and Fig.2.3D). 
This requirement is not mediated by Dll because Dll expression remained intact in mutant clones (Fig. 
2.2J) and in leg discs from Sp1- homozygous animals (Fig. 2.3D). In contrast, Sp1 was dispensable for 
rhoE-lacZ expression (Fig. 2.2L and Fig. 2.3F). In addition, although Sp1 is required for the activation of 
vnE at L2 larval stage (Fig. 2.2J and Fig. 2.3D), at the beginning of L3 larval stage Sp1 was no longer 
required for vnE (Fig. 2.3G). We also assessed if vnE and rhoE are regulated by buttonhead (btd), an Sp1 
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paralog that is co-expressed with Sp1 in leg discs (Estella and Mann, 2010b). We found that neither EOC 
enhancer requires btd (Fig. 2.3G, H) and it is unlikely that rhoE requires both Sp1 and Btd redundantly 
since we did not detect Sp1/Btd binding sites or in vivo binding at rhoE for Sp1. Together, these results 
support a model in which vnE activation requires Wg and Dpp together with Dll and Sp1; later, vnE 
activity becomes independent of Wg, Dpp and Sp1, but still requires Dll (Fig. 2.2Q). Similarly, although 
the timing differs, rhoE requires initial input from Wg, Dpp, and Dll but later only requires Dll for its 
maintenance (Fig. 2.2R). These differences in the timing of onset of expression might be explained by 
the differences in the requirement for Sp1. Additionally, differences in TF occupancy between vnE and 
rhoE may make these CRMs differently sensitive to the same levels of a given TF; vnE may act earlier 
because it has more functional binding sites for a given regulator. 
 To investigate if positive feedback from EGFR is required for vnE and rhoE, we examined the 
expression driven by these CRMs in the background of mutants for EGFR pathway components. vnE- 
and rhoE-driven expression was normal in pnt∆88 (Scholz et al., 1993) mutant clones or Egfrtsla (Kumar et 
al., 1998) mutant clones at the restrictive temperature (Fig. 2.2M, N, O, P). Further, neither vnE nor rhoE 
were upregulated in ectopic clones expressing a constitutively dimerized form of EGFR, Egfrλtop 
(Queenan et al., 1997; Fig 2.5 E,F). Capicua (Cic), another downstream component of EGFR (Roch et al., 
2002), is expressed in leg discs (Fig. 2.3I) but mutant clones also did not affect vnE and rhoE activity (Fig 
2.3J, K).  
  
 





(A-P) lacZ reporter gene expression driven by vnE or rhoE in mutant clones as indicated. Absence of GFP marks the clone. Insets are 2x scale compared to disc images. 
(A) vnE in arr2 clones generated 48h PEL;  
(B) vnE in arr2 clones generated 72h PEL;  
(C) rhoE in arr2 clones generated 72h PEL; 
(D) rhoE in arr2 clones generated 90h PEL;   
(E) vnE in Mad1-2 clones generated 48h PEL;  
(F) vnE in Mad1-2 clones generated 72h PEL;  
(G) rhoE in Mad1-2 clones generated 72h PEL;  
(H) rhoE in Mad1-2 clones generated 90h PEL;  
(I) vnE in DllSA1 clones generated 48h PEL.  
(J) vnE in Sp1HR clones generated 48h PEL;  
(K) rhoE in DllSA1 clones generated 48h PEL;   
(L) rhoE in Sp1HR clones generated 48h PEL;  
(M) vnE in pnt∆88 clones generated 48h PEL;  
(N) vnE in Egfrtsla clones generated 48h PEL;  
(O) rhoE in pnt∆88 clones generated 48h PEL;  
(P) rhoE in Egfrtsla clones generated 48h PEL.  
(Q, R) Schematics summarizing vnE and rhoE regulation by inputs, respectively. 
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Figure 2.3: Additional genetic analysis of vnE and rhoE inputs  
(A-C) vnE-driven lacZ expression in wing discs in Dll ectopic overexpression clones in WT background (A); Dll ectopic 
overexpression clones in arr2 mutant background (B); Dll overexpression clones in Mad1-2 mutant background (C).  
(D-E) vnE-driven lacZ expression in leg discs of Sp1HR mutant animals (D); Sp1HR mutant clones generated at 72h PEL (E).  
(F) rhoE-driven lacZ expression in leg discs of Sp1HR mutant animals.  
(G-H) vnE- (G) or rhoE- (H) driven lacZ expression in btdXA mutant clones generated at 48h PEL.  
(I) cic-lacZ expression in leg discs.  
(J-K) vnE- (J) or rhoE- (K) driven lacZ expression in leg discs with cicQ474X mutant clones generated at 48h PEL.  
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We next carried out epistasis experiments using the MARCM technique (Lee and Luo, 2001) in 
which we overexpressed one vnE or rhoE input and removed another. We excluded Sp1 from this 
analysis because Sp1 sometimes affects Dll expression making results difficult to interpret (data not 
shown). For both vnE and rhoE, we found that while ectopic activation of Dll induced the activity of these 
enhancers in wildtype tissue (Fig. 2.4A, E, C, G), in clones compromised for either Wg or Dpp signalling 
neither vnE nor rhoE were activated by ectopic Dll (Fig. 2.4B, F, D, H). Dll was also unable to induce vnE-
lacZ expression in ectopic clones in other imaginal discs when Wg and Dpp signalling was compromised 
(Fig. 2.3C, D, E). Further, consistent with previous results (Campbell et al., 1993; Diaz-Benjumea et al., 
1994; Struhl and Basler, 1993), ectopic Wg and Dpp pathway activity induced vnE- and rhoE-lacZ 
expression and created additional EOCs in leg discs when these clones were located close to an 
endogenous source of Dpp and Wg, respectively (Fig. 2.4I, M, K, O). However, when these clones were 
also mutant for Dll, these pathways are not able to activate either vnE or rhoE, and hence EGFR 
signalling (Fig. 2.4J, N, L, P). 
Finally, we observe that the activators we have identified, such as Dll, are expressed in much 
broader domains than those of vnE and rhoE. In particular, because vn appears to be co-expressed with 
the distal leg markers C15, Aristaless (Al) and dLim1, we wondered if these transcription factors might 
be required to maintain vn expression in the center of the leg disc. We generated mitotic clones mutant 
for these factors in the distal leg as well as for the TF dac to assess the possibility of medial negative 
regulation. We find that vnE is unaffected in all of these clones (Fig. 2.5C-F) indicating none of these 
factors is individually required for vnE activity; however, removal of multiple distal activators at once 












(A-P) vnE- or rhoE-directed lacZ reporter gene expression in MARCM clones of:  
(A and C) Dll ectopic expression in WT background;  
(B and D) Dll ectopic expression in arr2 mutant background;  
(E and G) Dll ectopic expression in WT background;  
(F and H) Dll ectopic expression in Mad1-2 mutant background;  
(I and K) arm∆N ectopic expression in WT background;  
(J and L) arm∆N ectopic expression in DllSA1 mutant background;  
(M and O) tkvQD ectopic expression in WT mutant background;  
(N and P) tkvQD ectopic expression in DllSA1 mutant background. 
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lacZ reporter expression in clones ectopically expressing activated Egfr for vnE (A) and rhoE (B) 
lacZ reporter gene expression driven by vnE in mutant clones generated at 48h PEL lacking Al (C), C15 (D), Lim1 (E) and Dac (F). 
Clones indicated by absence of signal in green channel. 
 
Note on author contributions:  
RV performed the experiments in panels B and D. SN performed the experiments in panels A and C and made the figure. 
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Dissection of vnE and rhoE molecular inputs 
 
Our genetic analysis suggests a complex interplay between the signalling pathways Wg and Dpp 
and the transcription factors Dll and Sp1 on the vnE and rhoE enhancers. To investigate the 
configuration of binding sites and the transcription factor grammar of these CRMs, we searched for 
putative binding motifs using available position weighted matrices (PWMs) (Zhu et al., 2011) and 
computational methods for identifying consensus Pan (downstream effector of Wg signalling), Mad 
(downstream effector of Dpp signalling), Dll and Sp1 binding motifs (Sosinsky et al., 2003). We 
performed a comprehensive in vivo mutagenesis analysis for both enhancers (Fig. 2.6A, Table A2). This 
analysis revealed that vnE activation requires 14 Pan binding sites, 12 Mad sites, and 11 Dll sites (Fig. 
2.6A, B, D and Fig. 2.7A, B). In contrast, the rhoE enhancer required only 4 Pan, 3 Mad and a single Dll 
binding site (Fig. 2.6A, C, E). Curiously, in the case of Dll we found 5 additional putative sites in rhoE that 
were not required (Fig. 2.7E, Table A3). The dispensable Dll sites in rhoE still bind Dll protein in vitro and 
ectopic expression of Dll in animals mutant for the required site indicate that they may be capable of 
binding Dll in vivo but do not under wild-type conditions (Fig. 2.8). In general, the identified binding sites 
for the two enhancers had an additive effect on the expression levels of vnE and rhoE because partially 
mutated enhancers drove diminished levels of reporter expression (Fig. 2.7 A, B, C, D). We also 
confirmed the binding of the TFs involved in vnE and rhoE regulation by in vitro binding assays (Fig. 2.6F 
and Fig. 2.8A, B). 
Consistent with the genetic requirement for Sp1, we identified two putative Sp1 binding sites in 
vnE. However, when we mutagenized them reporter gene expression was unaltered (Fig. 2.6 B, D). 
Therefore, we scanned the enhancer by EMSA using overlapping fragments (Table A2) in order to 
identify additional Sp1 binding sites in an unbiased manner. We found that Sp1 binds with low affinity to 
some Mad binding sites (Fig. 2.6F, right-most panel) but not in a cooperative manner with Mad (data not 
shown). Because both Sp1 and Mad can bind to similar sequences, loss of vnE-lacZ expression when 
Mad sites are mutated may be a consequence of eliminating all Mad and some of the Sp1 inputs. 
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Because Sp1 and Dll are co-expressed during leg development, we also scanned all of vnE using 
overlapping oligos (Table A2) to determine if these proteins might bind cooperatively to DNA. For these 
experiments we used full-length Dll and nearly full-length Sp1 proteins (see Methods). Although these 
experiments confirmed Dll binding to its binding sites, we failed to detect any cooperative binding 
between Dll and Sp1 (data not shown).  Taken together, our results suggest that Sp1 regulates vnE 









(A) Schematic representation of binding sites in vnE and rhoE.   
(B) Expression pattern of WT vnE-driven expression and mutant vnE enhancer-driven expression.  
(C) Expression pattern of WT rhoE-driven expression and mutant rhoE enhancer-driven expression.  
(D) Quantification of WT and mutant vnE-driven expression levels in third instar leg discs (WT vnE n=41, 2xSp1 n=48, 14xPan 
n=24, 12xMad n= 32, 11xDll n=49 where n indicates number of leg discs analyzed). For normalization, fluorescence was calculated 
as a ratio of β-gal:Dll intensity in the center of the leg disc (see Methods for details). 
(E) Quantification of reduction of WT and mutant rhoE-driven expression in third instar leg discs (WT rhoE n=39, WT rhoEMIN n=35, 
4xPan n=78, 3xMad n= 61, 1xDll n=15 where n indicates number of leg discs analyzed). For normalization, fluorescence was 
calculated as a ratio of β-gal:Dll intensity in the center of the leg disc (see Methods and Table A4 and Table A6 for raw data and 
statistics) 
(F) EMSA analysis of selected WT vs mutant binding sites.  
 
 
Note on author contributions: 
RV made all binding site mutations in vnE and performed the initial assessment and imaging of expression levels. SN made all 
binding site mutations in rhoE and performed the initial assessment and imaging of expression levels. SN performed the 





Figure 2.7: Expression of partially mutant vnE and rhoE reporters 
 
(A, C, E) vnE- (A) and rhoE- (C, E) driven expression of WT and intermediately mutant CRMs.  
(B and D) schematic representation of binding sites in vnE and rhoE, respectively. Mutated sites for the CRM-reporter genes 
shown in A, C, and E are indicated by the *, † and ‡.  
(F) Quantification of expression levels; fluorescence was calculated as a ratio of b-gal:Dll intensity in the center of the discs. WT 
rhoEMIN n=23, 6xDll n=14, 1xDll n= 18, 5xDll n=27 where n indicates number of leg discs analyzed. (see Methods and Table A5 and 
Table A7 for raw data and statistics). 
 
Note on author contributions: 
RV made all binding site mutations in vnE and performed the initial assessment and imaging of expression levels. SN made all 
binding site mutations in rhoE and performed the initial assessment and imaging of expression levels. SN performed the 
quantification of fluorescence for all binding site mutants shown and made the figure. 
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Figure 2.8: Dispensable (putative) Dll sites in rhoE are functional in vitro and in vivo  
 
 
(A) Schematic representation of Dll binding motifs in rhoE 
(B) EMSA analysis of wild type and mutant Dll binding sites #5 and #2 
(C) Ectopic “flip-out” clone expressing Dll in a WT rhoE background 
(D) Ectopic “flip-out” clones expressing Dll in a site #5-mutant rhoE background 
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Regulatory logic of EGFR pathway activation 
 The EGFR signalling pathway is a potent activator of diverse cell outcomes that are crucial for 
normal development. As such it is often involved in diseases ranging from cancers to birth defects 
(Brandt et al., 2006; Kasahara et al., 2018). Preventing oncogenic upregulation of this pathway is a key 
therapeutic approach and so understanding the mechanisms by which this pathway may be activated is 
of broad scientific interest. The core components of EGFR signalling have been studied in detail in no 
small part because of their oncogenic potential. However, the mechanism of transcriptional regulation 
that governs how and when the genes encoding EGFR inputs are expressed are not well understood. 
Improving this understanding necessarily involves the identification and characterization of tissue-
specific CRMs, as these elements are crucial for a cell’s ability to interpret developmental and 
environmental cues in order to activate the appropriate transcriptional program. This is a key mechanism 
that permits a widely used signalling pathway like EGFR to achieve a particular developmental outcome 
in a cell-type specific manner (reviewed in Simon, 2000). 
Here we present a detailed characterization of CRMs upstream of the genes encoding the EGFR 
ligand Vein (Vn) and the ligand-processing protease Rhomboid (Rho). These CRMs are active in the 
distal leg, where EGFR signalling establishes an organizing center necessary to pattern the tarsus. 
Further, these CRMs are necessary and sufficient to drive expression of their respective target genes. 
These CRMs directly integrate cues from the transcription factors Dll and Sp1 as well as Wg and Dpp 
signalling effectors, signals already shown to be crucial for proper leg patterning, in a partially redundant 
manner in order to activate a signalling cascade along the P-D axis of the distal leg. While we have 
observed no requirement for positive feedback from EGFR inputs or downstream genes individually, it is 
still possible that these factors are important for maintaining vn or rho expression in their highly distally 
constrained patterns in the leg. Further analysis using clones mutant for combinations of distal EGFR 
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target genes al, C15 and Lim1 or for additional candidate medial repressors would help to complete the 
model for distally restricted activation of EGFR input expression. 
While vnE and rhoE are both activated by direct binding of Dll, Mad and Pan, they differ 
significantly in the occupancy of these TFs necessary for robust expression. Surprisingly, rhoE is not 
only low occupancy, but requires Dll binding at only a single site making it highly sensitive to mutations. 
We might hypothesize that lack of robustness might be compensated for by the presence of other 
ligand-processing proteases, however we find no evidence for expression of the rho homolog roughoid 
(ru) in the center of the leg disc (Fig. 3.5). Despite this sensitivity of rhoE, lack of rho expression in the 
distal leg does not affect leg patterning or viability because of compensation from vein. However, the 
importance of the expression or secretion of multiple EGFR ligands in a single tissue, beyond just 
redundancy, is still an open question. Further the relevance of the differences in the timing and exact 
pattern of expression between vein and rho in the distal leg is not understood. 
 
 
Broader applications of the EGFR input regulatory program 
The signals required to activate vnE and rhoE are the same as those required to activate Dll 
expression in the distal leg imaginal disc via the Dll-LT CRM. We hypothesize that this represents a 
commonly used regulatory cassette for activation of leg patterning genes and that this signature could 
be used, in combination with an assessment of open chromatin, to scan the genome for novel 
enhancers active in the leg. Rebecca Delker performed bioinformatic analysis to identify points of 
intersection of Dll and Sp1 ChIP binding peaks, Mad and Pan binding motifs in regions of open 
chromatin as determined by FAIRE analysis (McKay and Lieb, 2013). Roumen Voutev cloned 10% of the 
identified “intersection” peaks and tested them for the ability to drive reporter expression in the leg. We 
find that indeed these criteria are highly predictive of leg activity. We tested 23 of the 442 identified 
intersections (~5%) and find that 18 (or 78%) drive lacZ expression in leg discs (see Appendix 4.4). This 
demonstrates that our detailed characterization of the regulation of a small set of leg CRMs is highly 
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relevant not only for understanding their individual transcriptional programs but as an efficient approach 
for predicting functional CRMs that drive expression in related tissue-specific patterns. 
CRMs are less constrained by sequence conservation in divergent species than coding DNA and 
mutations that affect TF binding can be overcome by compensatory changes in neighboring sequence, 
which drives sequence changes over evolutionary time differently than in coding regions. The study of 
selection pressures on regulatory loci is impeded by the fact that the rules or logic for sequence 
constraint have not been well-established. However, sets of CRMs that are regulated by trans-acting 
factors in a recognizable regulatory organization have been used to successfully study how regulation of 
loci involved in a single developmental process has evolved over time (Crocker et al., 2008), There are 
likely to be homologous limb or EGFR-related enhancers in mammals and the model we establish here 
of a sequential activation of multiple EGFR ligands and leg patterning genes via tissue-specific CRMs 
may apply in those contexts. Moreover, understanding the specific ways in which important conserved 
signalling pathways converge on developmental CRMs has broad practical implications since the 
homologous mammalian pathways (BMP, Wnt, Shh and Dlx) are known to be important for regulating 
FGF signalling in the mammalian limb bud (Amano et al., 2009; Lettice et al., 2014; Rodrigues et al., 
2017). Our observations that these pathways directly regulate CRMs upstream of EGFR in Drosophila 
limb development are particularly important given that many cancer-associated single-nucleotide 
polymorphisms (SNPs) occur in non-coding regions upstream of EGFR ligands and therefore likely often 
affect gene expression by perturbing TF binding at enhancers ( Kristensen et al., 2006; Chaleshi et al., 
2013; Chen et al., 2014).  
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2.5: Chapter 2 Addendum - roughoid regulation in the leg 
Introduction 
The Drosophila genome encodes at least seven Rho-family proteases, the most commonly-used 
of which is Rhomboid (rho-1). However there are many tissues in which the rho paralog roughoid (ru or 
rho-3) is known to play an important role in activating EGFR signalling (Wasserman et al., 2000; Gallio et 
al., 2004). Despite earlier reports (Campbell, 2002), it seems that Ru does not play a key role in activating 
EOC ligands to pattern the distal tarsus (see Fig. 3.3K, L). However, although ru expression cannot be 
detected in the leg by in situ (Fig. 3.5F; Campbell, 2002), ru may be important for later EGFR activation 
along the P-D axis of the developing leg either for non-EOC tarsal patterning or later joint patterning 
along with Notch signalling, as leg disc expression can be detected from a lacZ enhancer trap, ruinga  
(Gallio et al., 2004). Supporting this possibility, we have identified a leg CRM upstream of ru that drives 
expression in a medial ring starting in mid L3 (Fig. 3.5E, H). Other studies of tissues in which multiple 
Rho proteases are expressed indicate that non-rho-1 Rhomboids (Rho-2 and Rho-3/Ru) can cleave the 
chaperone Star in addition to transmembrane TGF-α ligand and therefore may function to attenuate 
EGFR signalling by limiting the amount of ligand that is trafficked through the secretory pathway (Tsruya 
et al., 2007; Yogev et al., 2008). To facilitate a more detailed analysis of the roles of multiple EGF 
activating proteases in leg P-D patterning, we sought to compare the mechanism of genetic regulation 
of rhoE and ruinga in the leg.  
 
Results 
We performed preliminary experiments to characterize the regulation of roughoid using the ruinga 
lacZ enhancer trap, which drives expression in mid-late L3 leg discs. ruinga is maintained in arr- clones 
and in Sp1 mutant animals indicating that roughoid may not rely on these inputs for its expression (Fig. 
2.9A, C). The disc shown in Fig. 2.9C is third instar, but Sp1 mutant animals often show various 
perturbations of disc morphology. ruinga was absent in Mad- clones and upregulated in clones that 
ectopically express either Dll or an activated form of Tkv (Fig. 2.9 B, D, E).  
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Figure 2.9: roughoid regulation in the leg 
 
(A-B) ruinga-lacZ expression in mitotic clones lacking either Wg (A) or Dpp (B) signalling. 
(C) ruinga-lacZ expression in Sp1-null animals 
(D-E) ruinga-lacZ expression in ectopic clones of constitutively active Thickveins (D) or Distalless (E). 
 
Arrowheads indicate the location of clones. Gray arrowheads indicate the location of a clone that does not affect lacZ expression. 
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Of the set of regulators identified in the work presented in this chapter, ruinga appears to require 
Dpp inputs, and may require Dll input but is unaffected by removal of Wg signalling or Sp1. More 
experiments will be necessary to determine if this is representative of the true transcriptional program for 
the ru gene or whether the presence of the enhancer trap perturbs regulation. Further, a more exhaustive 
bashing of the ru locus may reveal additional fragments whose mechanism of regulation could be 
assessed along with that of ruLLE. As will be discussed further in the following chapter, deletion of the 
ruLLE CRM alone or in combination with other medial ring drivers of EGFR inputs may produce a tarsal 
patterning phenotype that would more clearly implicate Ru in this process. In any case, targeting of all 
rho-adjacent CRMs is an important first step to performing chromatin conformation capture assays 
aimed at reliably assigning CRM-promoter physical interactions. This is an important question to answer 
for any CRM, but more important for closely-spaced paralogs which may be regulated by some of the 
same enhancers (Ibn-Salem et al., 2017). Any of these enhancer studies would be complimented by a 
more sensitive method to detect endogenous ru gene product via smRNA-FISH, by raising an antibody 
against Ru or by using CRISPR-mediated genome editing to tag the endogenous protein so that 
perturbations can be assessed not only for a downstream effect on EGFR targets or leg patterning, but 
more directly for an effect on ru expression. 
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CHAPTER 3: A multi-source model of EGFR activation 
in the tarsus  
 
Note: Chapters 2 and 3 of this dissertation are derived from a manuscript that has been submitted for 
publication. Specifically, the data presented in Figures 3.2, 3.3, 3.5 and 3.6 were included in the 
manuscript. I have written new introductions and discussions for each chapter and have included 
additional information in the results and materials/methods sections where appropriate. Supplementary 
tables and figures can be found in Appendices 3 & 4. 
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 Activation of EGFR signalling to achieve tissue-specific outcomes requires expression of 
multiple inputs in precise spatio-temporal patterns. The exact combination of inputs differs between 
developmental contexts to modulate downstream signalling that is interpreted by target genes and other 
intracellular factors. There are multiple levels at which EGFR activation can be regulated. The preceding 
chapter presented a detailed analysis of the molecular mechanism of regulation of the genes encoding 
two known EGFR inputs in the distal leg: the ligand Vein (Vn) and the TGF-α ligand-activating protease 
Rhomboid (Rho). The results presented in this chapter establish that the ligand activated by Rho 
cleavage in the leg is Spitz. Further we describe experiments to identify whether other EGFR inputs or 
domains of activation of vein and rho may contribute to tarsal P-D patterning. Deletion of vnE and rhoE 
eliminates vn and rho expression in the center of the leg imaginal discs, respectively and animals in 
which both vnE and rhoE are deleted show distal, but not medial, leg truncations. Removal of additional 
candidate EGFR inputs in the background of the double CRM deficiency does not worsen this distal 
truncation suggesting that EOC activity is established by the combined expression of only vn and rho 
and is only required for distal-most fates. Our results support a model in which the P-D axis of the tarsus 
is patterned by multiple local sources of EGFR inputs rather than a single, long-range gradient. 
 
3.2: Introduction 
 Drosophila present an attractive model in which to study signalling pathways and gene 
regulatory networks relevant to vertebrate biology or human disease because flies are evolutionarily 
similar enough to be instructive but have fewer genes than vertebrates making genetic analysis more 
facile. Despite the fact that the number of potential inputs into EGFR signalling in flies is reduced 
compared to humans, there are still at least four ligands and seven ligand-processing proteases to 
contend with. Ostensibly these varied inputs can be used in different tissues in different combinations to 
finely tune the level of EGFR signalling that a cell receives resulting in a unique and developmentally 
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appropriate cell fate. It is therefore important to characterize in detail which inputs are involved in each 
specific developmental context in order to understand how that instance of EGFR signalling may be 
regulated. Mutations that increase potency or cause misexpression of EGF ligands have enormous 
oncogenic potential, yet many of the mechanisms of ligand action are poorly understood. Therefore, a 
detailed understanding of the way specific combinations of ligand act in various developmental contexts 
is relevant to the development of therapies that target EGF ligand in cancers. 
 While a rudimentary P-D axis of the Drosophila leg is established by the beginning of larval 
development by the concentric expression of Dll, Dac and Hth, the distal imaginal disc must be further 
patterned into domains of expression that prefigure the segments of the adult tarsus. This patterning is 
achieved by the expression of a battery of genes downstream of the EGFR signalling pathway 
(Campbell, 2002; Galindo, 2002; Natori et al., 2012). EGFR is activated in the distal leg imaginal disc as a 
result of the expression of the neuregulin-like ligand Vein (Vn) and the ligand-processing metalloprotease 
Rhomboid (Rho). Rhomboid proteases are required to cleave the transmembrane TGF-α EGF ligands 
Spitz (Spi), Keren (Krn) and Gurken (Grk) in order for them to be secreted into the extracellular space 
where they bind and activate EGFR ( Urban et al., 2002a; reviewed in Shilo, 2003). While Rhomboid is 
known to be expressed in the distal leg (Campbell, 2002; Galindo et al., 2005), the TGF-α ligand it 
cleaves in this tissue has not been identified. A number of inputs are capable of activating EGFR and are 
expressed at varying levels in different tissues in order to direct a specific cellular outcome. The 
mechanism by which different ligand combinations modulate the downstream EGFR signalling cascade 
is poorly understood. Further, the number of possible EGFR activators is significantly expanded in 
mammals where this signalling pathway is an important driver of a number of cancers. Therefore, 
identification of the mechanisms of receptor activation in the presence of different combinations of 
ligand is of great utility. 
In the preceding chapter we presented a detailed analysis of two inputs known to be expressed 
and important for the leg P-D patterning role of EGFR. Several questions remain, however, about what 
other inputs may be involved and the relative roles and importance of various inputs to activating 
downstream genes. These questions are complicated by the redundancy of EGFR inputs in the leg and 
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by the fact that EGFR signalling is important for patterning the leg in multiple spatiotemporally dynamic 
roles (Galindo et al., 2005). One model for EGFR’s role in patterning the tarsus is that an EGFR 
organizing center (EOC) established in the distal leg serves as a source of secreted ligand that patterns 
the entire tarsus. This long-range morphogen model is supported by the observation that graded 
removal of EGFR activity using a temperature-sensitive allele of Egfr leads to correspondingly severe 
truncations of the tarsus (Campbell, 2002). Further, the mechanism of expression of EGFR target genes 
appears to differ in a systematic manner with the most distally-expressed tarsal genes requiring the 
highest levels of EGFR signal for their activation.  
However, it is also possible that EGFR ligands secreted from multiple sources along the P-D axis 
may contribute to tarsal patterning; a model supported by the observation that both vn and rho are 
expressed in medial domains in third instar leg discs in addition to their distal expression (Fig. 2.1; 
Galindo et al., 2005). Further, while Vn is thought to be capable of diffusing relatively long distances over 
imaginal disc epithelium, it is not clear whether Vn alone is capable of activating EGFR in certain 
contexts (Zecca and Struhl, 2002a, this study). Additionally, Spi is unlikely to serve as a long-range 
morphogen as its diffusion is thought to be highly restricted (Miura et al., 2006; Steinhauer et al., 2013; 
Fig. 3.1E, F). Under this second model, expression of tarsal patterning genes would be activated by 
integrating relatively local sources of EGFR signalling, likely in combination with inputs from other 
intracellular signalling pathways or tarsal transcription factors that together would serve to establish 
position along the P-D axis. 
We tested these models by deleting CRMs that drive expression of the EGFR inputs vn and rho 
in the distal leg (vnE and rhoE, respectively) and find that these enhancers are both necessary and 
sufficient for their respective target gene expression (Figure 2.1). Under the gradient model, this double-
CRM deletion would phenocopy early third instar knockdown of Egfr and cause severe tarsal 
truncations. However, we observe only local perturbations of the distal-most segments in support of the 
multiple-source model for EGFR patterning of the tarsus. Further, this mild phenotype is not likely to be 
the result of redundancy from other sources of EGFR ligand as we find no evidence for expression of the 
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TGF-α ligands Krn or Grk or for the Rho paralog Roughoid (Ru) in the distal leg and the mild distal 
truncation produced by the double-CRM deficiency could not be worsened by mutants of these 
potentially redundant inputs (Fig. 3.2). Therefore, medial sources of EGFR ligand in addition to the distal 





EGFR activity in imaginal discs 
 In order to assess the pattern and strength of EGFR signalling in both wild type and mutant 
contexts we wanted to identify useful readouts of EGFR signalling in the leg. Although antibody stain 
against phosphorylated MAPK represents a relatively direct readout of EGFR activity, this is not feasible 
as this antibody is extremely unreliable (Campbell, 2002) even with modified staining protocols (Helman 
and Paroush, 2010). We detected endogenous phospho-MAPK signal only occasionally, but could 
reliably detect signal in clones that ectopically expressed EGFR inputs (ostensibly at higher than normal 
levels) (Figure 3.1A, B, C, D). For most experiments we relied instead on antibody staining against EGFR 
target genes in the distal leg as readouts of upstream signalling; in particular, against the homeodomain 
TFs Aristaless (Al), C15 (Clawless) and Bar (Higashijima et al., 1992; Campbell and Tomlinson, 1998; 
Campbell, 2005; Kojima et al., 2005). 
 It can be easily appreciated from the wild-type pattern of MAPK activation that EGFR signalling 
is a ubiquitous and highly spatio-temporally dynamic signalling pathway (Gabay et al., 1997). Its 
activation in the wing disc prefigures the venation pattern of the adult wing. Expression was detected 
along the morphogenetic furrow of the eye imaginal disc where EGFR is known to function (Rodrigues et 
al., 2005) and, of particular relevance for this work, in the distal domain of the leg disc (Fig. 3.1 A). While 
MAPK activity or downstream gene expression was apparent in clones ectopically expressing Rho, 
constitutively active forms of known EGFR pathway activators like Ras, or the receptor itself (Figure 
 69 
3.1B, C, E), ectopic clones expressing the known EGFR ligand Vn could not activate downstream 
signalling events as has been previously described (Fig 3.1 D, Zecca and Struhl, 2002b). Interestingly, 
ectopic clones expressing both Vn and Rho behaved differently than those expressing only Rho (Fig. 
3.1E, G). While expression of the EGFR target gene C15 can be activated in clones that ectopically 
express Rho in a limited fashion (Fig. 3.1 E), in clones that ectopically co-express both Vn and Rho, C15 
activation can be observed in larger clones that are relatively more distant from the endogenous 
expression domain than was possible with ectopic Rho alone (Fig. 3.1G). 
Additionally, we observe differences in activation of downstream EGFR target genes between 
endogenously produced ectopic Spi (from UAS-rho clones) and constitutively secreted ectopic Spi 
(UAS-sspi) (Schweitzer et al., 1995b). When an ectopic clone expressing Rho of appropriate size and 
position activates C15 expression, the boundaries of the clone (marked by GFP) and of C15 antibody 
stain coincide (Fig. 3.1E). This indicates that the cleaved Spitz produced by this clone does not diffuse 
from the source at sufficient levels to activate target genes in this context. However, in ectopic clones 
expressing a constitutively secreted form of Spi we consistently observe uneven extensions of C15 
staining beyond the boundaries of the endogenous expression domain (Fig. 3.1F). This transgenic sspi 
construct has also proven to be highly toxic in other contexts (Freeman, 1996; unpublished 
observations). This indicates that the artificially secreted Spi produced by these clones is able to diffuse 
away from its source to a greater extent than wild-type cleaved Spi and activates C15 expression only 




Figure 3.1: EGFR signalling in the imaginal discs 
 
 
Activity pattern of phospho-MAPK in wild type third instar larval imaginal discs (A), ectopic clones expressing: activated Ras (B), 
constitutively dimerized EGFR (C) and Vein (D). 
Expression pattern of EGFR target gene C15 in ectopic clones expressing Rhomboid (E), constitutively secreted Spitz (F) and both 
Rhomboid and Vein (G).  
Yellow arrowheads and yellow dotted lines indicate the positions of clones, white arrows indicate activity of endogenous phospho-
MAPK in parapodial cells. 
 
Note on author contributions: 




Genetic analysis of vnvnE-Df and rhorhoE-Df mutants 
Individually, both vnvnE-Df and rhorhoE-Df are viable as homozygotes, exhibit normal leg disc 
patterning (Fig. 3.3 A, C), and form morphologically normal and functional legs (Fig. 3.3 B, D), consistent 
with previous reports that vn and rho single mutants do not affect the leg disc or adult leg pattern 
{Campbell:2002ca, Galindo:2005ku}. However, when we examined the combined effect of these 
deficiencies in rhorhoE-Df, vnvnE-Df double mutant flies we found that the expression of EGFR downstream 
genes C15 and aristaless (al) was abolished in these animals (Fig. 3.2A, B and Fig. 3.3 E, F), and the 
expression of BarH1/H2, a pair of more proximally expressed PD genes (Kojima et al., 2000), collapsed 
from a ring pattern to a central circular domain in the leg disc (Fig. 3.2 B). In agreement with the leg disc 
pattern changes, adult rhorhoE-Df, vnvnE-Df double mutants exhibited distal leg truncations that lack a 
pretarsus and parts of tarsal segment V (Fig. 3.2N). rhorhoE-Df, vnvnE-Df double mutant flies die in late pupal 
stages most likely because of an inability to exit the pupal case.  
A sequence comparison between D. melanogaster and D. virilis, two Drosophila species that 
diverged from each other ~50 million years ago (Powell, 1997) , revealed that vnE is well conserved 
(45.8% identity over 0.65 kb) and at a similar location upstream of the D. virilis vn transcription start site. 
In contrast, rhoE could not be identified by sequence homology in D. virilis. These observations 
prompted us to ask if the orthologous D. virilis vnE (vnED.vir) could substitute for the function of D. 
melanogaster vnE and rescue the rhorhoE-Df, vnvnE-Df phenotype. We performed the swap of the vn 
enhancers (see Methods) and found that, indeed, the leg imaginal discs of rhorhoE-Df vnvnE-D.vir flies had 
normal PD patterning (Fig. 3.2C) and normal adult legs (Fig. 3.2Q). This result suggests that the function 
of vnE has been maintained over tens of millions of years and this enhancer element plays a conserved 




Spitz and Vein are the relevant EGFR ligands for tarsal leg patterning  
Rho is an EGFR ligand-processing metalloprotease that has the potential to cleave the 
membrane-bound ligands Spi, Krn, and Grk in order to convert them into active secreted forms, while Vn 
secretion does not require Rho function (Shilo, 2003). Although we did not detect any expression of Krn 
and grk in leg discs (Fig. 3.5M, O), this does not exclude the possibility that these genes function in leg 
disc development at a level of expression below what is detected by in situ hybridization. To address 
this possibility, we performed genetic experiments and found that the single null mutants (data not 
shown) Krn27-7-B (McDonald et al., 2006) and grk∆FRT (Lan et al., 2010), and the double mutant grk∆FRT; 
Krn27-7-B, do not exhibit any leg disc patterning defects (Fig. 3.2D) or adult leg phenotypes (Fig. 3.2R). In 
addition, rhorhoE-Df, vnvnE-Df, Krn27-7-B triple mutant (Fig. 3.3G, H) and grk∆FRT; rhorhoE-Df, vnvnE-Df, Krn27-7-B 
quadruple mutant (Fig. 3.2E) leg discs had similar defects as rhorhoE-Df, vnvnE-Df double mutants (Fig. 3.2B), 
even though the quadruple mutant larvae died at late L3, just before pupation. These results support our 
conclusion that Krn and Grk are unlikely to be involved in EGFR activation during leg development.  
The remaining Rho-dependent EGFR ligand, Spi, is expressed broadly in leg discs (Fig. 3.5J, K) 
and is a good candidate for participating in EOC activity under the temporal and spatial control of Rho. 
To confirm the role of Spi, we used RNAi (see Methods) to examine the phenotypes of animals depleted 
for both spi and vn in leg discs.  We found that, indeed, Spi is the EGFR ligand processed by Rho in the 
center of leg discs, because spi, vn double RNAi (driven by Dll-Gal4) caused loss of expression of the 
downstream EGFR gene C15, and the near elimination of Bar expression (Fig. 3.2J).  This phenotype is 
stronger than any other combination of EGFR pathway components, similar to Egfrtsla mutants grown at 
the restrictive temperature of 30°C (Fig. 3.2L, P). In addition, in animals depleted for spi and vn using 
RNAi we observed leg truncations (Fig. 3.2O) similar to those observed in Egfrtsla mutants at 30°C (Fig. 
3.2P). Taken together, these results suggest that Vn and Spi are likely the only ligands that activate 
EGFR signalling during fly leg development. 
Removal of vn expression alone, either in whole animals (Fig. 3.4 D) or specifically in leg discs 
using Dll-GAL4 to drive RNAi (Fig 3.4E, F) produces normally patterned imaginal discs (Fig. 3.4D, E) and 
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adult legs (Fig. 3.4F, vn null animals die as pharate adults: (Austin et al., 2014). Removal of Spi either in 
mitotic clones (Fig. 3.4A) or in whole legs, again with Dll-GAL4-driven RNAi, also produces normally 
patterned discs (Fig. 3.4B) and adult legs, however the claws of spi-deficient animals are unpigmented 
and sometimes mildly perturbed (Fig 3.4C, previously observed in rho-, ru- adults in (Campbell, 2002), 
supplement). Interestingly, gene expression in imaginal discs and leg patterning was perturbed when we 
performed whole-leg knockdown of spi in the background of the vnEDf (Fig. 3.4G, H) but less severely 
than from RNAi knockdown of both spi and vn (compare Fig. 3.4G, H to Fig. 3.2J, O). This result, 
combined with our observation that no distal vn expression persists in the vnE deficiency, indicates that 
although we identified no CRMs that drive vn expression in the medial disc, some additional, non-EOC 
source of that ligand contributes to distal patterning. Finally, knockdown of both vn and spi in the distal 
leg only using vn-GAL4 (itself a vn null allele: (Austin et al., 2014) recapitulates the limited distal leg 
truncation phenotype of the vnE, rhoE double enhancer deficiency (Fig. 3.3I, J). 
 
Genetic dissection of rhomboid and roughoid in leg development  
The triple ru1, rho7M43, vnL6 mutant, but not the rho7M43, vnL6 double mutant, produces a strong leg 
truncation phenotype, similar to Egfrtsla animals grown at 30°C, suggesting that Ru is involved in 
patterning the adult leg together with Vn and Rho (Campbell, 2002). vnL6 is a nonsense mutation and a 
null by genetic criteria (Donaldson et al., 1994; Simcox et al., 1996). rho7M43 is also a null allele 
(Wasserman et al., 2000), although we were unable to identify any amino acid changes in the rho coding 
sequence of this allele (data not shown). ru1 is a nonsense mutation that leads to a premature stop 
codon after residue 55, prior to the Rhomboid domain, suggesting that it is also a null allele (Yu et al., 
2010). A potential caveat to this conclusion is that ru1/Df  (including Dfs ruPLLb and ruPLJc) results in a 
stronger ‘rough-eye’ phenotype than the ru1 homozygote, implying that ru1 is a hypomorph (Wasserman 
et al., 2000; Yu et al., 2010). However, ru, together with several other genes, is located in the intron of 
the protein tyrosine phosphatase encoding gene, Ptp61F, which plays a role in EGFR/MAPK signalling 
(Fig. 3.5E; Tchankouo-Nguetcheu et al., 2014). Consequently, deficiencies that remove ru could also 
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affect MAPK/EGFR signalling by reducing Ptp61F expression and could potentially lead to stronger 
phenotypes compared to the cleaner ru1 allele. Taken together, these observations suggest that ru1 is 
likely to be a null mutation. Notably, rho and ru are physically close to each other on chromosome 3L, 
with rhoE ~55 kb away from the ru promoter, raising the possibility that rhoE could also regulate ru (Fig. 
2.1G and Fig. 3.5E). To test this possibility, we examined the lacZ expression pattern driven by the ruinga 
enhancer trap (Gallio et al., 2004) in the background of the homozygous rhorhoE-Df (see Methods). We did 
not detect any effect of rhorhoE-Df on ruinga-lacZ expression in leg discs (Fig. 3.3K, L), suggesting that ru is 
not regulated by rhoE.  
Because the triple ru1, rho7M43, vnL6 mutant produces adult leg truncations (Campbell, 2002) that 
are stronger than those observed in our rhorhoE-Df, vnvnE-Df double mutant, we carried out additional 
experiments to address a potential role for ru in leg disc patterning. In the first experiment, instead of 
examining adult legs we examined ruinga, rhorhoE-Df, vnL6 triple mutant clones in leg discs (see Methods). 
Notably, leg disc patterning in these mutant discs was similar to the pattern observed in the rhorhoE-Df, 
vnvnE-Df double mutant (Fig. 3.2F), and even a small patch of WT tissue in the center of the leg disc could 
restore a relatively normal PD pattern (Fig. 3.2G). In a second test, we generated ru1, rho7M43, vnvnE-Df triple 
mutant clones and, as in the previous experiment, we observed the loss of C15 and collapse of BarH1 
expression (Fig. 3.2H), similar to the rhorhoE-Df, vnvnE-Df double mutant, and a rescue of C15 expression if 
some distal cells remain wild type (Fig. 3.2I).  
Together, these results suggest that ru does not contribute significantly to EOC activity in the 
early L3 stage to pattern the L3 imaginal disc. Instead, these results suggest a model in which EOC 
activity is mediated primarily by vnE and rhoE, while the later rings of EGFR activation are controlled by a 
distinct set of enhancers (including rhoLLE1, rhoLLE2, and ruLLE, as well as rhoE, which also appears to 
drive some late ring expression) (Fig. 3.5 C, D, H), and that this second wave of EGFR activity is 
important for patterning medial regions of the adult leg. In addition, these data suggest that ru, and 
perhaps other rho proteases, play a role later in leg development through its ring-like expression pattern 
to ultimately impact adult leg patterning.   
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Figure 3.2: vnE and rhoE requirement for PD patterning of leg discs and adult legs  
 
 
All RNAi experiments were carried out in a heterozygous spiDf, vn- background (see Methods). 
 
(A-L) Effects on distal PD genes (C15 and Bar) in third instar leg discs in: (A) rhorhoE-Df vnvnE-Df /+; (B) rhorhoE-Df vnvnE-Df ; (C) rhorhoE-Df 
vnvnE-D.vir ; (D) grk∆FRT; Krn27-7-B; (E) grk∆FRT; rhorhoE-Df vnvnE-Df Krn27-7-B;  (F,G) ruinga rhorhoE-Df vnL6 mutant clones; (H,I) ru1 rho7M43 vnvnE-Df 
mutant clones; 
(J) spi vn double RNAi; (K) Egfrtsla/+ WT leg disc at restrictive temperature; and (L) Egfrtsla mutant leg discs at restrictive temperature 
(M-R) Adult leg morphology of: (M) WT; (N) rhorhoE-Df vnvnE-Df mutant; (O) spi vn double RNAi driven by Dll-Gal4 (legs with tarsal 
segments I-II: n=21/102, I-III: n=19/102, I-IV: n=35/102, I-V: n=27/102); (P) Egfrtsla mutant at restrictive temperature (remaining 
10/42 legs less severely truncated); (Q) rhorhoE-Df vnvnE-D.vir; and (R) grk∆FRT; Krn27-7-B mutant. n refers to number of individual legs with 
a given number of tarsal segments present (even if distal-most segment perturbed). Arrowheads indicate intact (filled) or perturbed 
(open) tarsal segments. 
 
Note on author contributions: 
RV made all strains shown in panels A-I, including the vnvnE-D.vir CRISPR replacement strain. 
SN performed all RNAi and EGFR knockdown experiments in larvae and adults and made the figure. 
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Figure 3.3: Additional genetic analysis of vnvnE-Df, rhorhoE-Df and other EGFR-activating components  
 
All RNAi experiments were carried out in a heterozygous 
spiDf, vn- background (see Methods). 
 
(A) Expression pattern of C15 and Al in vnvnE-Df mutant.  
(B) Adult leg of vnvnE-Df mutant. Filled arrowhead indicates 
intact pretarsal claw.  
(C) Expression pattern of C15 and Al in rhorhoE-Df mutant.  
(D) Adult leg of rhorhoE-Df mutant. Filled arrowhead 
indicates intact pretarsal claw.  
(E) Expression pattern of Al and BarH1 in WT (rhorhoE-Df 
vnvnE-Df/+) and  
(F) rhorhoE-Df vnvnE-Df double mutant.  
(G) Expression pattern of C15/Bar/Dac in WT (rhorhoE-Df 
vnvnE-Df Krn27-7-B/+) and  
(H) rhorhoE-Df vnvnE-Df Krn27-7-B triple mutants.  
(I-J) spi vn double RNAi driven by vn-GAL4.  Expression 
pattern of C15 and BarH1 in third instar leg discs (I) and 
adult leg (J). Open arrowhead indicates absent pretarsal 
claw). 
(K-L) Expression pattern of ruinga-lacZ in ruinga rhorhoE-Df/+ 
(K) and ruinga rhorhoE-Df/ rhorhoE-Df (L) leg imaginal discs. 
 
Note on author contributions: 
RV performed the staining for panels A, C, E-H, K & L. 
SN performed the RNAi for panels I & J and took the 




Figure 3.4: Knockdown of Individual EGFR inputs in the leg 
 
 
All RNAi experiments were carried out in a heterozygous spiDf, vn- background (see Methods). 
(A) spi mutant clones and Dll-GAL4-driven RNAi knockdown of spi in the background of a heterozygous spi deficiency in leg discs 
(B) and adult legs (C). 
(D) leg discs from vein null animals and Dll-GAL4-driven RNAi knockdown of vn in the background of a heterozygous vn null in leg 
discs (E) and adult legs (F). 
Dll-GAL4-driven RNAi knockdown of spi in the background of a heterozygous spi deficiency and homozygous vnvnE deficiency in 




Note on author contributions: 




Identification of other sources of EGFR inputs for tarsal P-D patterning 
In addition to the distal leg expression of vein and rho described and analyzed in detail in the 
preceding chapter (Figure 2.1) we observe more medial and proximal domains of expression of both 
genes, as has been previously described (Galindo et al., 2005). Additionally, the distal imaginal disc 
expression (in legs as well as in antennae) is recapitulated by vnE and rhoE in reporter assays (Figs. 2.1 
and 3.5). Our search for leg disc enhancers across the vn locus uncovered only vnE, while in rho we 
identified two additional rho leg disc enhancers rhoLLE1 and rhoLLE2 (Fig. 3.5G, LLE stands for ’late leg 
enhancer’) that drive expression in ring patterns starting in mid-third instar leg discs (90-92h PEL) (Fig. 
3.5C, D; Table A1). These enhancers do not participate in EOC formation because they are active at later 
developmental stages and drive expression in medial/proximal ring patterns (Fig. 3.5C, D). 
We also re-examined the expression pattern of additional EGFR ligands and proteases using 
enhancer-reporter assays (Fig. 3.5E, I, L; Table A2), in situ hybridization (Fig. 3.5 F, J, M, O) and available 
enhancer trap lines (Fig. 3.5 G) and found that ru (as previously reported (Campbell, 2002) and spi (Fig. 
3.5G, J), but not Krn or grk (Fig. 3.5M, O), were expressed in leg discs during third larval instar. 
Curiously, ru expression was only detected by an enhancer trap (ruinga-lacZ) and by a newly identified 
enhancer, ruLLE, that recapitulates the ruinga expression pattern (Fig. 3.5H) but was not detected by in 
situ hybridization (Fig 3.5F; see also Campbell, 2002). spi was expressed broadly in leg discs (Fig. 3.5J), 
and this pattern was recapitulated by a ~10 kb region that includes its promoter and introns (Fig. 3.5K). 
Although there are five additional rho-family proteases encoded in the Drosophila genome (Wasserman 
et al., 2000), previous genetic analysis suggests that rho and ru are the most relevant (Campbell, 2002; 
Galindo et al., 2005). 
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(A-B) Expression pattern of vnE (A) and rhoE (B) in third instar eye-antennae discs.   
(C-D) Expression pattern of (C) rhoLLE1 and (D) rhoLLE2 throughout leg disc development.  
(E) Schematic representation of ru genomic locus with enhancer bashing results. Fragments represented in tan did not drive 
expression in leg discs. 
(F-H) Expression pattern of ru from in situ (F), ruinga (G) and ruLLE (H).  
(I) Schematic representation of spi genomic locus with enhancer bashing results.  
(J-K) Expression pattern of spi from in situ (J) and spi-lacZ reporter construct (K).  
(L) Schematic representation of Krn genomic locus with enhancer bashing results and Krn27-7-B mutant. Fragments represented in 
tan did not drive expression in leg discs. 
(M) Expression pattern of Krn from in situ.  
(N) Schematic representation of grk genomic locus with grk∆FRT mutant.  
(O) Expression pattern of grk from in situ. 
 
Note on author contributions: 
RV cloned and assessed expression for the rhoLLE enhancers and for spiZ. SN cloned and assessed ruLLE expression. SN 
performed all in situ hybridizations and made the figure including all schematics 
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Figure 3.6: Summary of PD axis patterning by EGFR 
 
 
Schematic representation of EOC and non EOC sources of EGFR activation along the PD axis in leg discs (A) and adult legs (B). 
Later, in pupal development EGFR inputs (orange) are expressed in rings that abut the presumptive joints (C, Galindo et al, 2005). 
 
Note on author contributions: 






Despite its involvement in a variety of important biological processes, human development and 
disease (reviewed in Wee and Wang, 2017), much remains to be explored about how the EGFR pathway 
functions to direct downstream cell fate. An even broader biological question relates to the mechanisms 
by which secreted factors control tissue patterning in a concentration dependent manner (reviewed in 
(Lander, 2007). Signalling by so-called morphogens is an important phenomenon for establishing 
patterns in many developmental contexts, including in mammalian limb patterning (Towers et al., 2012; 
Bökel and Brand, 2013), however examples of patterning events directed by morphogen gradients are 
often complicated in real systems and the importance of and mechanisms by which graded signals are 
produced is still an open question in many cases (reviewed in Wilcockson et al., 2017). 
Here we aim to address the question of how a gradient of EGFR signalling might pattern the 
distal leg in Drosophila by first establishing the subset of EGFR activators involved in this process and 
then removing all EGFR ligand at the putative source, the EGFR organizing center (EOC), which fate-
maps to the distal adult leg. After deletion of two CRMs that drive EOC expression of the EGFR inputs 
vein (vn) and rhomboid (rho), we observe disruption, not of the entire tarsus as would be expected from 
removal of a long-range morphogen, but a relatively local effect with truncations of the claw and tarsal 
segment 5 and corresponding perturbations of distal gene expression in the leg imaginal disc. These 
phenotypes are significantly weaker than distal leg truncations resulting from removal of EGFR signalling 
in the whole leg (Fig. 3.2M, N, O, P). Because we observe no signal in the distal leg from in situs done on 
either the vnE or rhoE homozygous deficiency we conclude that no redundant enhancers exist to 
produce distal EGFR ligand. However, it is possible that such enhancers do exist, but drive expression 
below the sensitivity of this assay. Our conclusions could be strengthened by testing the vnE and rhoE 
deficiencies, respectively, as transheterozygotes with whole-locus deficiencies in the background of a 
homozygous deficiency of the other enhancer and then assessing whether the leg truncation phenotype 
is worsened compared to the double enhancer deficiency alone. Assuming that vnE and rhoE are 
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together the sole source of distal EGFR signalling, secretion of EGF ligand from the EOC may still act to 
establish these distal-most fates in a graded fashion, additional sources of EGFR signalling must 
contribute to patterning more proximal domains of the tarsus. 
These non-EOC sources of EGFR are likely to include both the ligand Vein as well as TGF-α 
ligand (and their required processing proteases) because knockdown of either of these inputs alone 
does not perturb medial/proximal tarsal patterning (Fig. 3.4A-F). We have identified CRMs that drive 
expression of both rhomboid and the paralogous Rho-protease roughoid (ru) in medial rings in third 
instar larval leg imaginal discs. Medial expression of vein in mid and late third instar leg discs (Fig. 2.1) 
warrants re-examination of the vn locus to identify additional CRMs. While expression of EGFR inputs in 
rings is known to play an important role, in coordination with Notch signalling, in patterning the leg joints 
later in leg development (Galindo et al., 2005; Córdoba and Estella, 2014), it is likely that some of these 
ring CRMs contribute to tarsal patterning. Discerning the contributions of various medial sources of 
EGFR ligand, alone and in combinations, will be an important next step in refining our model of dynamic 
EGFR signalling during leg development. 
The redundancy of EGFR inputs makes genetic and other analyses based on perturbing 
upstream signalling difficult to interpret. The presence of seven rho-like proteases in the Drosophila 
genome suggests a caveat to the interpretation presented above. We focused on the ligand Vein and the 
two Rhomboid proteases Rho and Ru because previous studies have demonstrated large or abundant 
rho, ru, vn triple mutant clones in the leg produce tarsal truncations similar in severity to those resulting 
from strong Egfrtsla knockdown, suggesting that additional Rho-family proteases are not involved in tarsal 
development (Campbell, 2002; Galindo et al., 2005). The observation that the vnvnE-Df, rhorhoE-Df double 
deficiency generates distal leg truncations indicates that no additional proteases are expressed in the 
distal leg at levels sufficient to activate Spi secretion. Further, knockdown of ru in the context of the 
double CRM deficiency did not worsen truncations. This conclusion could be strengthened however by 
additional genetic and expression analysis of the other five Drosophila rho homologs or by generation of 
better-characterized mutants using recently improved genome editing approaches. 
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Modulation of EGFR ligand activity 
Understanding of how even short-range gradients of secreted signal are established in fields of 
cells requires a thorough characterization of the properties ligands themselves and the tissues over 
which they diffuse. It is important to determine if a gradient is achieved by diffusion alone or by a more 
complicated means such as facilitated transport or contributions from other factors that establish ligand 
sinks or otherwise limit diffusion (reviewed in Wilcockson et al., 2017). A number of examples of such 
mechanisms have been described and may be relevant for EGFR ligands. Diffusion of Spi is known to be 
restricted by palmytolation lipid modification that serves to tether secreted ligand to the plasma 
membrane of secreting cells (Miura et al., 2006). Indeed, we indirectly observe differences in the 
diffusion properties of endogenously produced Spi compared to a transgenic allele (sspi) which is 
constitutively secreted because a premature STOP codon leads to the production of protein lacking the 
transmembrane domain (compare Fig. 3.1E and F). Interestingly, this truncation leaves the previously 
described site of palmitoylation intact, indicating that other domains on endogenously secreted Spi 
protein may be important for regulating diffusion. One other under-appreciated aspect of signalling 
which may apply to Spi secretion in Drosophila is the apical-basal distribution of ligand and receptor on 
epithelial cells (Steinhauer et al., 2013). In human intestinal epithelial contexts mechanisms of ligand 
delivery to the primarily baso-laterally deposited receptor have been shown to be important (Kuwada et 
al., 1998). Different ligands in Drosophila likely have different inherent abilities to access receptor 
expressed in different membrane domains (reviewed in Singh and Coffey, 2014). 
The mechanisms by which Vn diffuses and activates EGFR after secretion are not well 
understood. We and other groups have observed that Vn is capable of activating gene expression at 
much longer distances across imaginal disc epithelium than Spitz (Zecca and Struhl, 2002b). It has also 
been demonstrated that any of the three TGF-α EGF ligands are capable of rescuing the activity of Vn 
(Austin et al., 2014). However, unlike Spi, ectopic Vn expression is not capable of activating EGFR 
signalling except in the context of a vein null background in some contexts (Zecca and Struhl, 2002b). 
This observation is curious because vn has been shown to be genetically required along with rho for leg 
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fates downstream of EGFR signalling and legs mutant for rho and ru develop normally indicating that 
endogenously produced Vn is sufficient to pattern the leg (Fig. 3.4C; Campbell, 2002). Further, ectopic 
clones expressing vn in a vn null background could rescue target gene expression patterns in a highly 
non-cell-autonomous manner often restoring near-wild type patterns of gene expression quite distant 
from the ectopic source of Vein (Zecca and Struhl, 2002b). This indicates that Vein is capable of long-
range diffusion but requires some other local condition to be met in order to initiate signalling in target 
cells.  
Recently, a screen for modulators of Vn-induced EGFR signalling in Drosophila identified a 
potentially relevant negative regulator of Vn activity, Sulf1, which encodes an enzyme that modifies 
heparin sulfate protein modifications. The study further demonstrated that Vein binds Heparin in vitro 
(Butchar et al., 2012). Heparin Sulfate Proteoglycans (HSPGs) are known to affect a number of biological 
processes including ligand deposition (reviewed in Sarrazin et al., 2011) and this process has been 
shown to play a role in regulating the binding of neuregulin EGF ligands in mammals (Marchionni et al., 
1993; Raab and Klagsbrun, 1997; Umeda et al., 2001). Further, the Vn protein has a complex 
architecture including a number of domains thought to affect its potency by regulating binding to 
receptor or other factors as well as its degradation (Donaldson et al., 2004). More detailed 
characterization of how the properties of this ligand contribute to robust and dynamic EGFR signalling in 
combination with other ligands and potential cofactors will improve our understanding of the 
mechanisms by which upstream EGFR signalling is regulated in flies and other taxa. Indeed, different 
human EGFR ligands in human cells have been shown to differ in the mechanism by which they 
preferentially bind and/or facilitate receptor homo- or hetero-dimerization and thus different ligands may 
respond differently to therapeutic interventions intended to prevent oncogenic activation of signalling 




Alternate Approaches and Future Directions 
Our RNAi knockdown of vn and spi was highly efficient when carried out in the background of 
heterozygous mutants for both genes; the severity of the tarsal truncation phenotype is comparable to 
that of EGFR null legs. However, this approach may potentially leave some low level of signalling intact 
and therefore confound interpretation of results. Genetic approaches, while more technically 
challenging, could be used to complement our RNAi experiments. We generated recombinant 
Drosophila strains that would hypothetically allow a genetic removal of both ligands from the leg disc by 
employing a BAC rescue of the spi gene onto chromosome 3L, where the vn gene is also located. When 
recombined with an appropriate FRT, this transgenic rescue could be used to generate mitotic clones 
mutant for both vein and spi simultaneously despite these genes being located on different 
chromosomes in wild-type flies. By using Dll-GAL4 to drive FLP-FRT recombination in combination with 
the Minute technique, it may be possible to produce leg discs that are genetically null for vn and spi. 
This approach would avoid the possibility of low levels of EGFR ligand being produced by the mutant 
cells, providing that the clones produced were large enough to preclude diffusion of ligand from any 
remaining wild-type tissue in the leg disc. In practice, these recombinant strains were highly time-
consuming and arduous to produce and genotype. Further, it may be difficult to obtain surviving leg 
discs composed of mainly mutant tissue. In preliminary trials, we employed the smallest spi-containing 
BAC available (BAC CH322-02O22, BACPAC Resources) to avoid artifacts from increasing the copy 
number of neighboring genes. Transformants carrying this BAC on the third chromosome (attP2) did 
rescue a homozygous spi null, however only in around 10% of male flies. This rescue may not be 
sufficient to produce enough progeny to carry out the experiment as designed. 
In addition to our approach being more technically feasible than the mitotic clone approach 
described above, RNAi affords us the ability to knock down multiple factors at once in specific sub-
domains of the developing leg disc relatively easily. Having observed that our vnE, rhoE double enhancer 
deficiency produced truncations affecting only the most distal tarsal segments and not the entire tarsus 
as we would predict based on the long-range gradient hypothesis, we wanted to test whether removing 
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all sources of EGFR inputs in different domains of the future tarsus could account for this observation. 
The result of our distal-only knockdown using vn-GAL4 do not contradict the alternate model that the 
tarsus may be patterned by a distal “EOC” ligand source in combination with secondary non-EOC 
sources (Fig. 2.3I, J). However, the observation that vn-GAL4-driven RNAi against vn and spi affects only 
the distal tarsus could also be explained if vn-GAL4 is a relatively weak driver compared to the Dll-GAL4 
driver used for whole-leg knockdown.  
The question of whether a distal source of EGFR ligand contributes to patterning medial fates in 
the tarsus is an important one, especially given previous observations that the presence of wild-type 
tissue in the distal domain can rescue medial patterning of otherwise rho, ru, vn triple mutant legs 
(Campbell, 2002). However, this rescue was only partial and medial fates were still perturbed in this 
context. Additionally, while early third instar temperature shifts of Egfrtsla animals produced distal tarsal 
truncations, short, later temperature shifts affected only medial/proximal fates leaving tarsal segment V 
and the claw intact (Campbell, 2002). This result can be explained by our two-source model of tarsal 
EGFR activation and underscores the importance of timing in addition to levels of EGFR activity for leg 
patterning. We expanded on these previous analyses with a detailed examination of the patterns of gene 
expression in the imaginal discs and observe that rho, ru, vn clones generated phenotypes similar to 
those produced by the vnvnE-Df, rhorhoE-Df double enhancer deficiency. In an attempt to complement these 
experiments, we have performed vn, spi double RNAi knockdown using medial leg drivers but have not 
been able to observe a phenotype. This approach is complicated by the fact that many drivers that 
produce a medial ring pattern in the leg disc are themselves EGFR targets and so would produce a 
negative feedback in the context of vn, spi knockdown and are therefore not suitable. One medially-
expressed gene that avoids this complication is dac, for which several GAL4 lines exist, however we 
have not been able to obtain progeny from dac-GAL4-driven RNAi against vn and spi in the sensitized 
background of heterozygous vn and spi mutants (as was done for the parallel, whole-leg RNAi 
experiments). dac-GAL4-driven RNAi in a wild-type background produced no observable phenotype in 
either third instar imaginal discs or adult legs. RNAi against vn and spi in a wild-type background using 
Dll-GAL4 produced only a weak phenotype, so the lack of result from Dac-GAL4 may be due to the 
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strength of the driver. However, the dac expression also may not extend distally enough to have an 
effect on all non-EOC EGFR inputs. 
To assess the role of non-EOC sources of EGFR ligand for tarsal patterning, a more fruitful 
approach would involve deletion of the identified ring enhancers of rho and ru alone and in various 
combinations, as well as a new search for additional leg enhancers of vn that might drive its weak medial 
expression. Our experiments thus far suggest that any contribution of a medial source of EGF would 
include both Vn and a Rho-dependent ligand (Spi) since removal of both these ligands is necessary to 
perturb medial/proximal tarsal fates. Additionally, tarsal phenotypes resulting from RNAi against spi 
alone in the background of the homozygous vnE deficiency is less severe than RNAi against both ligands 
indicating that a medial source of Vn contributes to tarsal P-D patterning (Fig. 3.4G, H). Careful 
characterization of phenotypes of these ring enhancer deletions will be important to discern the 
difference between perturbations of tarsal segment identity or patterning and joint defects, as a later 
wave of EGFR signalling activated in rings along the P-D axis is important for patterning the leg joints by 
constraining Notch signalling (Bishop et al., 1999; Galindo et al., 2005; Córdoba and Estella, 2014). 
A more complete model of tarsal patterning will need to include assessment of the precise 
timing of activation of these multiple sources of EGFR ligand active throughout the developing leg at 
different times and levels of expression. One mechanism often proposed to explain how a single signal 
might be able to produce a variety of cellular outcomes is that the level of signalling must be tightly 
controlled. This mechanism may be particularly important in organisms with a linear downstream EGFR 
signalling cascade where initiation of different downstream signalling branches as occurs in mammalian 
EGFR signalling is not relevant. Receiving cells must possess a mechanism to detect changes in level of 
signalling output and for transcriptional targets to differentially respond to these levels. This aligns with 
our observations of EGFR signalling in the leg, for example where we see high distal signal from in situ 
hybridization of EGFR activators compared to weaker signal in more medial domains of the leg disc. 
Published RNA-seq data also shows widely varying levels of expression of EGFR activators between 
tissues and developmental time points (McKay and Lieb, 2013). However, we currently lack a 
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quantitative approach to assess the objective or comparative level of EGFR signalling in a high-
resolution manner. Tools designed to assess RTK activity in cells known as kinase translocation 
reporters (KTRs) have been developed in other systems and application of these techniques in flies 
would allow more nuanced assessment of the effects of perturbing EGFR signalling inputs (Harvey et al., 
2008; Albeck et al., 2013; de la Cova et al., 2017). Answering the question of how level of EGFR 
signalling contributes to establishing distinct downstream fates as well as whether perturbations of 
particular upstream inputs significantly affect intracellular signalling is vitally important for developing a 
mechanistic model that connects secreted EGFR inputs with tissue specific transcriptional outcomes. 
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3.5: Chapter 3, Addendum 1 - probing enhancer function in situ 
 
Introduction 
 Two enhancers that drive expression of the EGFR inputs Vein and Rho (vnE and rhoE, 
respectively) differ in the timing of their activation in the distal leg disc. Yet mutation of either gene alone 
does not affect leg patterning. No sufficient explanation exists for the maintenance of these 
spatiotemporal differences if these two enhancers are truly redundant in leg patterning. We wondered if 
perturbing this timing or patterning would affect tarsal development and give some insight into the 
importance of the differences in their expression. We hypothesized that replacement of rhoE with vnE 
would activate both genes with the earlier timing and slightly broader domain of vn and that replacing 
vnE with rhoE would activate both genes with the later and tighter expression pattern of rho and that this 
might impact downstream target gene expression or tarsal morphology (see Methods, Fig. 3.8A, C). This 
is an interesting question even outside the field of leg development because it allows us to ask if the 
enhancer itself is sufficient to confer a gene’s particular pattern and timing in the context of an otherwise 




Interestingly, we find that replacement of vnE with rhoE does not in fact produce a rho-like vn 
expression pattern as we expected. Instead, rhoE rescues a wild-type vn expression pattern and timing 
(compare to Fig. 3.8B to Fig. 2.1D) indicating that other features of the vn locus serve to constrain the 
timing and pattern of expression of the target gene. rhoE appears to be capable of driving expression in 
the context of the vn locus but is not sufficient to assert the rho expression pattern and timing. This 
result underscores the importance of evaluating putative enhancers in their endogenous loci in addition 
to exogenous reporter contexts in order to appreciate regulatory contributions from other elements in 
situ. This and other results also indicate that while our bashing of the vn locus revealed only one 
 90 
fragment that drives expression in imaginal discs, other elements contribute to spatio-temporal control 
of gene expression. An approach to reveal long-range genomic interactions with either vnE or the vn 
promoter in an unbiased manner would be an interesting next step to further characterize this seemingly 
complex locus.   
 
 
Figure 3.8: rhoE drives wild-type pattern of vein expression 
 
(A) genome schematic depicting replacement of vnE with 
rhoE (not to scale). Orange triangles represent RMCE scars. 
(B) vein expression in leg imaginal discs from larvae with vnE 
replaced with rhoE. Yellow arrowheads indicate distinctive 
vein-like expression pattern in late L3 disc. 
(C) genome schematic depicting replacement of rhoE with 








When we perform the converse experiment, replacing rhoE with vnE and thereby driving both 
genes with vnE we find that flies homozygous for this replacement do not survive beyond the second 
larval instar (data not shown). This result is not particularly surprising as vn expression in the distal leg is 
broader and of longer duration than that of rho (see Figure 2.1) and we have observed in other contexts 
that misexpression of spi can be lethal (data not shown; (Freeman, 1996). Additionally, this replacement 
may be lethal if vnE is active at other developmental timepoints not assessed in this study or somehow 
disrupts the proper functioning of other required rho CRMs. Regardless, this finding points to an 
important difference between these two loci; where substitution of vnE fails to convert the vn expression 
pattern to that of rhoE, replacement of rhoE appears to have some gain of function, even if we cannot 
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observe the expression pattern or adult leg phenotype in homozygous animals. In order to be able to 
assess the leg phenotype of rhovnE we have recombined this replacement with FRT80B in order to 
generate Dll-GAL4-driven mitotic clones in a Minute- background, however no larvae survive. Additional 
temporal control using GAL80TS will likely be required to assess this replacement in vivo. 
 
Discussion 
 While the results of this enhancer swap experiment do not necessarily shed any light on the 
importance of the difference in timing and duration of activation of vn and rho in the leg, they do 
underscore some important considerations when assessing enhancer function in vivo. While enhancers 
are modular to a certain extent, their activity in reporter contexts cannot be assumed to reflect their 
normal function within the endogenous gene locus. While vnE and rhoE have a number of important 
similarities (both are necessary and sufficient for their target gene expression, both are regulated by a 
similar set of transcription factors and both are expressed in the same tissue at the same time during 
development) they appear to function differently with respect to the mechanism by which they activate 
their endogenous target promoters. Further, expression patterns of both vnE- and rhoE-lacZ reporters 
appear to differ from endogenous expression as visualized by in situ (compare Fig. 2.1 C&D and H&I). 
Some of this difference could be attributed to differences in these visualization methods, particularly the 
possibility of perdurance of β-gal protein, however some differences may be caused by additional local 
effects not present in an exogenous reporter context. An interesting test might be to make a direct 
comparison between a transgenic reporter insertion and the endogenous locus by using targeted 
genome editing to replace either the vn or rho gene with lacZ. 
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3.6: Chapter 3, Addendum 2 - Assessing RTK activity 
A promising tool was recently developed for C. elegans that might facilitate quantitative 
assessment of RTK signalling levels in flies. An approach described by de la Cova et al combines an 
existing fluorescently-tagged kinase translocation reporter (KTR) with an additional nuclear marker to 
permit direct quantification of EGFR on the level of individual cells in live tissue (de la Cova et al., 2017). 
Phosphorylation of MAPK target sites on the KTR construct drives nuclear export visualized via a GFP 
tag. When expressed as a bi-cistronic protein with an additional, nuclear-localized RFP the nuclear 
red/green ratio serves as a quantitative readout of MAPK activity as a proxy for upstream EGFR 
signalling input (Fig. 3.7). Should it function in flies, this tool would be a powerful way to correlate direct 
measurements of EGFR signalling level (either in endogenous contexts or in mutants/enhancer deletions) 
with downstream readouts of EGFR signalling (gene expression or morphology). To that end, we tested 
whether this biosensor functions in Drosophila larval tissue using constructs generously provided by 
Clare de la Cova, Andrew Tomlinson and Gary Struhl. 
 
Figure 3.7: “The Nuclear Ratio ERK-nKTR Design” 
 
de la Cova et al., 2017 
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Results & Discussion 
Direct fusion of the ERK-nKTR cassette to a tubulin promoter produced no detectable signal in 
transgenic fixed or unfixed larvae (data not shown). When driving the ERK biosensor cassette (UAS-
ERKnKTR) in flies, signal was relatively low but detectable in fixed larval tissue. We examined the larval 
wing pouch because EGFR signalling induces MAPK phosphorylation in a distinct pattern that prefigures 
the wing veins (see Fig. 3.1A). We reasoned that this pattern might be visually distinguishable in the 
nuclear red/green ratio of cells expressing ERK-nKTR. Despite the fact that both the mClover-tagged 
ERK-nKTR and the nuclear mCherry were detectably expressed when driven by act-GAL4, no difference 




Figure 3.8: ERK-nKTR signal in the larval wing pouch 
 
 
Signal from the ERK biosensor tagged with mClover (A), the bicistronically expressed nuclear mCherry (B), and merge (C). 




The ability to reliably quantify RTK signalling activity in live or fixed Drosophila tissues would be 
a powerful tool to augment assessment of the patterning role of EGFR in wild-type and various mutant 
contexts. However, the fact that we were not able to detect changes in the nuclear red/green ratio in 
imaginal discs indicates that additional modifications to the ERK-nKTR tool are necessary for its use in 
flies. As a first step, additional insertions of the cassette and modulation of the driver should be 
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assessed to determine if tuning the expression level of the bicistronic sensor allows detection of nuclear 
export and pixel ratios should be quantified in addition to visual inspection. Further, any issues in the 
nuclear localization or export signal sequences or T2A would compromise the utility of this biosensor 
and should be assessed. Finally, assessment in ectopic clones expressing upstream EGFR activators 
such as EGFR λtop or activated Ras driven by an alternate binary system such as LexA/LexAoP or the Q-
system would offer a useful positive control for ERK-nKTR function in the context of constitutively high 
levels of EGFR signalling. 
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CHAPTER 4: General Discussion & Future Directions 
The experiments and our interpretations relayed in the preceding chapters represent significant 
progress toward understanding how EGFR signalling is activated to pattern the fly tarsus. We provide 
new findings that elaborate on existing models of EGFR ligands as morphogens. Further, we have 
characterized in detail the molecular mechanisms by which expression of known EGFR inputs Vein (Vn) 
and Rhomboid (Rho) are activated at the transcriptional level. We have also clearly demonstrated the 
utility of targeted genome modification for advancing the study of CRMs and their role in patterning and 
other developmental phenomena. Importantly, these experiments have generated a set of tools that will 
be invaluable for further characterization of EGFR signalling in the leg and of CRM biology in general. 
Below I describe our immediate goals for the future of this project in the Mann lab, as well as our views 
on the significance of this project in the context of various biological fields. 
 
Disentangling the multiple roles of EGFR signalling in leg development 
 The findings presented in this dissertation indicate that the role of EGFR signalling in leg P-D 
axis patterning may be more complex than originally thought. However, more work remains to discern 
exactly how EGFR signalling is activated along the length of the tarsus as distal sources of EGF ligand 
do not explain more proximal segment patterning. This question is particularly challenging because 
medial rings of expression of EGFR inputs that may be involved in tarsal patterning must be 
distinguished from rings that are important for the later joint patterning role (see Galindo et al., 2005). A 
precise characterization of the roles that each source of EGFR input plays in activation of signalling 
during these two dynamic patterning events will require a sophisticated approach that combines cutting-
edge genome editing with classical genetics. In particular, it will be important to carefully discern what 
phenotypes are caused by perturbation of tarsal patterning rings as compared to joint defects.  
 Having identified leg enhancers of a number of EGFR target genes affords us the opportunity to 
assess the molecular mechanisms by which these genes become expressed in tightly intercalated 
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circles and rings along the P-D axis. This set of genes likely requires direct regulation by a number of 
important factors for expression in their proper pattern including activation by downstream effectors of 
EGFR as well as relief of repression in combination with domain-specific cross-repression or 
autoregulation to precisely define boundaries of expression (Boisclair Lachance et al., 2014). A battery of 
leg CRMs corresponding to multiple genes expressed in different domains along the P-D axis will permit 
these various regulatory questions to be assessed directly. Further, it will be interesting to compare 
enhancers of genes that are co-expressed, C15 and Al or Bar-H1and Bar-H2, for example, as similarities 
and differences in activation may help to reveal whether there is a consistent mechanism of EGFR target 
gene correlated to position along the P-D axis. 
 Finally, it is likely that EGFR signalling is important for the separable phenomena of patterning 
and growth. Indeed, previous studies have shown that intermittent or low levels of RTK-ERK activation 
fail to induce translocation of activated ERK into the nucleus, yet are still capable of promoting cell 
division and growth without enacting a downstream transcriptional response, while stronger, sustained 
pulses of RTK signalling were associated with nuclear translocation (Chen et al., 1992; Marshall, 1995). 
Approaches that permit quantitative assessment of EGFR signalling strength (Harvey et al., 2008; de la 
Cova et al., 2017) in the background of various perturbations of upstream inputs, either mutants or 
enhancer deletions, would be very illuminating as to which sources of ligand and what strength of signal 
are important for the various roles of EGFR in patterning versus growth of the leg.  
 
Extension of analysis to repression and negative regulation 
 In order for tissue-specific, spatiotemporally dynamic signals to produce robust morphological 
patterns, their regulation must include both activation and repression. Repression importantly constrains 
the strength and range of signals (especially secreted signals) and refines activity pattern to produce 
distinct, bounded domains (Gabay et al., 1997). To date, no upstream negative regulator of EGFR 
signalling is has been identified that constrains activity in the distal leg. The expression patterns of the 
secreted antagonist argos coincides with that of vn and rho in the distal leg as does that of the 
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membrane bound repressor sprouty (data not shown; Campbell, 2002). There are additional upstream 
repressors, such as the transmembrane repressor Kekkon that may act to constrain EGFR signalling 
during tarsal patterning via negative feedback (Ghiglione et al., 2003; Alvarado et al., 2004).  
 In addition to post-translational repression mechanisms, vnE and rhoE are also likely subject to 
repression at the transcriptional level. The distally-constrained patterns of expression of these two genes 
cannot be explained by the transcriptional activators identified so far because they are expressed in a 
broader pattern than vnE and rhoE. Additional, distally constrained activators or medial/proximal 
transcriptional repressors must contribute to their activity. It is also possible that transcriptional 
repression is interpreted by other CRMs in these loci. For example, when vnE is replaced with rhoE, vein 
RNA is still expressed in the wild-type pattern, indicating that other aspects of the locus determine its 
final pattern of activity (Fig. 3.8). A search for activators and repressors of these genes with respect to 
their distal expression pattern will therefore need to be carried out with the context of the endogenous 
locus in mind. Identification of additional repressors expressed in the proximal or medial leg will help to 
refine the model of regulation of EGFR activity along the P-D axis. 
 
Using genome editing to analyze enhancer function in vivo 
Many of the techniques described in this dissertation have been in use for decades or more; and 
though they continue to allow us to expand our understanding of developmental biology and genetics, 
the recent and rapid rise of precise genome editing provides a novel opportunity to study the role of 
enhancers in gene expression, development and disease. 
Our understanding of the biophysical mechanisms of enhancer action is relatively limited given 
their obvious importance for development in all organisms. Strategies for identification of enhancers in 
unbiased ways are improving as is our understanding of the importance of the three-dimensional 
structure of DNA at multiple organizational levels for proper regulation of gene expression. This study 
has generated detailed information about a growing set of enhancers that are all involved in a well-
studied, coordinated developmental process and that share a number of common features of their 
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regulatory programs. Each enhancer and its relationship to or importance for activating expression of its 
target gene and for leg patterning is interesting in and of itself, but a single enhancer offers limited 
potential for gaining a larger understanding of how enhancers work in general. Instead, a relatively large 
set of well-studied CRMs that have some known relationship to one another in terms of their role in a 
specific developmental context offer an excellent model to compare and contrast enhancer regulation 
and function in order to draw conclusions about the role of enhancers in gene regulation. Additionally, 
the production of well-characterized enhancer tools such as our attP-marker “swappable” CRM 
replacements offers the chance to study enhancers in three dimensions and in their natural environment: 
the gene locus. 
 Some of our results, as well as many recent findings in the field, have demonstrated the 
importance of assessing enhancer function in the context of the endogenous locus. Transgenic reporters 
are a crucial tool for identifying and characterizing enhancers as we have done in the experiments 
presented in Chapter 2 and 3. However, sufficiency of a genomic fragment to drive expression of a 
reporter does not necessarily reflect a requirement in the endogenous locus or the existence of physical 
CRM-promoter interaction. Further, recent studies suggest that position of a CRM with respect to the 
coding sequence of the target gene may be important for its ability to drive expression (Galindo et al., 
2011). Transgenes of candidate enhancers that lie 3’ to the endogenous gene but were assessed 5’ of 
the lacZ CDS in reporter constructs (as most are) may need to be reassessed. 
 Some unexpected but important technical constraints arose during our initial attempts to target 
and replace specific genomic loci and subsequent RMCE to replace the targeted loci with various 
constructs. Because of the use of long homology arms upstream and downstream of the targeted sites, 
we feel it is unlikely that orientation of the initial replacement should be a concern. Indeed, all four 
independently established transformant strains positive for dsRed expression after our Dll-LT/304 
targeting contained the intended replacement cassette in the correct locus. It is, however possible that 
off-target mutations might result from the targeting process that would be difficult to detect. Outcrossing 
would help to prevent confounding off target effects on other chromosomes. Indeed, one of the four 
confirmed positive LT/304-dsRed transformants does not survive as a homozygous strain, either 
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because of some de novo mutation or some other undetermined effect of targeting. These issues can be 
ameliorated by establishment of multiple independent trasnformant strains, should targeting be efficient 
enough. 
 Further, we encountered difficulties in screening RMCE replacements at our targeted loci. 
Because we wanted to determine the orientation of the replacement construct with respect to the 
endogenous gene, we chose PCR as a screening method as opposed to Southern Blot. However, 
efficiency of PCR reactions was highly variable and it was often extremely difficult to amplify from these 
templates, particularly in the “deletion” RMCEs where targeted loci were replaced with an 80-bp multiple 
cloning site. Likely, the inverted repeats of the attP sites confer secondary structure to the template DNA 
which interferes with amplification. This effect is, predictably, worse the closer the IRs are to one 
another, as in the MCS replacements. In most cases, PCR product could not be obtained in a 
heterozygous background because the amplicon from the wild-type chromosome dominated the 
reaction. 
Further, even after successful PCR, it was often difficult to confirm the orientation of 
replacement cassettes. We used PCR primers designed against the distal interior of the replacement 
sequence paired with a primer in the endogenous genomic sequence. Despite the fact that this primer 
pair should produce a characteristic band size corresponding to the orientation of insertion of the 
replacement fragment, we routinely observed bands corresponding to both orientations from a single 
reaction. This is likely due to an authentic amplicon combined with a partial amplicon from the reverse 
orientation which nevertheless anneals in subsequent rounds of PCR to produce a misleading band. 
Despite these technical considerations, the ease of targeted genomic manipulation achieved in 
recent years now allows us to ask more nuanced questions about regulation of loci in a holistic manner. 
Despite modularity as a defining feature of enhancers, our concept of how genes are regulated in cis 
must shift from a pure module model to include more consideration of the interplay between multiple 
CRMs and promoters in complex loci. Individual enhancers may be redundant for certain aspects of 
gene expression, as seems to be the case for Dll-LT/304, but may, however, serve different functions in 
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other tissues at other developmental time points or under stress conditions (reviewed in Hobert, 2010). 
Multiple enhancers may need to act synergistically to properly constrain gene expression as may be 
occurring with vnE. Replacing this enhancer with a similar (but slightly different driver) is not sufficient to 
alter the expression pattern of the endogenous target gene, likely because other parts of the locus are 
involved in constraining its activity (Fig. 3.8). Such a hypothesis has been proposed for other Drosophila 
loci where multiple enhancers appear necessary to refine highly dynamic expression patterns (El-Sherif 
and Levine, 2016). Historically, approaches to identify and characterize CRMs have relied on examining 
them in exogenous reporter constructs that remove the complexity of the locus that is so important for 
gene function. The ability to modify enhancers in situ offers the most direct way to probe their 
mechanisms in biologically relevant contexts. 
Understanding the way in which the dynamics of complex loci affect gene expression and 
developmental readouts will require more efficient identification of all CRMs relevant to a given locus. 
Techniques that permit assessment of genome interactions in a cell-type-, locus- or protein-specific 
manner such as cgChIP (Agelopoulos et al., 2014) or ChIA-PET-seq (Zhang et al., 2012) have the 
potential to be fruitful tools for exhaustive identification of all interacting regulatory loci for a given 
promoter but are often technically challenging in practice. CRISPR-based genome editing techniques 
can also be used to perform a saturating mutagenesis of a given region by tiling of guide RNAs in order 
to identify all loci required for gene expression or a particular phenotype of interest (reviewed in Delker 
and Mann, 2017). A set of DNA modules that interact to direct a gene’s expression under wild-type 
conditions could then be assayed when one or more CRMs are deleted or mutated to disentangle the 
independent roles of each module for affecting gene expression in a given tissue. 
Hypotheses about how a well-characterized complex CRM-gene locus may function could be 
readily tested in mutant enhancer contexts using swappable landing site enhancers like the ones we 
describe in Chapters 2 and 3. We have identified multiple required direct regulators of the enhancers 
presented in this study and these findings could be leveraged to probe the precise mechanism by which 
these factors direct gene expression via CRMs. Although enhancer-promoter looping is likely an 
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important mechanism, we might address more directly whether binding of specific regulators at CRMs is 
required for looping or other aspects locus kinetics by introducing mutant enhancers into our CRISPR-
targeted CRM landing site constructs and assessing interactions. Further, paralogous enhancers like the 
rho/ru or BarH1/H2 pairs identified in this study offer an interesting system in which to probe how similar 
and closely-spaced enhancers achieve specificity for their target promoters. Targeted modification of 
these loci might allow us to abolish enhancer-promoter specificity between paralogs, for example.  
In short, advances in methods to assess inter-locus interactions will be incredibly useful when combined 
with the ability to modify loci in situ because we can replace well-characterized CRMs with tagged or 
mutant constructs of our choosing in order to compare interactions between wild-type and modified 
genotypes.  
Such techniques could also be applied on the scale of nuclear localization. In recent years, 
models of regulation of gene expression at the level of the genome have expanded with the identification 
of so-called transcription factories (Pombo et al., 2000). It has been observed that highly expressed loci 
tend to be positioned near the nuclear interior with silenced genes enriched near the periphery and that 
sets of co-expressed genes are often co-localized in regions referred to as transcriptional hubs 
(Schoenfelder et al., 2010b; Kohwi et al., 2013). We are beginning to assess the universality of this 
process as well as how it is regulated in the context of development (Canals-Hamann et al., 2013). 
Interestingly, disruption of global organization of the genome into topologically associated domains 
(TADs) has been shown to be associated with cancer (Valton and Dekker, 2016). By leveraging our ability 
to modify and visibly tag specific genomic loci (enhancers as well as their target genes) we can make 
tools of the loci we wish to study in the context of the organization of the whole genome within the 
nucleus. Tools to carry out specific locus tagging for the purposes of visualization as well as approaches 
to collect data (via imaging or 3C technologies) are already being successfully applied by members of 
the Mann lab and others; reviewed in (Dekker and Misteli, 2015). Continued application to modified 
enhancer loci will permit specific studies of how enhancers themselves might not only rely on but also 
drive nuclear organization of the genome (reviewed in Ulianov et al., 2015).  
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Beyond this, we can also begin to ask questions about the role that sub-nuclear organization of 
related loci might play in the context of regulating specific developmental processes like leg 
development. The work presented here describes in detail the molecular regulation of enhancers 
activated to initiate EGFR signalling in the distal Drosophila leg. This characterization, combined with our 
targeted replacement of these CRMs with landing sites, invites a number of questions as to how exactly 
these enhancers and their molecular activators work to direct gene expression. As leg patterning CRMs 
appear to favor a common transcriptional program (see Chapter 2), they may also be co-regulated within 
the 3-D space of the nucleus in a tissue-specific manner. Therefore, our analysis of these leg enhancers 
and the mode of targeted CRM modification we describe could be leveraged on a larger scale to assess 
whether and how regulation of a large set of co-expressed loci might facilitate their co-localization within 
nuclear sub domains in a specific tissue. 
The experimental results presented in this dissertation represent significant advances in our 
understanding of the molecular mechanism by which EGFR signalling is activated to pattern the fly 
tarsus. Further, these results have broad implications for several fields. Morphogen gradients generated 
by the secretion of diffusible factors from organizing centers play a central role in patterning during many 
developmental contexts. However, the precise mechanisms and importance of graded activation of 
downstream signalling is still not well understood. Additionally, the specific mechanisms by which EGFR 
signalling can be activated by different combinations of inputs in different tissues to direct fate decisions 
in downstream cells is vitally important not only to our models of signalling in development, but to 
understanding how these signals are upregulated to drive tumorigenesis. Finally, our ability to 
specifically investigate the physical mechanisms by which cis-regulatory modules integrate these cellular 
signals and direct transcriptional programs within differentiated cells is on the verge of exciting advances 
with the incorporation of targeted genome editing techniques into powerful existing molecular biology 
and functional genomic approaches. 
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Materials & Methods 
Drosophila Genetics 
 The following mutant alleles and enhancer trap alleles were used in this study: arr2, btdXA, 
cicQ474X, cicP[PZ]08482, dacp7d23 (dac-Gal4), DllSA1, Dllem212 (Dll-Gal4), Egfrtsla, Egfrf24, grk∆FRT, Krn27-7-B, Mad1-2, 
pnt∆88, rho7M43, ru1, ruinga, Sp1HR (shared ahead of publication, (Córdoba et al., 2016) spiSC1, spiDf(2L)Exel8041, 
vnL6, vnGAL4, alex, dLim1E9, C153. Transgenic alleles used for in vivo clonal ectopic expression of genes 
were: UAS-arm∆N, UAS-tkvQD, UAS-Dll, UAS-Egfrλtop, UAS-rho, UAS-vn, UAS-sspi. 
 To perform RNAi knockdown of vein and spitz the following strains were used: UAS-vnRNAi 
(TRiP.HMC04390)/CyO, Dfd:EYFP; UAS-spiRNAi (TRiP.HMS01120) crossed to either Dll-GAL4 (Dllem212), 
spiDf(2L)Exel8041/ CyO, Dfd-EYFP; vnL6/TM6B, or spiDf(2L)Exel8041/CyO, Dfd-EYFP; vnGAL4/TM6B (vnGAL4 is a null 
allele (Austin et al., 2014). Crosses were raised at 18°C, then shifted to >25°C at the start of L3. For 
assessment of larval phenotypes, crosses remained at 25°C until fixation and dissection as wandering 
larvae. For assessment of adult leg phenotypes, crosses were returned to 18°C after 24h until eclosion.  
 For generation of mutant clones that encompass the entire Dll-expressing leg disc region a yw; 
Dll-Gal4 (Dllem212), UAS-Flp; Ubi-GFP M- y+ FRT80B/C(2L;3R)Tb strain was crossed to a corresponding 
FRT80B-containg mutant strain: ruinga rhorhoE-Df vnL6 or ru1 rho7M43 vnvnE-Df. For Flp-FRT inducible mitotic 
recombination and subsequent mosaic clonal analysis fly larvae were heat-shocked at 48h post egg 
laying (PEL), 72h PEL or 90h PEL and dissected for staining as crawling stage larvae at around 120h 
PEL. For generation of Flp-FRT mitotic recombination clones, larvae were heat-shocked for 40 minutes 
at 37°C (or 5-8 minutes for “flip-out” clones). Mitotic recombination clones were generated using the 
following strains: w hs-Flp1.22 Ubi-RFP FRT19A, yw hs-Flp1.22; Ubi-GFP FRT40A /CyO; E/TM6B, yw hs-
Flp1.22; FRT42D Ubi-GFP/CyO; E/TM6B, yw hs-Flp1.22; E/CyO; Ubi-GFP FRT80B /TM6B, yw hs-Flp1.22; 
E/CyO; FRT82B Ubi-GFP/TM6B, yw hs-Flp1.22; FRT42D M- hs-GFP/CyO; E/TM6B, yw hs-Flp1.22; E/CyO; 
Ubi-GFP M- FRT80B/TM6B. The corresponding strains carrying mutant alleles were used in crosses for 
generation of mutant clones in the resulting progeny. E in these genotypes designates either vnE-lacZ or 
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rhoE-lacZ inserted in landing sites 51D or 86Fa on chromosome II and III, respectively. To induce GFP 
expression in larvae marked with hs-GFP, an additional heat-shock was given 1 h before dissection for 
20 min to 1 hour at 37°C.  
 The following strains were used for MARCM experiments where E designates either vnE-lacZ or 
rhoE-lacZ inserted in site 86Fa: yw hs-Flp1.22 tub-Gal4 UAS-GFP; tub-Gal80 FRT40A/CyO; E/TM2, yw hs-
Flp1.22 tub-Gal4 UAS-GFP; FRT42D tub-Gal80/CyO; E/TM2, yw; Mad1-2 FRT40A; UAS-Dll/C(2L;3R)Tb, 
yw; FRT42D arr2; UAS-Dll/C(2L;3R)Tb, yw; FRT42D DllSA1; UAS-arm∆N/C(2L;3R)Tb, yw; FRT42D DllSA1; 
UAS-tkvQD/ C(2L;3R)Tb, yw; y+ FRT40A; UAS-Dll/C(2L;3R)Tb, yw; FRT42D y+; UAS-Dll/C(2L;3R)Tb, yw; 




Plasmids and transgenes 
 All wildtype and mutagenized enhancer-reporter transgenic constructs were made using the lacZ 
reporter vector pRVV54 as an acceptor vector (Slattery et al., 2013). Coordinates of the genomic 
fragments PCR-amplified in the enhancer bashing experiments are listed in Table A1 and Table A10. The 
ΦC31 system was used for transgenesis and plasmids were introduced in landing sites 51D or 86Fa 
(Bischof et al., 2007). 
 Site-directed mutagenesis of the vnE and rhoE enhancers was performed according to the 
QuikChange II protocol (Agilent Technologies). vnE and rhoE enhancers were first introduced in 
pBluescript SK+ vector for site-directed mutagenesis and the resulting mutated enhancers were 
consequently transferred to pRVV54 for in vivo analysis in the fruit fly. Primers used for mutagenizing of 
putative binding site are listed in Table A2.  
 Plasmids for recombinant protein production were made by introducing cDNA sequences into 
pET21 series vectors (Novagen-EMD Millipore) and their derivatives, resulting in C-terminally tagged His 
proteins. Primers used to generate Dll-His (full-length Dll), Sp1Zn-finger-His (only the Zn-finger domains; 
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used for confirming in vitro binding to Sp1 sites), Sp1424AA-His (used to examine cooperativity with Dll), 




 The vnE and rhoE CRISPR/Cas9 alleles were generated by using pCFD4 vector for driving gRNA 
expression (Port et al., 2014) and a germline-expressing Cas9 donor strain for plasmid mix injection 
(Kondo and Ueda, 2013). The following sequences were used as gRNAs for generation of the vnEDf 
allele: CGATTTTAATGCGAAAGCTA and TTTGGCTTTCAACGCTTAAT. The following sequences were 
used as gRNAs for generation of the rhoEDf allele: GAGCCGAGGGCACAAATTGA and 
ATGATGATGATGTATTGCCC. We created a vector containing a cassette with P3-RFP (Bischof et al. 
2007) and FRT(F5)-hs-neo-FRT(F5) selectable markers flanked by minimal inverted ΦC31 (Groth et al. 
2004) attP sites (pRVV613). This vector was used for insertion of upper and lower homologous arms for 
generation of donor vectors for creation of platforms for cassette-exchange. Primers used for PCR-
amplification of the homologous arms are listed in Table 4.2. vnE and rhoE pCFD4-based gRNA vectors 
(250ng/µl) were co-injected with the corresponding vnE and rhoE homologous arm donor cassette 
vectors (500ng/µl) and resulting flies were screened for P3-RFP expression. To generate rhoE deletion 
allele in the background of ruinga, injections to generate the rhoEDf were repeated in a nos-Cas9/CyO; 
ruinga/TM3 strain. Positive fly lines were verified by PCR for correct insertion of the donor cassettes. 
Deletion alleles without P3-RFP were generated through RMCE by injection with an empty multiple 
cloning site vector containing inverted ΦC31 attB sites (pRVV578). The WT vnE, rhoE and the D. virilis 
vnE enhancers were cloned into pRVV578 and resupplied by RMCE in a similar manner (primers are 






 Recombinant proteins were expressed in BL21 (DE3) cells (Agilent Technologies) through IPTG 
induction for 4h. Proteins were subsequently purified through Cobalt chromatography with TALON Metal 
Affinity Resin (Clontech, #635501). EMSA gels were performed as previously described (Gebelein et al., 




Immunohistochemistry and adult leg analysis 
 Immunostainings of fly imaginal discs and embryos was performed by standard protocol. The 
following antibodies were used in this study: rabbit anti-β-galactosidase (Cappel), mouse anti-β-
galactosidase (Sigma-Aldrich, #G4644), guinea pig anti-Dll (Estella et al. 2008), rat anti-Sp1, guinea pig 
anti-Hth (Noro et al. 2006), mouse-anti-GFP (ThermoFisher Scientific, #A11121), rat anti-C15 (Campbell, 
2005), rat anti-Al (Campbell et al. 1993), rat anti-BarH1 (Charlton-Perkins et al., 2011), rabbit anti-BarH1 
(Higashijima et al., 1992), mouse anti-Dac (Mardon et al., 1994). AlexaFluor488-, AlexaFluor555-, and 
AlexaFluor647-conjugated secondary antibodies from ThermoFisher Scientific or Jackson 
ImmunoResearch Laboratories were used at 1∶500 dilution.  
 Adult legs were dissected, mounted, and analyzed by light microscopy. All adults of the relevant 
genotype that eclosed within an 8-hour period were scored. Roman numerals in the figure legends 
indicate the tarsal segments present in each phenotypic class (with the distal most segment perturbed). 
For example, a truncation designated as I-III means that tarsal segments I, II and III were present, with 






In situ Hybridization 
 To generate vectors for in situ probes vn, ru, spi, Krn, and grk DNA sequences were amplified 
from genomic DNA and rho DNA sequence was amplified from cDNA clone (LD06131; DGRC clone 
#3528) using primers listed in Table A2. DNA fragments were cloned into pBluescript SK+ (Agilent 
Technologies). 
 RNA antisense probes were transcribed with either T3 or T7 RNA polymerase (depending on the 
cDNA sequence orientation in the vectors listed in Table A2) and labeled using DIG UTP mix (Sigma, 
#11175025910). Sense RNA probes were used as negative controls. rho probes were then hydrolized for 
30 minutes at 60°C as previously described (Morris et al., 2009). Third instar larvae were 
dissected in cold 1xPBS and fixed for 16h at 4ºC in 4% PFA + 2mM EGTA. In situ hybridization was then 
performed as previously described (Morris et al., 2009) and signal was developed in BM-Purple AP 
substrate (Sigma #11442074001) after staining with anti-DIG -AP antibody at a concentration of 1:2000 
(Roche #1093274).  
  
Fluorescence Quantification 
 Mid-third instar larvae carrying wild-type or mutant vnE- or rhoE-lacZ reporter constructs were 
raised, fixed, stained and imaged in parallel according to standard immunohistochemical protocols. 
Average fluorescence was measured for the area within the central/tarsal domain of all unobstructed leg 
imaginal discs using ImageJ software (http://rsb.info.nih.gov/ij) and reported as the ratio of β-gal:Dll 
(staining control) in arbitrary units (AU). Ordinary one-way ANOVA adjusted for multiple comparisons 
(Dunnett's test) were performed and graphed in Prism software (graphpad.com) to compare wild-
type fluorescence to mutant enhancer genotypes where ns = not significant, * = p£0.0332, ** = 
p£0.0021, *** = p£0.0002  and **** = p<0.0001 (adjusted p-values). Analysis of ERK-nKTR image pixel 





 Triplicate pools of 100 yw and 100 Sp1-GFPBAC L3 wandering larvae were used to perform 
independent chromatin IPs as previously described (Slattery et al. 2011). The Sp1-GFPBAC is a GFP-
tagged Sp1 in BAC clone CH321-64M02 inserted in landing site VK00033 (gift from Dr. Rebecca 
Spokony). All 6 leg discs from each larva were used as material for each IP. Chromatin from the yw 
larvae pools was immuno-precipitated with goat anti-Dll antibody (sc-15858, Santa Cruz Biotechnology, 
1.5 µg/ml for IP) while chromatin from the Sp1-GFPBAC larvae pools was immuno-precipitated with rabbit 
anti-GFP antibody (ab290, Abcam, 1∶300 dilution for IP). DNA from non-immunoprecipitated 10% 
chromatin input was isolated from each pool as reference control. Both control and immunoprecipitated 
DNA samples were prepared for Illumina sequencing using the Epicentre Nextera DNA Sample 
Preparation Kit and sequenced on an Illumina HiSeq 2000 according to the manufacturer's 
specifications. Experiments were performed in duplicate and peak calling was based on merged reads 
for duplicate ChIPs. Sequences were aligned to the Drosophila genome using the Burrows-Wheeler 
Aligner and ChIP-seq peaks were called using MACSv2 (Zhang et al. 2008; Li and Durbin 2009). Peak 
regions were defined using a p-value cutoff of 1.00e-02, but only those peaks passing a more stringent 
q-value cutoff of 1.00e-04 were used for further analysis. Datasets generated for the current study are in 











Bioinformatic intersection analysis (Appendix 4, performed by RV and RD) 
 PWMs for Dll, Sp1, Pan, and Mad were extracted from The Fly Factor Survey Database using 
the command grep within the MotifDb Bioconductor/R package. To generate BED files containing 
position information for each of the above PWMs, the matchPWM command from the Biostrings 
Bioconductor/R package was used. In-house code was used to run the command iteratively through the 
chromosomes (using DM3 build). Only hits above a minimum score of 80% were retained. IGVtools 
within the Integrative Genomics Viewer (IGV) was used to sort and index the BED files prior to 
intersection. Intersections of all BED files (derived from PWM analysis and ChIP-seq and FAIRE peak 
calling analysis) were done using Bedtools2 run locally from the command line. ChIP-seq peaks for Dll 
and Sp1 were first intersected with the FAIRE peaks. The product of this intersection was then 
sequentially intersected with each of the PWM files, always returning the peak coordinates from the 
initial file. The command intersectBed was used with options: -wa, -F 1.0, -u. To determine the gene 
nearest to each of the intersected ChIP peaks, packages within R/Bioconductor were used. The 
annotation package TxDb.Dmelanogaster.UCSC.dm3.ensGene was downloaded and annotated 
transcripts extracted. The distanceToNearest function was used to find the nearest annotated transcript 
to each of the ChIP Peaks. In-house R script was then used to generate the table containing the 
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In the appendices to this dissertation I present some additional experimental results, as well as 
data tables that enhance and support the work described in chapters 2 and 3.  
 
 
Appendix 1 describes the identification of CRMs of genes downstream of EGFR signalling in the distal 
leg imaginal disc.  
 
Appendix 2 describes the deletion of leg enhancers 5’ of the Dll gene thought to be important for initial 
leg P-D patterning. The regulatory inputs into one of these CRMs, Dll-LT, are very similar to the inputs 
we identified for vnE and rhoE in chapters 2 and 3 and were the basis for the bioinformatic analysis 
carried out by RV and RD. 
 
Appendix 3 contains the supplementary data tables for the results described in chapters 2 and 3. 
 
Appendix 4 presents selected results of the intersection analysis performed by RV and RD that is 
discussed in Chapter 2. 
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Appendix 1: Identification of EGFR target gene CRMs in the leg 
 
Introduction 
Signalling by EGFR results in cell fate decisions by activating downstream genes that induce 
differentiation and cell proliferation (Shilo, 2005; Avraham and Yarden, 2011). In Drosophila, EGFR 
signalling results in phosphorylation of the ETS transcription factor Pointed (Pnt), which translocates into 
the nucleus to activate a downstream transcriptional program by relieving obligate repression by the TFs 
Yan or Capicua (Andreu et al., 2012; Jiménez et al., 2012; Boisclair Lachance et al., 2014). The tarsus of 
the adult fly is patterned during the third larval instar when EGFR signalling induces expression of a 
number of genes in waves of increasingly intercalated circular and ring domains. These EGFR-
responsive genes activated along the P-D axis of the tarsus are a collection of transcription factors that 
activate segment-specific programs of gene expression (figure A1.1; reviewed in Estella et al., 2012). 
However, the molecular mechanisms by which many of these genes are activated via cis-acting DNA 
elements have not been characterized.  
Previous studies suggest a model in which the final pattern of gene expression in the leg 
imaginal disc corresponding to differentiated segments in the adult tarsus depends on a distal-to-
proximal gradient of EGFR signalling (Campbell, 2002; Galindo et al., 2005; reviewed in Kojima, 2005; 
Estella et al., 2012; Kojima, 2005). Our results (presented in Chapter 3) indicate that, instead, multiple 
local sources of EGFR signalling pattern the distal and proximal tarsus independently. However, these 
ligand sources may still produce a short-range gradient. Patterning a field of cells into discrete domains 
by a such a morphogen gradient relies on the ability of cells to interpret the local concentration of signal 
as positional information and then induce the appropriate program of gene expression (reviewed in 
Barkai and Shilo, 2009; Wolpert, 2011). Further, cross-repression between genes expressed in abutting 
domains, autoregulation and activity of repressors all must be integrated to produce the final pattern of 
gene expression. These sets of inputs are integrated and interpreted at tissue-specific CRMs to produce 
the proper timing and levels of gene expression necessary to give the cell its fate. Therefore, 
identification of distal leg enhancers of the genes expressed along the P-D axis of the leg is an important 
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component in establishing whether an over-arching, EGFR-dependent transcriptional program is 
responsible for tarsal patterning. 
During the third instar, genes encoding the homeodomain transcription factors (TFs) Aristaless 
(Al) and C15 (clawless) and the Lhx (LIM-Hox) TF dLim1 begin to be co-expressed in small overlapping 
circles in the central domain of the third instar leg imaginal disc, which fate-maps to the pretarsus, or 
claw, of the adult leg (Fig. A1.1C & D, purple). C15 and al are independently activated by high levels of 
EGFR signalling, while dLim1 is likely downstream of Al and/or C15 (Campbell, 2005). Just proximal to 
the presumptive pretarsal domain, the paralogous homeodomain TFs Bar-H1 and H2 (hereafter referred 
to collectively as Bar) are expressed in a ring that prefigures tarsal segments IV and V. Bar expression is 
activated by lower levels of EGFR signalling than the pretarsal genes and, by late third instar, partially 
coincides with rings of expression of POU TF Nubbin (Nub) and the Lhx TF Apterous (Ap) in presumptive 
tarsal segments V and IV, respectively (Campbell, 2005; Turchyn et al., 2011). While graded EGFR 
signalling is a direct activator of these distal tarsal genes, a complex system of activation and cross 
repression maintains and refines the distinct domain boundaries apparent in the final pattern (Galindo 
and Couso, 2000; Kojima et al., 2000; 2005; Pueyo and Couso, 2004; Campbell, 2005). These factors 
also often physically co-regulate target genes as Al and C15 have been demonstrated to bind together 
(Kojima et al., 2005). Further, Notch signalling is also required in some instances for indirect regulatory 
relationships between genes whose expression domains do not immediately abut (de Celis Ibeas and 
Bray, 2003; Campbell, 2005; Greenberg and Hatini, 2009). For example, the Notch-dependent zinc-
finger TF Bowl is activated by C15 to represses ap expression in tarsal segment V (Campbell, 2005). 
Early in the third instar, the expression domain of Bar abuts proximally with the distal border of 
Dac expression resulting from mutual cross repression of these genes (Giorgianni and Mann, 2011; 
Natori et al., 2012). However, by the end of larval development a number of rings of gene expression 
required for patterning the medial tarsus become intercalated between these domains (Fig. A1.1B, 
green). One of the factors required for establishing these medial patterns is, refreshingly, not a 
transcription factor. The tarsal-less (tal) locus encodes four short secreted peptides which appear to be 
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responsible for activating medial rings of gene expression in a graded fashion (Pueyo and Couso, 2008). 
The TFs Rotund (Rn), Bric-á-Brac (Bab) and Spineless (Ss) are expressed in overlapping, highly 
spatiotemporally dynamic ring patterns that further subdivide the proximal tarsus. As in the distal tarsus, 
these gene products generate a complex regulatory network of positive and negative feedback that 
maintains their precise patterns and timing of expression with respect to one another, as well as their 
proximal and distal neighbors (reviewed in Estella et al., 2012). Further, the growth of the disc itself is an 
important factor for affecting the regulatory relationships between these genes and for affecting the 
levels of signals that cells receive as they move as a result of tissue growth. In this way, distinct 
positions along the P-D axis of the tarsus are likely specified by the unique combinations of transcription 
factors expressed in these ring and circular domains which establishes their adult fates, ostensibly by 
activating position-specific transcriptional programs. 
There are many ways in which cells might interpret morphogen level to activate gene expression 
programs corresponding to distinct cell fates (reviewed in Lander et al., 2002; Rogers and Schier, 2011). 
At the simplest level, differences in levels of upstream signalling input may manifest as differences in 
activity of the downstream transcriptional effectors. This activity might be determined by a combination 
of several factors including, but not limited to, crosstalk between intracellular factors as well as binding 
site number, affinity and the requirement for combinations of positive and/or negative inputs at 
regulatory DNA elements (Ashe and Briscoe, 2006). In order to achieve sufficient robustness to 
overcome normal biological noise such as temperature, size differences between individuals or gene 
dosage, there is often reinforcement of positional boundaries established along the gradient in that 
genes activated in adjacent domains with different developmental fates are able to inhibit one another’s 
expression ( Eldar et al., 2004; Ashe and Briscoe, 2006). These mechanisms have been studied in 
various cases of morphogen signalling, though their relative importance for patterning in different 
contexts is still an open area of investigation.  
In many cases, the precise and complex set of genetic interactions necessary for establishment 
of these tarsal gene expression domains have been described in detail (see Pueyo and Couso, 2004; 
2008; Campbell, 2005; Kojima, 2005; Kojima et al., 2005; Natori et al., 2012). Further, many instances of 
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direct regulation by binding of DNA elements have been identified for leg P-D genes and their enhancers 
(Giorgianni and Mann, 2011; Baanannou et al., 2013; Mojica-Vazquez et al., 2017). In order to further this 
understanding of how distinct sets of target genes integrate signals from EGFR, neighboring tarsal 
patterning genes and other signalling pathways or upstream leg patterning factors we have identified leg 
enhancers of genes encoding the EGFR target genes expressed in the distal-most domain of the leg 
disc; aristaless (al) and C15. We have also minimized an enhancer of the Bar-H2 homeobox transcription 
factor expressed in the domain immediately proximal to that of al/C15 that was initially identified by the 
FlyLight Project (Jory et al., 2012). These enhancers represent a set of EGFR response elements 
corresponding to different positional identities along the P-D axis of the distal tarsus. Characterization of 
how CRMs that drive expression at distinct positions along the P-D axis integrate upstream signals will 
be an important component in generating a model of how graded EGFR signalling directs leg patterning. 
. 
 
Figure A1.1: Summary of tarsal P-D gene expression and regulation 
 
 
adapted from (Estella et al., 2012) 
 
(A) Genes expressed along the P-D axis by the end of embryogenesis. Dac begins to be expressed during the second larval instar 
followed by activation and intercalation of multiple circles and rings of gene expression that subdivide the presumptive tarsus 
beginning in the early third instar (B). Genes activated along the P-D axis during the third instar display complex genetic and 
biophysical regulatory interactions that serve to define and refine expression patterns (C).  
The rudimentary P-D domains established by Hth/Dac/Dll is further subdivided into a pattern that prefigures the segments of the 





In order to characterize the mechanisms by which downstream EGFR signalling and other cues 
are integrated by transcriptional targets at different positions along the P-D axis of the leg we sought to 
identify EGFR target gene-associated CRMs active in the distal leg imaginal disc. We identified 
fragments upstream of the EGFR target genes al and C15 that drive lacZ reporter expression in the leg. 
Fragments upstream of al were cloned before my involvement in this project by Roumen Voutev. He 
identified fragment pRVV153 and then minimized it to the 506-bp fragment pRVV187; a single al CRM 
that drives lacZ reporter expression in a domain overlapping with Al protein expression in the center of 
third instar leg discs but absent from the dorsal-proximal domain where al is also expressed (Fig A1.2A - 
green bars, C, D – yellow arrowhead; Table A10). These fragments overlap with a fragment later 
identified in the FlyLight screen, R35F04 (Fig. A1.2A, B, Jory et al., 2012). Despite its overlapping 
expression pattern with Al protein, pRVV187-lacZ expression is unaffected in mutant mitotic clones of 
the EGFR downstream effector pnt, where Al protein expression is absent in similar clones (Fig. A1.3A, 
B). Expression of both al and pRVV187-lacZ are activated in clones that ectopically express EGFR inputs 
(Fig. A1.3C, D, E).  
We then scanned the C15 locus for leg CRMs. By excluding regions assessed by the FlyLight 
project that are not active in the leg imaginal disc, we identified one 1.3-kb fragment upstream of C15 
that drives reporter expression in the distal leg (Fig A1.2E, F, G; Table A10). C15-PD is coexpressed 
precisely with C15 protein in the distal leg disc but drives expression of a medial ring that is not 
observed in C15 antibody stains (Fig. A1.2G, yellow arrowhead). The region immediately 3’ of the C15 
CDS contains three distinct stretches of sequence that are highly conserved among fly species and 
could also be assessed for their ability to drive reporter expression (Fig. A1.2E, gray bars). 
We screened the FlyLight database for CRMs near the paralogs genes encoding the 
homeodomain transcription factors Bar-H1 & Bar-H2 expressed immediately proximally to al and C15 in 
leg discs. Both loci were covered by the FlyLight project and one fragment upstream of each gene was 
found to drive ring-like expression in distal third instar leg discs similar to the endogenous Bar 
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expression pattern (figure A1.2 H, J, L). The B-H1-associated fragment also drives a proximal ring of 
expression not observed in Bar antibody stains (Fig. A1.2I, L). These fragments are distinct from a “late 
enhancer” of BarH1/H2 that has been previously described (Kozu et al., 2006). We further minimized the 
fragment upstream of Bar-H2 to a 312-bp fragment that retains co-expression with Bar protein (Fig. 
A1.2H, J, K; Table A10). The FlyLight fragment upstream of Bar-H1 that co-expresses with Bar protein 
(R81D05) also overlaps with a second fragment that does not express in the distal leg (R81E05) (Fig. 
A1.2H). This and other aspects of the genomic context (conservation, open chromatin peaks) will permit 
significant minimization of the distal Bar-H1 fragment in order to identify sequences important for 









(A) Schematic representation of the al locus showing two fragments that drive expression in leg discs: pRVV153 (dark green) and 
pRVV187 (bright green) 
(B-D) Expression pattern of three overlapping candidate CRMs that co-express with al, a Flylight CRM (B), and the two overlapping 
al-adjacent fragments cloned by RV in third instar leg discs (C & D). 
Arrowheads indicate the presence (yellow) or absence (gray) of expression. 
(E) Schematic representation of the C15 locus showing the position of C15-PD (bright green) 
(F-G) Expression pattern of C15 with other patterning TFs (F) and of C15-PD-lacZ in third instar leg discs. 
Yellow arrowhead indicates the ectopic medial expression driven by C15-PD. 
(H) Schematic representation of the Bar locus showing the position of BarH2-PD (bright green) 
(I-L) Expression pattern of Bar with other P-D patterning TFs (I), B-H2R86B08-GAL4 (FlyLight, J), B-H2-PDMIN (K) and B-H181D05-GAL4 
(FlyLight) (L) in third instar leg discs. Gray dashed rectangle indicates predicted position of distal P-D-relevant portion of B-H181D05 
 
Schematics shown in this figure include representations of candidate CRM fragments cloned in the Mann lab that do (green) or do 
not (brown) express in leg discs. Also shown are candidate CRMs cloned as part of the FlyLight project that either do (blue bars) or 
do not (red bars) express in imaginal discs. Their IDs are listed in Table 4.9 and can be viewed at http://flweb.janelia.org/cgi-









pntΔ88 mitotic clones in the background of staining for Aristaless protein (A) or al(pRVV187)-lacZ (B) 
(C) Ectopic clones of activated Ras co-stained for Aristaless protein.  
Ectopic clones of EGFR (constitutively dimerized) (D) and Rhomboid (E) in the background of al(pRVV187)-lacZ. 
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Discussion & Future Directions 
The distal tarsal enhancers identified in this work represent an attractive system for studying the 
mechanism of EGFR target gene activation in the distal leg. The hypothesis that leg patterning genes are 
activated as a result of a gradient of EGFR signal along the tarsus requires that the cis-regulatory 
modules governing these genes’ expression be able to interpret that gradient to establish P-D fate. Data 
presented in Chapter 3 suggests that an EOC gradient may have only local effects in patterning the claw 
and tarsal segment V. The work presented in this appendix identifies CRMs driving expression that 
recapitulates the patterning of genes expressed in the domains of the leg imaginal disc that fate map to 
these adult leg segments. Having multiple examples of CRMs that drive gene expression at a given point 
along this P-D axis provides a system in which to test the molecular mechanisms for sensing upstream 
signalling levels. The positional relationships between sets of enhancers can be exploited to compare 
and contrast the mechanisms of their transcriptional regulation in order to discern if a systematic 
program is responsible for tarsal patterning along the P-D axis. 
We have identified leg enhancers of pairs of genes expressed at the most- and second-most 
distal domains of EGFR signalling in the leg: C15/Al and BarH1/H2, respectively. Further minimization of 
the C15 and Bar-H1 enhancers may be necessary in order to limit the sequence to be searched for 
transcription factor binding sites and to abolish erroneous medial reporter expression (Fig A1.1G). 
Conversely, the al enhancer (pRVV187) sequence may need to be broadened as its activity does not 
correspond to that of endogenous al in clones lacking EGFR inputs. However, this discrepancy may also 
indicate that some other aspect of the endogenous al locus is necessary for this CRM to respond to 
cellular signals. This possibility highlights an important next step in characterizing these enhancers: 
CRISPR targeting at their endogenous loci and replacement with RMCE landing sites. These 
replacements allow assessment of the requirement of these enhancers to drive gene expression as well 
as other replacement experiments which may be instructive.  
The scope of these experiments can also be increased relatively easily because additional 
drivers are known for EGFR-responsive genes expressed in other domains along the P-D axis. 
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Enhancers for additional genes known to be involved in patterning more medial leg fates such as 
spineless, rotund and bric-á-brac have been identified and could be assessed in parallel with distal 
CRMs (Duncan et al., 2010; Natori et al., 2012; Baanannou et al., 2013). Additionally, drivers have been 
identified by the FlyLight project and other means that occur near EGFR target genes that have no 
established leg-patterning role yet show a leg P-D expression bias. These fragments can be cloned, 
minimized and deleted in order to increase the number of CRMs available for further analysis in this 
collection. 
There are several attractive hypotheses for the mechanisms by which EGFR target gene 
expression may be regulated in the leg. It is conceivable that enhancers responsible for expression of 
genes at the same P-D position have some similarity in the number or affinity of binding sites for 
downstream EGFR effector Pointed, and that this regulatory mechanism differs in a systematic way in 
genes expressed along the P-D axis. However, the mechanism us unlikely to be so straightforward as 
many other cues are likely to be integrated at these CRMs. Interestingly, although activation of EGFR 
targets by Pnt is often achieved via relief of repression by another ETS TF, Yan, Yan is not expressed in 
the leg discs (O'Neill et al., 1994; Flores et al., 2000; Vivekanand et al., 2004; Boisclair Lachance et al., 
2014). Another downstream EGFR repressor TF, Capicua (Cic) is expressed, but its role in affecting 
EGFR target gene expression is unclear (Boisclair Lachance et al., 2014). Assessment of enhancers of 
EGFR targets in the leg may shed light on this Yan-independent repression mechanism. Further, known 
or novel TF binding motifs for additional transcriptional regulatory inputs may emerge form a comparison 
of a large enough set of tarsal P-D patterning CRM sequences.  
 
 
Regulatory mechanisms in paralogous genes 
 The BarH1/H2 and rho/ru CRMs identified in this work offer an intriguing system to study how 
paralogous genes are regulated in cis. Paralogs are pairs or sets of genes resulting from chromosomal 
duplications during evolution. In addition to frequently being physically close in both the linear and 3-D 
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genome, they often share similar regulatory programs and participate in common pathways or cellular 
processes as a result of shared evolutionary lineage. Despite this, mechanisms of co-regulation of 
paralogs are not well understood.  In mammals, genes annotated as paralogs have been found to share 
the same enhancer contacts in 3C-based interaction studies more often that would be expected even for 
linearly close genes (Ibn-Salem et al., 2017).  The potential of targeted genome editing for assessment of 
the biophysical properties of functional enhancer action could be applied to systems like the Bar and rho 
paralogs to investigate open questions about enhancer biology. Is each enhancer dedicated to its 
closest gene? Do they have the same or similar regulatory mechanisms? One issue in studying the 
evolution of CRMs is that they experience less sequence constraint than protein-coding DNA and 
therefore can be more difficult to identify. Paralogous enhancers can be more readily identified and offer 
a system in which to study how regulatory DNA diverges as it takes on new roles as a result of evolution 
(Hadzhiev et al., 2007). 
 Paralogous genes and their enhancers may represent a specific case of so-called shadow 
enhancers. In the example of Bar expression in the fly leg, the expression patterns of the H1/H2 paralogs 
are entirely redundant, and the Bar genes seem to play a similar role in patterning the leg. Their 
redundancy at the level of the gene may contribute to robustness of leg patterning or so called genetic 
“canalization” (Wilkins, 1997). How are the paralogous enhancers identified by the FlyLight project 
related to this mechanism? Does cell context determine the interactions between the paralogous Bar 
genes and their respective enhancers? Are there developmental contexts where these genes or 
enhancers are more or less redundant? Emerging techniques to characterize inter-locus and sub-nuclear 
chromatin dynamics in high resolution will be reviewed in the general discussion. In short, paralogous 
gene/CRM systems may be fruitful systems in which to probe these interactions because these loci are 






Some of this work was done with the assistance of Hana Littleford when she rotated in the Mann lab. 
 
Roumen Voutev identified the aristaless enhancer as well as performed some C15 bashing that helped 
me greatly in narrowing down the location of C15-PD. 
 
Aurelie Jory, as part of her work on the FlyLight project (www.janelia.org/project-team/flylight), 
characterized the fragments cloned in that work as expressed or not expressed in imaginal discs and 
further assessed whether any disc-expressed fragments showed a P-D bias. This led to the identification 
of the BarH1 and BarH2 enhancers and allowed me to narrow down the C15 locus for further bashing 




Appendix 2: CRISPR Targeting of 5’ Dll leg CRMs 
 
Introduction 
 The Dll gene encodes a homeobox transcription factor required for the development of legs and 
involved in many other developmental contexts. Homologous proteins are also required for limb 
development in many diverse taxa (Cohen, 1990; reviewed in Panganiban et al., 1997; Panganiban and 
Rubenstein, 2002). In flies, Dll begins to be expressed in each of the six thoracic hemisegments during 
stage 10 of embryonic development and is the earliest known marker of legs. Its expression is highly 
spatiotemporally dynamic and maintained in leg primordia and then the developing leg imaginal disc. 
This expression is governed by a number of cis-regulatory elements located both upstream and 
downstream of the Dll gene. The 5’ and 3’ elements have been characterized separately in detail; 
reviewed in (McKay et al., 2009; Galindo et al., 2011). 
 Early embryonic Dll expression is activated in the thoracic primordia by Wg signalling and 
repressed dorsally by Dpp and EGFR (Kubota et al., 2000). The cells marked by Dll expression at this 
early stage will give rise to the Keilin’s organ, the ventral leg primordia as well as a dorsal thoracic 
appendage primordia (the wing or haltere in the 2nd and 3rd thoracic segments, respectively) (McKay et 
al., 2009). Leg specification occurs in this way in the 1st thoracic segment, however no dorsal appendage 
develops there likely due to repression from the Hox transcription factor Scr (Requena et al., 2017). Dll 
expression is repressed in the corresponding regions of the abdominal segments by AbdA and Ubx Hox 
inputs (Vachon et al., 1992; Gebelein et al., 2002). The early 5’ Dll leg enhancer Dll-304 is responsible for 
driving this expression and integrating these inputs (Fig. A2.1, McKay et al., 2009). By later embryonic 
stages, Dll expression becomes restricted to a group of cells that will give rise to only the distal portion 
of the leg, the telopodite. Its expression becomes surrounded by a ring of Homothorax/Extradenticle 
expression that marks the future proximal leg and body wall, or coxopodite. The primordia of the dorsal 
appendages initially marked by Dll expression have migrated dorsally by this time (Panganiban, 2000; 
McKay et al., 2009). This restricted region of ventral thoracic Dll expression now requires combined 
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inputs from Wingless and Dpp signalling and auto-regulatory input from Dll itself (Estella and Mann, 
2008). These inputs are integrated at the 5’ Dll215/LT CRM, directly upstream of Dll304 (Fig. A2.1; 
McKay et al., 2009; Agelopoulos et al., 2012). 
 During larval development, Dll-LT continues to drive the Dll expression pattern in the leg 
imaginal disc, which is further refined by the activation of Dachshund in the medial domain of the 
telopodite (Fig. 2.1A). During larval development Dll expression transitions from a requirement of Wg and 
Dpp signalling to relying only on self-activation by the late third instar as integrated by Dll-LT in 
coordination with a promoter-proximal “maintenance” CRM, Dll-M (Fig. A2.1A; Estella and Mann, 2008). 
At this point, the central domain of Dll expression marks only the future distal leg structures: the 
claw/pretarsus, tarsus and distal tibia, but a proximal ring marking the future trochanter appears late in 
larval development. While in early larval stages Dll and dac were expressed in mutually exclusive 
domains of expression based on mutual repression, by the late third instar these domains overlap 
medially as Dll expression becomes independent from Wg and Dpp signalling. This set of 5’ Dll CRMs 
(304, LT and M) are capable of recapitulating the complete embryonic and larval Dll expression pattern in 
transgenic reporter constructs. Further, these loci were assessed using a cell-type and gene-specific 
interaction assay, cgChIP and were found to be in physical proximity to the Dll promoter in leg 
primordia, but not in the corresponding thoracic domains where Dll expression is repressed 
(Agelopoulos et al., 2012; 2014). 
Additionally, a set of enhancers 3’ to the Dll gene have been identified with partially overlapping 
expression patterns and similar, but not identical regulatory programs to the 5’ CRMs (Galindo et al., 
2011). An embryonic and a larval enhancer, Dll-LP and Dll-LL, respectively, partially recapitulate the 
endogenous Dll expression pattern in reporter contexts. These 3’ CRMs are additionally interesting 
because they appear to drive expression robustly only when oriented 3’ to the reporter coding sequence 
as they would be with respect to Dll in their endogenous locus. This finding may be important for 
revision of the commonly accepted model of enhancer function where orientation with respect to the 
target promoter is thought to be minimally important compared to CRM sequence. For example, 
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because enhancers are routinely assessed 5’ of reporter genes and this may have led to false negatives 
in so-called enhancer “bashing” assays. Further, these enhancers have been shown to be required for 
leg development in the Dll locus, as a deletion that includes these fragments severely perturbs leg 
development and patterning (Galindo et al., 2011). This finding also indicates that the previously 
identified 5’ enhancers 304 and 215/LT, while able to drive the Dll expression pattern in reporters, do not 
appear to be sufficient to rescue leg development in an endogenous context as they are intact in this 3’ 
regulatory region deletion. This observation underscores the importance of functional characterization of 
candidate CRMs in situ for the most accurate characterization of a given fragment’s necessity and 
sufficiency for gene expression. Such assessments are becoming increasingly feasible with the recent 
rise of targeted genome engineering approaches such as CRISPR/Cas9. 
 
Results 
In order to assess the requirement of the 5’ Dll leg CRMs for endogenous Dll expression and leg 
patterning in flies, we used CRISPR/Cas9 genome editing to replace the -304 and -LT CRMs with a 
selectable marker flanked by inverted attP sites to facilitate later ΦC31-mediated RMCE at this locus 
(Fig. A2.1A, Table A8). The -304 and -LT CRMs are immediately adjacent in the genome and so were 
replaced in one targeting step (see Methods). The replacement was highly efficient with the majority of F0 
parents producing a high frequency of positive transformant progeny. All positive transformants were 
confirmed by PCR and 3 out of 4 of the independently established lines are homozygous viable.  
Flies homozygous for the enhancer dsRed deficiency were assessed for Dll expression at the 
developmental timepoints when Dll-304 and Dll-LT are known to be active: embryonic stage 10-11 and 
embryonic stage 14 – third larval instar, respectively. We found Dll protein to be expressed in the leg 
primordia and imaginal discs and all adult animals had normally patterned legs (Fig. A2.1B-G). This was 
unsurprising given the established insufficiency of these enhancers to rescue normal leg development in 
the 3’ Dll deficiency (Galindo et al., 2011).  
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Figure A2.1: Dll-LT/304 CRM targeting 
 
 
(A) Schematic representation of Dll locus with the LT, 304 and M enhancers in blue. Homology arms used to target LT-304 in green 
and target sites for guide RNAs in purple.  
Expression of Dll protein in mid- and late-stage embryos and late L3 leg discs and adult leg morphology in the background of 
homozygous LT-304 enhancer deficiency (DsRed replacement) (B-D) or wild-type animals (E-G). 
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 The finding that deletion of LT/304 does not abolish Dll expression in the leg primordia or discs 
is expected given previous findings that they are insufficient for Dll expression and leg patterning in the 
background of a 3’ deletion (Galindo et al., 2011). However, replacement with a true deletion (for 
example, MCS construct as was done for rhoE and vnE; see Chapters 2 & 3) is still an important next 
step to confirm that the replacement cassette is not itself somehow responsible for maintained 
expression of Dll. The replacement itself is also a useful tool as new approaches are developed to 
assess local chromatin interactions and nuclear localization. 
 Galindo et al hypothesize that these upstream Dll CRMs, while not necessary to drive 
endogenous Dll expression may serve as an auto-activatory input that reinforces Dll expression or may 
be required as redundant enhancers under stress conditions (Galindo et al., 2011). The concept of a 
shadow enhancer has evolved from an initial idea of complete redundancy to a more nuanced model 
where enhancers of a single gene that share similar transcriptional programs may in fact serve to buffer 
gene expression against different kinds of stress (reviewed in Hobert, 2010). It would be interesting to 
use this Dll-LT/304 deletion as a sensitized background to test for conditions that necessitate their 
function. Further, in addition to contributing to appendage development in the thoracic segments, these 
CRMs are known to be repressed in the abdominal segments to prevent legs from developing in cells 
that are capable of expressing Dll ( McKay et al., 2009; Agelopoulos et al., 2012). It would be interesting 
to replace this LT/304 platform with constructs mutant for sites necessary for Hox-based repression and 
observe the effect in abdominal segments. 
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Appendix 3: tables and supplementary data 
Table A1: Enhancer Bashing 
Vector name Coordinates (Genome release: BDGP R5/dm3) 
vn enhancer bashing 






























pST1 = rhoE[MIN] chr3L:1,445,386-1,445,802 
pRVV217 = rhoE chr3L:1,445,379-1,445,934 
pRVV15 chr3L:1,456,843-1,459,784 





pRVV660 = rhoLLE2 chr3L:1,467,354-1,471,366 
 
spi enhacer bashing  
pRVV10 chr2L:19,568,998-19,578,284 
 










pST228 = ruLLE chr3L:1,367,706-1,369,173 
 
Note: RV made this table. All constructs beginning with “pST” were cloned by ST.
 
Table A2: Oligos & Vectors 
Primer 
purpose Left primer Right primer 
Corresponding 
plasmids 
For generation of vectors used for in situs 
ru  aaactcgagTCTCGTGTTTCTATGGGTGGG tttgcggccgcGAACAAAATCACAGCCATTAGC pST169 
rho  aaaagatctATGGAGAACTTAACGCAGAATG aaactcgagTTAGGACACTCCCAGGTCGTGC pST250 
vn  aaactcgagGGCGAGCAGCAAAATGCGTCG tttgcggccgcCGCTCACAGCCGTTTCGACCGC pST173 
spi  aaactcgagATACACACATCACCCCTAACTC tttgcggccgcTTGTATTCGCATCGCTGTCCC pST174 
grk  aaactcgagATTGTTGTTCGAGCCGAATC tttgcggccgcCCATTCCAGCTCTTGTAGGC pST176 
Krn  aaactcgagCCGCCTGCCAGCCAAAGCCAAG tttgcggccgcCCACACAGCACATGGCCATAAAC pST178 
    
    
For generation of vectors for His-tagged recombinant protein expression 
Dll  aagtcgacaaATGGACGCCCCCGACGC aagacgtcACTAGTGATGGATTCGTCTCG pRVV201 
Sp1[zn-finger] aaacatatgTATGCCGGACGGGCCACATGCG aaagcggccgcGGCCGTGCCATTGTGCGTC pRVV530 
Sp1[424-AA] aaaactagtATGGACAACCATCACATGC aaactcgagaTGAAGCATCACCGGCGAACC pRVV521 
Mad[MH1] aaaggatccgCACACCGACAGCAGCGCGATGTC aaagcggccgcATTCCCCTGGCCACCGTCGTTCGG pRVV580 
Pan[HMG] aaaggatccCCATATTAAGAAGCCACTAAATGC aaactcgagGCCTCCCGAATCCGTTGTCGATCTG pRVV579 
    
    
For generation of CRISPR donor vectors 
vnE upper 
homology 
arm aaacctgcaggTTGTCAAGAATAGTAAGGGTCATCAC aaacctaggCCAGCGAAACGTGAGCAACACCAAGGC pRVV587 
(upper+lower arm) vnE lower 
homology 
arm aaagctagcTATTGGCCGAAAGGATATTTTTCGCTCC aaaggtaccTTGGCGCCGCGGTTCCTGTAAGTTGGC 
rhoE upper 
homology 
arm aaacctgcaggAATTTGGCCTGCAGTCTGTGGCTGGG aaacctaggCTTAGGAGCTGAGGAGCTGAGCCCGC pRVV561 
(upper+lower arm) rhoE lower 
homology 
arm aaaggcgcgccAAGGAGGATCGTTTGTCGGCACG aaaggtaccGTTCTCCATTCGGATTTCGGTCATC 
    
    
For generation of RMCE donor vectors   
vnE (D. mel) aaagcggccgcaAATATTGTTTATATGAAATTTATTGTAAC aaaggatccGAAAATTGCAGCAGCTAAAGGATTAACC pRVV614 
rhoE tttaagcttCGGTTAAAGCGGGCTC aaaggtaccTGGCCACATCCAGGG pST249 
vnE (D. virilis) aaagcggccGCCCCGAAAATTGCAGCAGCTAAAGG aaaggatccCTTGAAAGGCAGCTCGTCACTATCTATAGG pRVV608 
    
    
EMSA oligos (Upper case indicates overhang used for priming and Klenow fill in; upper case red indicates mutant nucleotides)  
vnE Dll site 1 caggccggggtgggatggataaaatgcacttcctgctggcCGGAGAGGTCGCCTCC 
vnE Dll site 1 Mut caggccggggtgggatggaGGGaatgcacttcctgctggcCGGAGAGGTCGCCTCC  
vnE Dll site2 tgctggcggccacgtcggtgccgaggagcttaattaaagagcgCGGAGAGGTCGCCTCC  
vnE Dll site2 Mut tgctggcggccacgtcggtgccgaggagcttGGGGaaagagcgCGGAGAGGTCGCCTCC   




vnE Dll site3 Mut ggcttcctggaGGGGaaagagacaaactcgcCGGAGAGGTCGCCTCC  
vnE Dll site4 aactcgctaaatatttcagttaacgctttggtggtcCGGAGAGGTCGCCTCC  
vnE Dll site4 Mut aactcgctaCCCCtttcagttaacgctttggtggtcCGGAGAGGTCGCCTCC  
vnE Dll site5 ggtcttggcctataatttgctgctgttgctgcCGGAGAGGTCGCCTCC   
vnE Dll site5 Mut ggtcttggcctatGGGttgctgctgttgctgcCGGAGAGGTCGCCTCC  
vnE Dll site6  gacgctgacgggttttgtataaacaagtcgaagtcagctctcCGGAGAGGTCGCCTCC  
vnE Dll site6 Mut gacgctgacgggttttgtGGGaacaagtcgaagtcagctctcCGGAGAGGTCGCCTCC  
vnE Dll site7 cgaagtcagctctcaatcataaatgaatcatgcgcaCGGAGAGGTCGCCTCC  
vnE Dll site7 Mut cgaagtcagctctcaatGGGGaatgaatcatgcgcaCGGAGAGGTCGCCTCC  
vnE Dll site8 atgcgcaaattatatggccaagactggacggcggaccCGGAGAGGTCGCCTCC  
vnE Dll site8 Mut atgcgcaaGGGatatggccaagactggacggcggaccCGGAGAGGTCGCCTCC  
vnE Dll site9 cagcttttgctggcgctgcttaataaacaatcatcagcaacaaCGGAGAGGTCGCCTCC  
vnE Dll site9 Mut cagcttttgctggcgctgctGGGtaaacaatcatcagcaacaaCGGAGAGGTCGCCTCC  
vnE Dll site10 cagcttttgctggcgctgcttaataaacaatcatcagcaacaaCGGAGAGGTCGCCTCC  
vnE Dll site10 Mut cagcttttgctggcgctgcttaataaacGGGGatcagcaacaaCGGAGAGGTCGCCTCC  
vnE Dll site11 caagttgaagttgaagttgaagatgaagatCGGAGAGGTCGCCTCC  
vnE Dll site11 Mut gaagatgagtggttggGGGGcaacaacgccaacCGGAGAGGTCGCCTCC  
    
vnE Mad site 4 tcctgctggcggccaGTAAAGTTATTCATTG  
vnE Mad site 4 Mut tcctgctgAAAAccaGTAAAGTTATTCATTG  
vnE Mad site 5 cacgtcggtgccgagGTAAAGTTATTCATTG  
vnE Mad site 5 Mut cacgtcAAtgAAgagGTAAAGTTATTCATTG  
    
vnE Pan site 3 cctggaaatcaaagaggCGGAGAGGTCGCCTCC  
vnE Pan site 3 Mut cctggaaatGGGagaggCGGAGAGGTCGCCTCC  
    
vnE Sp1 site1 gtgtatttgtgggcggcaggagcagctacccagaggtgaaCGGAGAGGTCGCCTCC  
vnE Sp1 site1 Mut1 gtgtatttgtTTTTggcaggagcagctacccagaggtgaaCGGAGAGGTCGCCTCC  
vnE Sp1 site1 Mut2 gtgtatttgtgggcTTTTggagcagctacccagaggtgaaCGGAGAGGTCGCCTCC  
vnE Sp1 site2  caggccggggtgggatggataaaatgcacttcctgctggcCGGAGAGGTCGCCTCC  
vnE Sp1 site2 Mut caggccgggTTTTgatggataaaatgcacttcctgctggcCGGAGAGGTCGCCTCC  
    
rhoE Dll site 5 ctaacaacataattgaagctcCGGAGAGGTCGCCTCC  
rhoE Dll site 5 Mut ctaacaacatGGttgaagctcCGGAGAGGTCGCCTCC  
rhoE Dll site 2 agatttgcataatttgagcgtCGGAGAGGTCGCCTCC  
rhoE Dll site 2 Mut agatttgcatGGtttgagcgtCGGAGAGGTCGCCTCC  
rhoE Dll site 4 ggagttcggtaatcgggaattCGGAGAGGTCGCCTCC  
rhoE Dll site 4 Mut ggagttcggtGGtcgggaattCGGAGAGGTCGCCTCC  
    
Scanning EMSA oligos for Sp1 sites in vnE 
  
 gttttaacaggccggggtgggatggataaaatgcacttcctgctCGGAGAGGTCGCCTCC   
 tcctgctggcggccacgtcggtgccgaggagcttaattaaagaCGGAGAGGTCGCCTCC   
 aaagagcggcggtgctcatttgactgggcccgagaggcttcctgCGGAGAGGTCGCCTCC   
 gcttcctggaaatcaaagagacaaactcgctaaatatttcagttCGGAGAGGTCGCCTCC   
 ttcagttaacgctttggtggtcttggcctataatttgctCGGAGAGGTCGCCTCC   




 aagtcgaagtcagctctcaatcataaatgaatcatgcgcaaattCGGAGAGGTCGCCTCC   
 tcatgcgcaaattatatggccaagactggacggcggaccgatctCGGAGAGGTCGCCTCC   
 accgatctgatctggagtccgaacgatggatatattgggaccCGGAGAGGTCGCCTCC   
 ggaccgagggacagatggcaggacacgcagatcgcaacttgcaCGGAGAGGTCGCCTCC   
 gcagcttttgctggcgctgcttaataaacaatcatcagcaacaaCGGAGAGGTCGCCTCC   
 gttttaacaggccggggtgggatCGGAGAGGTCGCCTCC   
 ggataaaatgcacttcctgctCGGAGAGGTCGCCTCC   
 gtgtatttgtgggcggcaggagcagctacccagaggtgaaCGGAGAGGTCGCCTCC   
 ggtgaactcatgtcaacgcttggctgagttcgccggccaCGGAGAGGTCGCCTCC   
 agttcgccggccatttcagttgtatttctcttagcaCGGAGAGGTCGCCTCC   
 atcagcaacaacaacaacattggcagggggatcaagttgCGGAGAGGTCGCCTCC   
 caagttgaagttgaagttgaagatgaagatgagtggttggttCGGAGAGGTCGCCTCC   
 gagtggttggttaacaacaacgccaacgcggccgccccCGGAGAGGTCGCCTCC   
 





Table A3: vnE, rhoE transcription factor binding sites 
   
Site WT TF sites and flanking sequences Mutagenesis oligos (lower case indicates mutated base pairs at a particular 
cycle of mutagenesis; the reverse complement was used as well) 
vnE   
vnE 
Dll 





site2 CCACGTCGGTGCCGAGGAGCTTAATTAAAGAGCGGCGGTGCTCATTTG CCACGTCGGTGCCGAGGAGCTTggggAAAGAGCGGCGGTGCTCATTTG 
vnE 
Dll 
site3 CTGGGCCCGAGAGGCTTCCTGGAAATCAAAGAGACAAACTCGCTA CTGGGCCCGAGAGGCTTCCTGGAggggAAAGAGACAAACTCGCTA 
vnE 
Dll 
site4 GAAATCAAAGAGACAAACTCGCTAAATATTTCAGTTAACGCTTTGGTGGTC GAAATCAAAGAGACAAACTCGCTAccccTTTCAGTTAACGCTTTGGTGGTC 
vnE 
Dll 
site5 CGCTTTGGTGGTCTTGGCCTATAATTTGCTGCTGTTGCTGCTTCTG CGCTTTGGTGGTCTTGGCCTATgggTTGCTGCTGTTGCTGCTTCTG 
vnE 
Dll 
site6 GCCGACGCTGACGGGTTTTGTATAAACAAGTCGAAGTCAGCTCTC GCCGACGCTGACGGGTTTTGTgggAACAAGTCGAAGTCAGCTCTC 
vnE 
Dll 
site7 CAAGTCGAAGTCAGCTCTCAATCATAAATGAATCATGCGCAAATTATATGG CAAGTCGAAGTCAGCTCTCAATggggAATGAATCATGCGCAAATTATATGG 
vnE 
Dll 
site8 CAATCATAAATGAATCATGCGCAAATTATATGGCCAAGACTGGACGG CAATGGGGAATGAATCATGCGCAAgggATATGGCCAAGACTGGACGG 
vnE 
Dll 















site1 GCTTCCTAGGGTGTATTTGTGGGCGGCAGGAGCAGCTACCCAGAGG GCTTCCTAGGGTGTATTTGTGGatatCAGGAGCAGCTACCCAGAGG 
vnE 
Mad 
site2 CATGTCAACGCTTGGCTGAGTTCGCCGGCCATTTCAGTTGTATTTCTC CATGTCAACGCTTGGCTGAGTTCaaaaaCCATTTCAGTTGTATTTCTC 
vnE 
Mad 

















site6 GCCGAGGAGCTTAATTAAAGAGCGGCGGTGCTCATTTGACTGGGCCCGAG GAAGAGGAGCTTAATTAAAGAGaaaaGGTGCTCATTTGACTGGGCCCGAG 
vnE 
Mad 
site7 GGTGCTCATTTGACTGGGCCCGAGAGGCTTCCTGGAAAT GGTGCTCATTTGACTGGatatGAGAGGCTTCCTGGAAAT 
vnE 
Mad 
site8 GACATCATTCGCATCTGATGCCGACGCTGACGGGTTTTGTATAAAC GACATCATTCGCATCTGATGCatAtaCTGACGGGTTTTGTATAAAC 
vnE 
Mad 
site9 CTCTCAATCATAAATGAATCATGCGCAAATTATATGGCCAAGACTGG CTCTCAATCATAAATGAATCATataCAAATTATATGGCCAAGACTGG 
vnE 
Mad 
site10 CAAATTATATGGCCAAGACTGGACGGCGGACCGATCTGATCTGGAGTCCG CAAATTATATGGCCAAGACTGGACatatGACCGATCTGATCTGGAGTCCG 
vnE 
Mad 
site11 GAGGGACAGATGGCAGGACACGCAGATCGCAACTTGCAGCTTTTGCTG GAGGGACAGATGGCAGGACAtaCAGATatCAACTTGCAGCTTTTGCTG 
vnE 
Mad 

















site5 GGCTTCCTGGAAATCAAAGAGACAAACTCGCTAAATATTTCAGTTAAC GGCTTCCTGGAAATGGGAGAGACcccCTCGCTAAATATTTCAGTTAAC 
vnE 
Pan 
site6 CGCTAAATATTTCAGTTAACGCTTTGGTGGTCTTGGCCTATAATTTGC CGCTAAATATTTCAGTTAACGCTggGGTGGTCTTGGCCTATAATTTGC 
vnE 
Pan 





















site10 CGAAGTCAGCTCTCAATCATAAATGAATCATGCGCAAATTATATGGCCAAG CGAAGTCAGCTCTCAATCATAAATGgggCATGCGCAAATTATATGGCCAAG 
vnE 
Pan 
site11 CAATCATAAATGAATCATGCGCAAATTATATGGCCAAGACTGG CAATCATAAATGGGGCATGCGCccATTATATGGCCAAGACTGG 
vnE 
Pan 










site14 CAACAACAACATTGGCAGGGGGATCAAGTTGAAGTTGAAGTTGAAGATG CAACAACAACATTGGCAGGGGGATgggGTTGAAGTTGAAGTTGAAGATG 
vnE 
Sp1 
site1 GATAAGCTTCCTAGGGTGTATTTGTGGGCGGCAGGAGCAGCTACCCAGAGG GATAAGCTTCCTAGGGTGTATTTGTttttGGCAGGAGCAGCTACCCAGAGG 
vnE 
Sp1 
site2 TTTTTTGGTTTTAACAGGCCGGGGTGGGATGGATAAAATGCACTTCCTGC TTTTTTGGTTTTAACAGGCCGGGtTttGATGGATAAAATGCACTTCCTGC 
   
 
 
   
rhoE   
rhoE 
Dll 
site1 CGCAAAGGACATTTGCAGCTCCATTAATGCAATTGTTTGCATTGAATTGG CGCAAAGGACATTTGCAGCTCCATgggTGCAATTGTTTGCATTGAATTGG 
rhoE 
Dll 
site2 CTTAGTCCTAAACAGATTTGCATAATTTGAGCGTTCCGATCTGGATGG CTTAGTCCTAAACAGATTTGCATggTTTGAGCGTTCCGATCTGGATGG 
rhoE 
Dll 
site3 CTGCTCAACTCAACTCCTCTAATTGCCCTTTCAGTGTCCG CTGCTCAACTCAACTCCTCTggTTGCCCTTTCAGTGTCCG 
rhoE 
Dll 
site4 GCTTGTTTTTGGAGTTCGGTAATCGGGAATCGCTTTGATCC GCTTGTTTTTGGAGTTCGGTggTCGGGAATCGCTTTGATCC 
rhoE 
Dll 






site6 CCTAAACCTGACCCAAAGCTAATTGTTTTGTGCCCCCTCTAACG CCTAAACCTGACCCAAAGCTggTTGTTTTGTGCCCCCTCTAACG 
rhoE 
Mad 










site3 CTTCAGTGATCGTTGATCAAGTGGCGATCCGATCCGATCCCCTAAC CTTCAGTGATCGTTGATCAAGTataGATCCGATCCGATCCCCTAAC 
rhoE 
Pan 
site 1 GCCCTTTCAGTGTCCGAAACAATTTTGGTTGATCGGATCGGCTTGTTTTTGG GCCCTTTCAGTGTCCGAAACAAggggGGTTGATCGGATCGGCTTGTTTTTGG 
rhoE 
Pan 
site2 GGTTGATCGGATCGGCTTGTTTTTGGAGTTCGGTAATCGGGAATTGC GGTTGATCGGATCGGCTTGTTTcccGAGTTCGGTAATCGGGAATTGC 
rhoE 
Pan 
site3 CGGTAATCGGGAATTGCTTTGATCCAGCCTAACAACATAATTGAAGC CGGTAATCGGGAATTGCTcccATCCAGCCTAACAACATAATTGAAGC 
rhoE 
Pan 
site4 CCTGACCCAAAGCTAATTGTTTTGTGCCCCCTTCTAACGATGAGC CCTGACCCAAAGCTAATTGTTcccTGCCCCCTTCTAACGATGAGC 
   
   





Table A4: Raw Data for Fluorescence Quantification (Figure 2.6) 
channel disc area mean min max ratio (Bgal/Dll mean intensity) 
WT vnE 
Dll 1 5860.882 99.058 0 255  
Bgal 1 5860.882 41.23 0 255 0.4162208 
Dll  2 4956.382 92.664 0 255  
Bgal 2 4956.382 45.165 0 255 0.487406112 
Dll 3 4926.538 87.363 0 255  
Bgal 3 4926.538 32.697 0 206 0.374265994 
Dll  4 6283.287 76.555 0 255  
Bgal 4 6283.287 22.188 0 255 0.289830841 
Dll 5 4965.565 76.71 0 255  
Bgal 5 4965.565 26.706 0 155 0.348142354 
Dll  6 4742.883 67.192 0 255  
Bgal 6 4742.883 17.967 0 255 0.267397905 
Dll 7 4538.567 77.854 0 255  
Bgal 7 4538.567 31.476 0 216 0.404295219 
Dll 8 4132.231 63.53 0 255  
Bgal 8 4132.231 24.489 0 240 0.385471431 
Dll  9 5452.25 69.572 0 255  
Bgal 9 5452.25 25.345 0 255 0.364298856 
Dll 10 4667.126 48.894 0 219  
Bgal 10 4667.126 12.039 0 130 0.246226531 
Dll  11 5059.688 50.506 0 255  
Bgal 11 5059.688 17.066 0 255 0.337900447 
Dll 12 6473.829 60.599 0 255  
Bgal 12 6473.829 11.916 0 131 0.196636908 
Dll  13 7047.75 60.424 0 255  
Bgal 13 7047.75 17.824 0 255 0.294982126 
Dll 14 6237.374 54.915 0 255  
Bgal 14 6237.374 10.468 0 144 0.19062187 
Dll 15 5445.363 85.242 0 255  
Bgal 15 5445.363 23.257 0 161 0.272834987 
Dll  16 6921.488 100.541 0 255  
Bgal 16 6921.488 39.439 0 255 0.392267831 
Dll 17 7509.183 59.932 0 255  
Bgal 17 7509.183 17.63 0 255 0.294166722 
Dll  18 6769.972 52.638 0 252  
Bgal 18 6769.972 9.247 0 145 0.175671568 
Dll 19 7169.421 61.474 0 255  
Bgal 19 7169.421 12.981 0 255 0.211162443 
Dll  20 5987.144 86.992 0 255  
Bgal 20 5987.144 23.045 0 179 0.264909417 
Dll 21 5879.247 106.43 0 255  
Bgal 21 5879.247 25.095 0 207 0.235788781 
Dll 22 5810.376 87.985 0 255  
Bgal 22 5810.376 16.407 0 165 0.186474967 
Dll  23 6042.241 65.312 0 255  
Bgal 23 6042.241 15.361 0 255 0.235194145 
Dll 24 5252.525 71.759 0 255  
Bgal 24 5252.525 12.884 0 156 0.179545423 
Dll  25 5160.698 68.48 0 255  
Bgal 25 5160.698 9.492 0 105 0.138609813 
Dll 26 6042.241 65.546 0 255  
Bgal 26 6042.241 11.815 0 128 0.180255088 
Dll  27 5743.802 82.705 0 255  
Bgal 27 5743.802 30.508 0 255 0.368877335 
Dll 28 4979.339 63.878 0 255  
Bgal 28 4979.339 16.272 0 157 0.25473559 
Dll 29 7359.963 72.11 0 255  
Bgal 29 7359.963 22.039 0 255 0.305630287 
Dll  30 7268.136 28.44 0 255  
Bgal 30 7268.136 11.729 0 255 0.412412096 
Dll 31 3262.167 30.518 0 255  
Bgal 31 3262.167 18.587 0 255 0.609050396 
Dll  32 3976.125 64.379 0 255  
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Bgal 32 3976.125 33.78 0 251 0.524705261 
Dll 33 3232.323 54.017 0 255  
Bgal 33 3232.323 30.383 0 255 0.562471074 
Dll  34 4690.083 47.399 0 255  
Bgal 34 4690.083 18.231 0 234 0.384628368 
Dll 35 2084.481 69.162 0 255  
Bgal 35 2084.481 6.392 0 142 0.092420693 
Dll 36 3606.52 73.997 0 255  
Bgal 36 3606.52 40.929 0 255 0.553117018 
Dll  37 3310.376 90.536 0 255  
Bgal 37 3310.376 62.425 0 255 0.689504727 
Dll 38 2871.901 87.011 0 255  
Bgal 38 2871.901 58.861 0 255 0.676477687 
Dll  39 4779.614 79.002 0 255  
Bgal 39 4779.614 43.673 0 255 0.55280879 
Dll 40 3551.423 50.921 0 255  
Bgal 40 3551.423 57.56 1 255 1.130378429 
Dll  41 1971.993 52.343 0 255  
Bgal 41 1971.993 66.897 3 255 1.278050551 
vnE - 13x Pan 
Dll 1 4235.537 71.869 0 255  
Bgal 1 4235.537 0.127 0 9 0.001767104 
Dll  2 3608.815 92.197 0 255  
Bgal 2 3608.815 0.255 0 13 0.002765817 
Dll 3 3468.779 112.315 0 255  
Bgal 3 3468.779 1.179 0 46 0.010497262 
Dll  4 7258.953 71.664 0 255  
Bgal 4 7258.953 0.25 0 19 0.003488502 
Dll 5 4499.541 51.425 0 240  
Bgal 5 4499.541 0.051 0 9 0.000991736 
Dll  6 4577.594 72.669 0 255  
Bgal 6 4577.594 0.297 0 33 0.004087025 
Dll 7 4077.135 78.053 0 255  
Bgal 7 4077.135 0.532 0 52 0.006815882 
Dll  8 6313.131 79.952 0 255  
Bgal 8 6313.131 0.231 0 21 0.002889234 
Dll 9 5440.771 65.513 0 255  
Bgal 9 5440.771 0.043 0 6 0.000656358 
Dll  10 7724.977 76.468 0 255  
Bgal 10 7724.977 0.251 0 16 0.003282419 
Dll 11 7070.707 60.554 0 255  
Bgal 11 7070.707 0.076 0 13 0.001255078 
Dll  12 4398.531 38.173 0 198  
Bgal 12 4398.531 0.013 0 7 0.000340555 
Dll 13 5941.23 79.906 0 255  
Bgal 13 5941.23 0.311 0 22 0.003892073 
Dll  14 6609.275 72.117 0 255  
Bgal 14 6609.275 0.141 0 9 0.001955156 
Dll 15 5355.831 52.285 0 226  
Bgal 15 5355.831 0.031 0 5 0.000592904 
Dll  16 6820.478 74.38 0 255  
Bgal 16 6820.478 0.249 0 24 0.003347674 
Dll 17 5036.731 77.328 0 255  
Bgal 17 5036.731 0.266 0 15 0.003439892 
Dll  18 6609.275 78.406 0 255  
Bgal 18 6609.275 0.499 0 33 0.006364309 
Dll 19 6469.238 46.319 0 238  
Bgal 19 6469.238 0.013 0 6 0.000280662 
Dll  20 5844.812 69.729 0 255  
Bgal 20 5844.812 0.088 0 38 0.001262029 
Dll 21 4506.428 52.476 0 255  
Bgal 21 4506.428 0.041 0 20 0.00078131 
Dll  22 3032.599 49.942 0 231  
Bgal 22 3032.599 0.009 0 13 0.000180209 
Dll 23 3735.078 47.512 0 241  
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Bgal 23 3735.078 0.011 0 5 0.00023152 
Dll  24 3248.393 50.299 0 234  
Bgal 24 3248.393 0.031 0 23 0.000616314 
vnE - 12x Mad 
Dll 1 3900.367 58.485 0 255  
Bgal 1 3900.367 0.296 0 15 0.005061127 
Dll  2 3735.078 51.463 0 255  
Bgal 2 3735.078 0.567 0 140 0.011017624 
Dll 3 3985.308 80.446 0 255  
Bgal 3 3985.308 1.214 0 46 0.015090868 
Dll  4 3735.078 74.032 0 255  
Bgal 4 3735.078 0.669 0 20 0.009036633 
Dll 5 3181.818 57.18 0 255  
Bgal 5 3181.818 0.269 0 54 0.004704442 
Dll  6 3092.287 62.993 0 255  
Bgal 6 3092.287 0.347 0 16 0.005508549 
Dll 7 3402.204 77.978 0 255  
Bgal 7 3402.204 0.886 0 22 0.011362179 
Dll  8 3312.672 55.975 0 233  
Bgal 8 3312.672 0.287 0 18 0.005127289 
Dll 9 3181.818 71.499 0 255  
Bgal 9 3181.818 0.899 0 153 0.012573602 
Dll  10 3620.294 103.993 0 255  
Bgal 10 3620.294 3.292 0 255 0.031655977 
Dll 11 3032.599 79.652 0 255  
Bgal 11 3032.599 1.198 0 76 0.015040426 
Dll  12 4331.956 64.338 0 255  
Bgal 12 4331.956 1.679 0 248 0.026096553 
Dll 13 3810.836 41.563 0 238  
Bgal 13 3810.836 0.201 0 43 0.004836032 
Dll  14 7497.704 36.763 0 198  
Bgal 14 7497.704 0.118 0 12 0.003209749 
Dll 15 5654.27 65.562 0 255  
Bgal 15 5654.27 0.977 0 31 0.014901925 
Dll  16 7793.848 74.004 0 255  
Bgal 16 7793.848 2.466 0 174 0.033322523 
Dll 17 8048.669 80.305 0 255  
Bgal 17 8048.669 2.162 0 109 0.026922359 
Dll  18 5617.539 60.375 0 255  
Bgal 18 5617.539 0.24 0 12 0.003975155 
Dll 19 6882.461 44.783 0 195  
Bgal 19 6882.461 0.176 0 33 0.003930063 
Dll  20 8962.351 33.849 0 229  
Bgal 20 8962.351 0.154 0 14 0.004549617 
Dll 21 7853.535 54.438 0 255  
Bgal 21 7853.535 0.978 0 80 0.017965392 
Dll  22 7871.901 53.165 0 255  
Bgal 22 7871.901 0.588 0 23 0.011059908 
Dll 23 7070.707 67.204 0 255  
Bgal 23 7070.707 1.758 0 38 0.026159157 
Dll  24 5548.669 82.671 0 255  
Bgal 24 5548.669 2.142 0 45 0.025909932 
Dll 25 6264.922 66.901 0 255  
Bgal 25 6264.922 0.419 0 19 0.006262986 
Dll  26 10688.705 53.832 0 255  
Bgal 26 10688.705 0.673 0 139 0.012501858 
Dll 27 3973.829 39.786 0 218  
Bgal 27 3973.829 0.454 0 138 0.011411049 
Dll  28 3810.836 54.573 0 243  
Bgal 28 3810.836 0.967 0 208 0.017719385 
Dll 29 3480.257 47.023 0 255  
Bgal 29 3480.257 0.251 0 17 0.005337813 
Dll  30 4577.594 52.232 0 255  
Bgal 30 4577.594 0.629 0 94 0.012042426 
Dll 31 6804.408 32.887 0 191  
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Bgal 31 6804.408 1.583 0 173 0.048134521 
Dll  32 8820.018 31.974 0 241  
Bgal 32 8820.018 0.99 0 69 0.030962657 
vnE - 2x Sp1 
Dll 1 9219.467 70.54 0 255  
Bgal 1 9219.467 11.96 0 255 0.169549192 
Dll 2 7724.977 50.635 0 255  
Bgal 2 7724.977 2.282 0 73 0.045067641 
Dll 3 7463.269 60.695 0 255  
Bgal 3 7463.269 4.944 0 161 0.081456463 
Dll 4 8657.025 65.712 0 255  
Bgal 4 8657.025 5.363 0 182 0.081613708 
Dll 5 9088.613 60.322 0 255  
Bgal 5 9088.613 9.897 0 255 0.164069494 
Dll 6 8319.559 47.113 0 255  
Bgal 6 8319.559 5.249 0 169 0.111412986 
Dll 7 8216.253 59.338 0 255  
Bgal 7 8216.253 20.528 0 255 0.345950319 
Dll 8 8831.497 69.055 0 255  
Bgal 8 8831.497 37.678 0 255 0.545623054 
Dll 9 8445.822 96.774 0 255  
Bgal 9 8445.822 39.147 0 255 0.404519809 
Dll 10 6280.992 71.358 0 255  
Bgal 10 6280.992 8.562 0 184 0.119986547 
Dll 11 6173.095 84.067 0 255  
Bgal 11 6173.095 52.717 0 255 0.62708316 
Dll 12 5860.882 89.618 0 255  
Bgal 12 5860.882 12.422 0 255 0.138610547 
Dll 13 6717.172 85.7 0 255  
Bgal 13 6717.172 11.731 0 255 0.136884481 
Dll 14 5856.29 70.955 0 255  
Bgal 14 5856.29 18.403 0 255 0.259361567 
Dll 15 5743.802 83.106 0 255  
Bgal 15 5743.802 12.875 0 211 0.154922629 
Dll 16 10142.332 31.727 0 197  
Bgal 16 10142.332 9.189 0 255 0.289627131 
Dll 17 8080.808 65.232 0 255  
Bgal 17 8080.808 55.267 0 255 0.847237552 
Dll 18 6274.105 62.455 0 255  
Bgal 18 6274.105 21.671 0 255 0.34698583 
Dll 19 7258.953 81.087 0 255  
Bgal 19 7258.953 19.252 0 255 0.237424001 
Dll 20 7509.183 82.117 0 255  
Bgal 20 7509.183 15.199 0 255 0.185089567 
Dll 21 10348.944 60.856 0 255  
Bgal 21 10348.944 70.878 0 255 1.164683844 
Dll 22 6813.59 61.401 0 255  
Bgal 22 6813.59 15.49 0 255 0.252276022 
Dll 23 9426.079 47.163 0 219  
Bgal 23 9426.079 74.217 0 255 1.573627632 
Dll 24 9694.674 65.97 0 255  
Bgal 24 9694.674 14.918 0 255 0.226133091 
Dll 25 8622.59 62.147 0 255  
Bgal 25 8622.59 88.994 0 255 1.43199189 
Dll 26 8409.091 65.778 0 255  
Bgal 26 8409.091 121.43 0 255 1.846057953 
Dll 27 9187.328 59.627 0 255  
Bgal 27 9187.328 32.44 0 255 0.544048837 
Dll 28 9471.993 59.275 0 255  
Bgal 28 9471.993 10.876 0 212 0.183483762 
Dll 29 10273.186 71.482 0 255  
Bgal 29 10273.186 25.826 0 255 0.361293752 
Dll 30 11942.149 90.991 0 255  
Bgal 30 11942.149 45.277 0 255 0.497598664 
Dll 31 9460.514 57.851 0 255  
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Bgal 31 9460.514 10.528 0 161 0.181984754 
Dll 32 13172.635 68.272 0 255  
Bgal 32 13172.635 17.054 0 255 0.249794938 
Dll 33 10837.925 55.48 0 255  
Bgal 33 10837.925 15.62 0 255 0.281542898 
Dll 34 12421.947 85.368 0 255  
Bgal 34 12421.947 21.564 0 255 0.252600506 
Dll 35 9873.737 57.704 0 255  
Bgal 35 9873.737 19.066 0 251 0.33041037 
Dll 36 8163.453 56.463 0 255  
Bgal 36 8163.453 14.737 0 255 0.261002781 
Dll 37 9846.189 56.532 0 255  
Bgal 37 9846.189 14.96 0 132 0.264628883 
Dll 38 7977.502 63.613 0 255  
Bgal 38 7977.502 5.6 0 177 0.08803232 
Dll 39 10560.147 64.155 0 255  
Bgal 39 10560.147 19.184 0 255 0.299025797 
Dll 40 11090.45 68.711 0 255  
Bgal 40 11090.45 8.748 0 255 0.127315859 
Dll 41 9483.471 65.967 0 255  
Bgal 41 9483.471 6.412 0 207 0.097200115 
Dll 42 8191.001 73.695 0 255  
Bgal 42 8191.001 2.226 0 67 0.030205577 
Dll 43 10654.27 59.319 0 255  
Bgal 43 10654.27 5.9 0 255 0.09946223 
Dll 44 8092.287 61.639 0 255  
Bgal 44 8092.287 5.345 0 147 0.08671458 
Dll 45 8092.287 61.768 0 255  
Bgal 45 8092.287 4.794 0 255 0.077613003 
Dll 46 9869.146 75.966 0 255  
Bgal 46 9869.146 11.679 0 255 0.153739831 
Dll 47 10103.306 58.524 0 254  
Bgal 47 10103.306 14.027 0 255 0.239679448 
Dll 48 8976.125 80.339 0 255  
Bgal 48 8976.125 14.96 0 255 0.186210931 
vnE - 11x Dll 
Dll 1 10984.848 58.904 0 255  
Bgal 1 10984.848 0.286 0 32 0.004855358 
Dll  2 4708.448 86.99 0 255  
Bgal 2 4708.448 0.128 0 10 0.001471433 
Dll 3 4967.86 77.421 0 255  
Bgal 3 4967.86 0.108 0 8 0.00139497 
Dll  4 5231.864 77.543 0 255  
Bgal 4 5231.864 0.171 0 18 0.002205228 
Dll 5 5959.596 99.095 0 255  
Bgal 5 5959.596 0.389 0 21 0.003925526 
Dll  6 8319.559 89.91 0 255  
Bgal 6 8319.559 0.413 0 19 0.004593482 
Dll 7 9219.467 82.019 0 255  
Bgal 7 9219.467 0.834 0 63 0.010168376 
Dll  8 7371.442 50.742 0 248  
Bgal 8 7371.442 0.019 0 6 0.000374443 
Dll 9 7137.282 102.613 0 255  
Bgal 9 7137.282 0.375 0 23 0.003654508 
Dll  10 7848.944 110.983 0 255  
Bgal 10 7848.944 0.99 0 51 0.008920285 
Dll 11 7426.538 89.823 0 255  
Bgal 11 7426.538 0.079 0 9 0.000879507 
Dll  12 9152.893 91.145 0 255  
Bgal 12 9152.893 0.065 0 21 0.000713149 
Dll 13 8723.6 66.333 0 255  
Bgal 13 8723.6 0.017 0 5 0.000256283 
Dll  14 10103.306 81.185 0 255  
Bgal 14 10103.306 0.121 0 17 0.001490423 
Dll 15 8140.496 103.309 0 255  
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Bgal 15 8140.496 0.203 0 18 0.001964979 
Dll  16 8684.573 66.819 0 255  
Bgal 16 8684.573 0.052 0 15 0.000778222 
Dll 17 6896.235 56.446 0 255  
Bgal 17 6896.235 0.029 0 8 0.000513765 
Dll  18 7963.728 55.779 0 254  
Bgal 18 7963.728 0.071 0 11 0.00127288 
Dll 19 8197.888 67.887 0 255  
Bgal 19 8197.888 0.159 0 12 0.002342127 
Dll  20 7729.568 59.898 0 255  
Bgal 20 7729.568 0.212 0 20 0.00353935 
Dll 21 8962.351 53.004 0 255  
Bgal 21 8962.351 0.045 0 45 0.000848993 
Dll  22 8622.59 82.769 0 255  
Bgal 22 8622.59 0.395 0 44 0.004772318 
Dll 23 7848.944 73.765 0 255  
Bgal 23 7848.944 0.054 0 9 0.000732054 
Dll  24 9570.707 87.047 0 255  
Bgal 24 9570.707 0.493 0 32 0.005663607 
Dll 25 9187.328 85.762 0 255  
Bgal 25 9187.328 0.223 0 31 0.002600219 
Dll  26 8326.446 109.377 0 255  
Bgal 26 8326.446 0.613 0 37 0.005604469 
Dll 27 8108.356 74.918 0 255  
Bgal 27 8108.356 0.058 0 16 0.00077418 
Dll  28 8140.496 109.915 0 255  
Bgal 28 8140.496 0.69 0 32 0.006277578 
Dll 29 7405.877 78.953 0 255  
Bgal 29 7405.877 0.048 0 8 0.000607957 
Dll  30 8516.988 96.314 0 255  
Bgal 30 8516.988 0.503 0 36 0.005222501 
Dll 31 5319.1 81.532 0 255  
Bgal 31 5319.1 0.057 0 10 0.000699112 
Dll  32 7988.981 79.449 0 255  
Bgal 32 7988.981 0.297 0 15 0.003738247 
Dll 33 6588.613 86.282 0 255  
Bgal 33 6588.613 0.397 0 41 0.004601191 
Dll  34 7224.518 62.713 0 255  
Bgal 34 7224.518 0.028 0 8 0.000446478 
Dll 35 8342.516 61.064 0 255  
Bgal 35 8342.516 0.036 0 15 0.000589545 
Dll  36 7731.864 103.091 0 255  
Bgal 36 7731.864 0.645 0 36 0.006256608 
Dll 37 8080.808 74.945 0 255  
Bgal 37 8080.808 0.354 0 40 0.004723464 
Dll  38 9345.73 53.638 0 255  
Bgal 38 9345.73 0.08 0 13 0.00149148 
Dll 39 8831.497 52.778 0 255  
Bgal 39 8831.497 0.105 0 19 0.001989465 
Dll  40 10264.004 75.218 0 255  
Bgal 40 10264.004 0.341 0 34 0.004533489 
Dll 41 8083.104 83.072 0 255  
Bgal 41 8083.104 0.74 0 62 0.008907935 
Dll  42 7853.535 46.95 0 230  
Bgal 42 7853.535 0.032 0 7 0.000681576 
Dll 43 7858.127 60.856 0 255  
Bgal 43 7858.127 0.07 0 14 0.001150256 
Dll  44 8218.549 72.912 0 255  
Bgal 44 8218.549 0.346 0 30 0.004745447 
Dll 45 7157.943 61.852 0 255  
Bgal 45 7157.943 0.133 0 25 0.002150294 
Dll  46 8434.343 50.977 0 255  
Bgal 46 8434.343 0.021 0 12 0.00041195 
Dll 47 8533.058 87.109 0 255  
Bgal 47 8533.058 0.174 0 20 0.001997497 
Dll  48 9724.518 83.237 0 255  
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Bgal 48 9724.518 0.435 0 40 0.005226041 
Dll 49 9116.162 57.98 0 255  
Bgal 49 9116.162 0.276 0 37 0.004760262 
WT rhoE 
Dll 1 5160.698 73.011 0 255  
Bgal 1 5160.698 45.801 0 255 0.627316432 
Dll 2 4336.547 89.23 0 255  
Bgal 2 4336.547 67.384 0 255 0.755172027 
Dll 3 4416.896 79.518 0 255  
Bgal 3 4416.896 37.147 0 255 0.467152091 
Dll 4 4765.84 77.514 0 255  
Bgal 4 4765.84 60.898 0 255 0.785638723 
Dll 5 5856.29 55.742 0 255  
Bgal 5 5856.29 31.468 0 255 0.564529439 
Dll 6 2134.986 45.217 0 246  
Bgal 6 2134.986 23.27 0 200 0.514629454 
Dll 7 2325.528 45.21 0 247  
Bgal 7 2325.528 23.695 0 195 0.52410971 
Dll 8 2001.837 52.77 0 255  
Bgal 8 2001.837 26.99 0 248 0.511464847 
Dll 9 4446.74 50.125 0 241  
Bgal 9 4446.74 27.679 0 255 0.552199501 
Dll 10 2323.232 66.973 0 255  
Bgal 10 2323.232 37.135 0 238 0.554477177 
Dll 11 3415.978 51.543 0 255  
Bgal 11 3415.978 27.169 0 206 0.527113284 
Dll 12 5516.529 53.757 0 255  
Bgal 12 5516.529 24.253 0 255 0.451159849 
Dll 13 3005.051 58.129 0 255  
Bgal 13 3005.051 22.08 0 157 0.379844828 
Dll 14 5057.392 38.232 0 214  
Bgal 14 5057.392 11.066 0 155 0.289443398 
Dll 15 3810.836 42.091 0 254  
Bgal 15 3810.836 7.692 0 207 0.182746906 
Dll 16 5089.532 78.019 0 255  
Bgal 16 5089.532 77.039 0 255 0.987438957 
Dll 17 4155.188 84.47 0 255  
Bgal 17 4155.188 84.288 0 255 0.997845389 
Dll 18 4600.551 59.079 0 255  
Bgal 18 4600.551 44.254 0 255 0.749064812 
Dll 19 5445.363 90.175 0 255  
Bgal 19 5445.363 59.127 0 255 0.655691711 
Dll 20 7208.448 83.304 0 255  
Bgal 20 7208.448 34.757 0 255 0.417230865 
Dll 21 7245.179 68.24 0 255  
Bgal 21 7245.179 24.763 0 252 0.362881008 
Dll 22 4235.537 80.636 0 255  
Bgal 22 4235.537 55.994 0 255 0.694404484 
Dll 23 4499.541 45.345 0 219  
Bgal 23 4499.541 17.128 0 182 0.37772632 
Dll 24 4724.518 63.292 0 255  
Bgal 24 4724.518 45.842 0 255 0.72429375 
Dll 25 5259.412 68.492 0 255  
Bgal 25 5259.412 47.794 0 255 0.697804123 
Dll 26 7268.136 80.113 0 255  
Bgal 26 7268.136 37.897 0 255 0.473044325 
Dll 27 10426.997 80.862 0 255  
Bgal 27 10426.997 29.133 0 255 0.360280478 
Dll 28 7598.714 67.01 0 255  
Bgal 28 7598.714 22.801 0 220 0.340262647 
Dll 29 3170.34 52.416 0 255  
Bgal 29 3170.34 28.957 0 199 0.552445818 
Dll 30 2674.472 89.291 0 255  
Bgal 30 2674.472 49.632 0 255 0.555845494 
Dll 31 7031.68 66.869 0 255  
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Bgal 31 7031.68 25.336 0 255 0.378890069 
Dll 32 4731.405 63.241 0 255  
Bgal 32 4731.405 28.482 0 255 0.450372385 
Dll 33 4348.026 60.448 0 255  
Bgal 33 4348.026 17.292 0 217 0.286064055 
Dll 34 4155.188 75.926 0 255  
Bgal 34 4155.188 65.97 0 255 0.868872323 
Dll 35 3376.951 60.832 0 247  
Bgal 35 3376.951 43.669 0 255 0.717862309 
Dll 36 4416.896 75.846 0 255  
Bgal 36 4416.896 59.324 0 255 0.782163858 
Dll 37 3174.931 83.724 0 255  
Bgal 37 3174.931 62.518 0 255 0.746715398 
Dll 38 4600.551 51.651 0 239  
Bgal 38 4600.551 33.384 0 255 0.646337922 
Dll 39 3480.257 48.129 0 255  
Bgal 39 3480.257 33.504 0 224 0.696129153 
WT rhoEMIN 
Dll 1 4873.737 96.657 0 255  
Bgal 1 4873.737 38.409 0 255 0.39737422 
Dll 2 4182.736 93.854 0 255  
Bgal 2 4182.736 39.116 0 255 0.416774991 
Dll 3 5736.915 102.024 0 255  
Bgal 3 5736.915 51.708 0 255 0.506821924 
Dll 4 6264.922 101.737 0 255  
Bgal 4 6264.922 46.39 0 255 0.455979634 
Dll 5 6804.408 108.74 0 255  
Bgal 5 6804.408 37.223 0 255 0.342311937 
Dll 6 3023.416 99.048 0 255  
Bgal 6 3023.416 116.694 0 255 1.178156046 
Dll 7 3151.974 90.225 0 255  
Bgal 7 3151.974 61.537 0 255 0.682039346 
Dll 8 2722.681 88.99 0 255  
Bgal 8 2722.681 101.552 0 255 1.141161928 
Dll 9 4320.478 62.706 0 255  
Bgal 9 4320.478 39.953 0 255 0.63714796 
Dll 10 4492.654 67.128 0 255  
Bgal 10 4492.654 47.81 0 255 0.712221428 
Dll 11 3037.19 84.351 0 255  
Bgal 11 3037.19 64.059 0 255 0.759433795 
Dll 12 3884.298 97.883 0 255  
Bgal 12 3884.298 81.843 0 255 0.836130891 
Dll 13 6480.716 92.162 0 255  
Bgal 13 6480.716 38.502 0 255 0.417764371 
Dll 14 5537.19 77.977 0 255  
Bgal 14 5537.19 39.727 0 255 0.509470741 
Dll 15 5346.648 63.279 0 255  
Bgal 15 5346.648 22.994 0 158 0.363374895 
Dll 16 6363.636 94.048 0 255  
Bgal 16 6363.636 43.305 0 255 0.460456363 
Dll 17 3659.32 57.589 0 231  
Bgal 17 3659.32 42.823 0 234 0.743596867 
Dll 18 4492.654 62.863 0 255  
Bgal 18 4492.654 18.793 0 215 0.298951689 
Dll 19 4779.614 71.141 0 255  
Bgal 19 4779.614 28.647 0 255 0.402679186 
Dll 20 5358.127 116.409 0 255  
Bgal 20 5358.127 61.757 0 255 0.5305174 
Dll 21 4501.837 87.771 0 255  
Bgal 21 4501.837 33.689 0 255 0.383828372 
Dll 22 6609.275 72.668 0 255  
Bgal 22 6609.275 30.347 0 255 0.417611603 
Dll 23 2805.326 73.902 0 255  
Bgal 23 2805.326 39.308 0 255 0.531893589 
Dll 24 2001.837 73.642 0 255  
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Bgal 24 2001.837 39.608 0 255 0.537845251 
Dll 25 2334.711 77.571 0 255  
Bgal 25 2334.711 33.408 0 255 0.430676413 
Dll 26 3402.204 85.951 0 255  
Bgal 26 3402.204 60.509 0 255 0.703994136 
Dll 27 4761.249 58.447 0 255  
Bgal 27 4761.249 15.104 0 188 0.25842216 
Dll 28 2665.289 74.555 0 255  
Bgal 28 2665.289 59.136 0 255 0.793186238 
Dll 29 2764.004 64.737 0 255  
Bgal 29 2764.004 61.581 0 255 0.951248899 
Dll 30 2805.326 50.5 0 229  
Bgal 30 2805.326 43.24 0 255 0.856237624 
Dll 31 4150.597 28.6 0 188  
Bgal 31 4150.597 8.529 0 139 0.298216783 
Dll 32 2405.877 55.733 0 242  
Bgal 32 2405.877 22.891 0 190 0.410726141 
Dll 33 2561.983 73.241 0 255  
Bgal 33 2561.983 59.761 0 255 0.815950083 
Dll 34 3737.374 56.318 0 255  
Bgal 34 3737.374 51.638 0 255 0.916900458 
Dll 35 3151.974 61.716 0 255  
Bgal 35 3151.974 52.743 0 255 0.854608205 
rhoEMIN - 4x Pan 
Dll 1 4074.839 98.49 0 255  
Bgal 1 4074.839 23.249 0 153 0.236054422 
Dll 2 3780.992 113.668 0 255  
Bgal 2 3780.992 37.638 0 255 0.331122216 
Dll 3 5355.831 77.967 0 255  
Bgal 3 5355.831 12.433 0 116 0.159464902 
Dll 4 4696.97 74.071 0 255  
Bgal 4 4696.97 14.874 0 255 0.200807334 
Dll 5 1834.252 42.223 0 255  
Bgal 5 1834.252 7.812 0 255 0.185017644 
Dll 6 1848.026 44.112 0 255  
Bgal 6 1848.026 7.411 0 255 0.168004171 
Dll 7 1315.427 46.769 0 234  
Bgal 7 1315.427 6.1 0 204 0.130428275 
Dll 8 2063.82 30.315 0 223  
Bgal 8 2063.82 4.505 0 255 0.148606301 
Dll 9 1285.583 65.155 0 255  
Bgal 9 1285.583 14.157 0 255 0.217281866 
Dll 10 1287.879 69.998 0 255  
Bgal 10 1287.879 9.129 0 154 0.130418012 
Dll 11 1173.095 48.831 0 233  
Bgal 11 1173.095 6.405 0 255 0.131166677 
Dll 12 1884.757 44.335 0 212  
Bgal 12 1884.757 3.931 0 151 0.08866584 
Dll 13 3491.736 34.715 0 192  
Bgal 13 3491.736 3.972 0 204 0.114417399 
Dll 14 3287.42 65.263 0 255  
Bgal 14 3287.42 10.532 0 255 0.16137781 
Dll 15 3636.364 64.908 0 255  
Bgal 15 3636.364 15.967 0 192 0.24599433 
Dll 16 3810.836 51.126 0 239  
Bgal 16 3810.836 11.842 0 249 0.231623831 
Dll 17 2470.156 66.322 0 255  
Bgal 17 2470.156 9.464 0 255 0.142697747 
Dll 18 2277.319 74.162 0 255  
Bgal 18 2277.319 13.385 0 255 0.180483266 
Dll 19 3248.393 59.394 0 255  
Bgal 19 3248.393 10.265 0 113 0.172828905 
Dll 20 2961.433 46.003 0 196  
Bgal 20 2961.433 7.266 0 78 0.157946221 
Dll 21 3335.629 65.107 0 255  
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Bgal 21 3335.629 17.362 0 255 0.266668715 
Dll 22 3895.776 57.732 0 255  
Bgal 22 3895.776 10.901 0 84 0.188820758 
Dll 23 3415.978 61.043 0 255  
Bgal 23 3415.978 10.335 0 255 0.169306882 
Dll 24 3151.974 65.513 0 255  
Bgal 24 3151.974 13.425 0 255 0.204921161 
Dll 25 3411.387 67.687 0 255  
Bgal 25 3411.387 13.99 0 123 0.206686661 
Dll 26 8083.104 54.862 0 255  
Bgal 26 8083.104 7.735 0 73 0.140990121 
Dll 27 9100.092 63.587 0 255  
Bgal 27 9100.092 10.396 0 173 0.163492538 
Dll 28 10934.343 51.513 0 255  
Bgal 28 10934.343 7.866 0 92 0.152699319 
Dll 29 5654.27 64.089 0 255  
Bgal 29 5654.27 18.935 0 255 0.295448517 
Dll 30 6280.992 72.196 0 255  
Bgal 30 6280.992 17.566 0 198 0.243309879 
Dll 31 7272.727 71.207 0 255  
Bgal 31 7272.727 27.164 0 255 0.381479349 
Dll 32 5355.831 76.272 0 255  
Bgal 32 5355.831 26.225 0 199 0.343835221 
Dll 33 6170.799 71.673 0 255  
Bgal 33 6170.799 17.337 0 115 0.241890252 
Dll 34 5399.449 84.241 0 255  
Bgal 34 5399.449 32.193 0 255 0.382153583 
Dll 35 5617.539 65.213 0 255  
Bgal 35 5617.539 24.59 0 255 0.377072056 
Dll 36 6609.275 58.766 0 255  
Bgal 36 6609.275 17.041 0 251 0.289980601 
Dll 37 7697.429 101.643 0 255  
Bgal 37 7697.429 46.542 0 255 0.457896756 
Dll 38 6923.783 67.964 0 255  
Bgal 38 6923.783 27.436 0 255 0.403684303 
Dll 39 6609.275 78.949 0 255  
Bgal 39 6609.275 44.088 0 255 0.558436459 
Dll 40 6609.275 67.738 0 255  
Bgal 40 6609.275 25.757 0 255 0.380244471 
Dll 41 8962.351 45.214 0 236  
Bgal 41 8962.351 4.113 0 53 0.090967399 
Dll 42 8216.253 51.851 0 241  
Bgal 42 8216.253 12.714 0 255 0.2452026 
Dll 43 7853.535 58.661 0 255  
Bgal 43 7853.535 6.533 0 167 0.111368712 
Dll 44 7098.255 66.021 0 255  
Bgal 44 7098.255 12.642 0 83 0.191484528 
Dll 45 7858.127 57.215 0 255  
Bgal 45 7858.127 8.16 0 141 0.142619942 
Dll 46 8197.888 68.835 0 255  
Bgal 46 8197.888 18.857 0 246 0.273944941 
Dll 47 7793.848 65.967 0 255  
Bgal 47 7793.848 20.311 0 255 0.307896372 
Dll 48 8652.433 92.191 0 255  
Bgal 48 8652.433 32.856 0 216 0.356390537 
Dll 49 8516.988 93.554 0 255  
Bgal 49 8516.988 37.362 0 255 0.399362935 
Dll 50 10114.784 59.006 0 255  
Bgal 50 10114.784 16.897 0 255 0.286360709 
Dll 51 9460.514 80.331 0 255  
Bgal 51 9460.514 14.366 0 178 0.17883507 
Dll 52 8831.497 66.375 0 255  
Bgal 52 8831.497 8.478 0 98 0.127728814 
Dll 53 7270.432 92.671 0 255  
Bgal 53 7270.432 16.998 0 161 0.183423077 
Dll 54 8657.025 62.898 0 255  
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Bgal 54 8657.025 8.446 0 99 0.134280899 
Dll 55 8962.351 79.332 0 255  
Bgal 55 8962.351 12.182 0 239 0.153557203 
Dll 56 9614.325 66.582 0 255  
Bgal 56 9614.325 10.367 0 93 0.155702742 
Dll 57 8333.333 79.993 0 255  
Bgal 57 8333.333 18.308 0 150 0.228870026 
Dll 58 9616.621 71.387 0 255  
Bgal 58 9616.621 10.101 0 81 0.141496351 
Dll 59 10948.118 51.778 0 250  
Bgal 59 10948.118 9.635 0 148 0.186082892 
Dll 60 12401.286 57.949 0 255  
Bgal 60 12401.286 15.685 0 255 0.270669037 
Dll 61 8684.573 53.411 0 247  
Bgal 61 8684.573 7.75 0 85 0.145101196 
Dll 62 4522.498 85.531 0 255  
Bgal 62 4522.498 56.443 0 255 0.65991278 
Dll 63 5160.698 54.96 0 241  
Bgal 63 5160.698 20.269 0 107 0.368795488 
Dll 64 5445.363 81.472 0 255  
Bgal 64 5445.363 31.849 0 244 0.39091958 
Dll 65 4938.017 67.152 0 255  
Bgal 65 4938.017 29.703 0 255 0.442324875 
Dll 66 4051.882 72.571 0 255  
Bgal 66 4051.882 46.02 0 255 0.634137603 
Dll 67 5778.237 51.106 0 247  
Bgal 67 5778.237 17.655 0 101 0.345458459 
Dll 68 4563.82 93.336 0 255  
Bgal 68 4563.82 36.6 0 166 0.392131653 
Dll 69 5516.529 73.82 0 255  
Bgal 69 5516.529 33.371 0 255 0.452059063 
Dll 70 7534.435 61.154 0 255  
Bgal 70 7534.435 7.398 0 81 0.120973281 
Dll 71 9152.893 41.296 0 246  
Bgal 71 9152.893 3.835 0 61 0.092866137 
Dll 72 10117.08 56.088 0 255  
Bgal 72 10117.08 10.767 0 174 0.191966196 
Dll 73 7314.05 56.4 0 255  
Bgal 73 7314.05 26.789 0 255 0.47498227 
Dll 74 7729.568 57.345 0 255  
Bgal 74 7729.568 15.242 0 140 0.265794751 
Dll 75 8342.516 74.142 0 255  
Bgal 75 8342.516 21.469 0 187 0.289565968 
Dll 76 7359.963 53.98 0 255  
Bgal 76 7359.963 13.443 0 75 0.24903668 
Dll 77 7805.326 77.154 0 255  
Bgal 77 7805.326 31.694 0 183 0.410788812 
Dll 78 6717.172 59.331 0 255  
Bgal 78 6717.172 19.951 0 182 0.336266033 
rhoEMIN - 3x Mad 
Dll 1 3572.084 50.204 0 255  
Bgal 1 3572.084 9.489 0 221 0.189008844 
Dll 2 5617.539 71.709 0 255  
Bgal 2 5617.539 9.725 0 124 0.135617565 
Dll 3 9490.358 67.359 0 255  
Bgal 3 9490.358 15.423 0 255 0.228967176 
Dll 4 6597.796 65.741 0 255  
Bgal 4 6597.796 8.639 0 184 0.131409623 
Dll 5 7488.522 52.667 0 255  
Bgal 5 7488.522 3.98 0 45 0.075569142 
Dll 6 5743.802 57.145 0 255  
Bgal 6 5743.802 5.203 0 61 0.091049086 
Dll 7 6542.7 41.118 0 255  
Bgal 7 6542.7 6.493 0 255 0.157911377 
Dll 8 5968.779 48.997 0 255  
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Bgal 8 5968.779 4.349 0 160 0.088760536 
Dll 9 7809.917 81.536 0 255  
Bgal 9 7809.917 12.648 0 222 0.155121664 
Dll 10 7502.296 62.341 0 255  
Bgal 10 7502.296 8.121 0 191 0.1302674 
Dll 11 6494.49 70.637 0 255  
Bgal 11 6494.49 10.294 0 214 0.145730991 
Dll 12 7146.465 40.157 0 229  
Bgal 12 7146.465 4.459 0 57 0.111039171 
Dll 13 3943.985 71.718 0 255  
Bgal 13 3943.985 17.836 0 165 0.248696283 
Dll 14 5346.648 58.575 0 255  
Bgal 14 5346.648 10.63 0 136 0.181476739 
Dll 15 5957.3 97.04 0 255  
Bgal 15 5957.3 16.451 0 255 0.16952803 
Dll 16 5452.25 66.065 0 255  
Bgal 16 5452.25 5.611 0 57 0.084931507 
Dll 17 6173.095 74.282 0 255  
Bgal 17 6173.095 11.643 0 180 0.156740529 
Dll 18 4327.365 47.109 0 232  
Bgal 18 4327.365 5.393 0 118 0.114479187 
Dll 19 5516.529 79.081 0 255  
Bgal 19 5516.529 13.663 0 191 0.172772221 
Dll 20 4777.319 66.063 0 255  
Bgal 20 4777.319 9.027 0 255 0.136642296 
Dll 21 2334.711 60.263 0 255  
Bgal 21 2334.711 3.522 0 98 0.058443821 
Dll 22 2814.509 55.674 0 255  
Bgal 22 2814.509 3.61 0 56 0.064841757 
Dll 23 3186.41 54.698 0 252  
Bgal 23 3186.41 4.101 0 255 0.074975319 
Dll 24 4501.837 57.345 0 255  
Bgal 24 4501.837 10.315 0 231 0.179876188 
Dll 25 3976.125 87.978 0 255  
Bgal 25 3976.125 19.044 0 255 0.216463207 
Dll 26 3852.158 65.02 0 255  
Bgal 26 3852.158 7.287 0 201 0.112073208 
Dll 27 3560.606 73.973 0 255  
Bgal 27 3560.606 18.678 0 255 0.252497533 
Dll 28 3390.725 59.088 0 255  
Bgal 28 3390.725 3.705 0 69 0.062703087 
Dll 29 4336.547 49.836 0 244  
Bgal 29 4336.547 2.05 0 30 0.041134923 
Dll 30 4742.883 50.877 0 230  
Bgal 30 4742.883 4.725 0 137 0.092871042 
Dll 31 6843.434 57.337 0 255  
Bgal 31 6843.434 4.178 0 85 0.072867433 
Dll 32 7729.568 75.069 0 255  
Bgal 32 7729.568 9.617 0 115 0.128108807 
Dll 33 8813.131 72.606 0 255  
Bgal 33 8813.131 12.953 0 187 0.178401234 
Dll 34 7858.127 61.073 0 255  
Bgal 34 7858.127 5.429 0 73 0.088893619 
Dll 35 6882.461 57.154 0 247  
Bgal 35 6882.461 4.14 0 46 0.072435875 
Dll 36 2940.771 66.379 0 255  
Bgal 36 2940.771 11.797 0 165 0.17772187 
Dll 37 3312.672 53.421 0 255  
Bgal 37 3312.672 6.093 0 101 0.11405627 
Dll 38 3572.084 54.143 0 241  
Bgal 38 3572.084 5.93 0 93 0.109524777 
Dll 39 4577.594 52.317 0 255  
Bgal 39 4577.594 8.41 0 255 0.160750808 
Dll 40 4182.736 51.902 0 255  
Bgal 40 4182.736 7.055 0 190 0.135929251 
Dll 41 4690.083 75.045 0 255  
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Bgal 41 4690.083 11.216 0 255 0.149456992 
rhoEMIN - 1x Dll 
Dll 1 5911.387 86.43 0 255  
Bgal 1 5911.387 28.937 0 233 0.334802731 
Dll 2 5957.3 109.703 0 255  
Bgal 2 5957.3 65.82 0 255 0.599983592 
Dll 3 6921.488 71.82 0 255  
Bgal 3 6921.488 22.557 0 156 0.314076859 
Dll 4 4327.365 29.15 0 223  
Bgal 4 4327.365 12.224 0 151 0.419348199 
Dll 5 5059.688 49.852 0 255  
Bgal 5 5059.688 37.141 0 253 0.745025275 
Dll 6 2961.433 58.65 0 255  
Bgal 6 2961.433 38.939 0 234 0.663921569 
Dll 7 7947.658 55.89 0 255  
Bgal 7 7947.658 11.975 0 155 0.214260154 
Dll 8 7828.283 60.295 0 255  
Bgal 8 7828.283 15.436 0 233 0.256007961 
Dll 9 4591.368 58.105 0 255  
Bgal 9 4591.368 12.568 0 187 0.216298081 
Dll 10 5658.861 40.335 0 232  
Bgal 10 5658.861 8.175 0 145 0.202677575 
Dll 11 5635.904 49.836 0 250  
Bgal 11 5635.904 11.471 0 139 0.230174974 
Dll 12 5309.917 68.628 0 255  
Bgal 12 5309.917 19.816 0 204 0.288745119 
Dll 13 5252.525 56.319 0 255  
Bgal 13 5252.525 11.125 0 219 0.197535468 
Dll 14 5025.253 71.622 0 255  
Bgal 14 5025.253 18.498 0 203 0.258272598 
Dll 15 4917.355 64.704 0 255  
Bgal 15 4917.355 20.262 0 153 0.31314911 
 
       
Note: SN collected this data and created the table.  
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Table A5: Raw Data for Fluorescence Quantification (Figure 2.7) 
channel disc area mean min max ratio (Bgal/Dll mean intensity) 
WT rhoEMIN 
Dll 1 3.746 10.133 2 28  
Bgal 1 3.746 23.354 4 108 2.304746867 
Dll 2 4.656 32.287 5 78  
Bgal 2 4.656 33.478 6 115 1.036887912 
Dll 3 4.196 30.328 12 62  
Bgal 3 4.196 18.162 3 68 0.598852546 
Dll 4 3.866 32.496 8 71  
Bgal 4 3.866 16.189 4 55 0.498184392 
Dll 5 4.199 17.23 4 43  
Bgal 5 4.199 14.058 1 74 0.815902496 
Dll 6 3.115 23.099 5 52  
Bgal 6 3.115 23.704 6 77 1.02619161 
Dll 7 3.864 29.066 10 55  
Bgal 7 3.864 29.647 5 115 1.019988991 
Dll 8 4.039 14.383 1 35  
Bgal 8 4.039 40.631 4 115 2.824932212 
Dll 9 4.151 14.414 1 35  
Bgal 9 4.151 40.454 4 115 2.806576939 
Dll 10 3.287 40.669 8 85  
Bgal 10 3.287 48.904 11 115 1.202488382 
Dll 11 6.003 35.051 6 79  
Bgal 11 6.003 21.599 3 96 0.61621637 
Dll 12 4.402 33.147 4 73  
Bgal 12 4.402 16.246 3 60 0.49011977 
Dll 13 6.007 44.577 10 85  
Bgal 13 6.007 18.26 2 71 0.409628284 
Dll 14 5.306 24.831 6 58  
Bgal 14 5.306 18.266 2 78 0.735612742 
Dll 15 5.767 18.975 4 44  
Bgal 15 5.767 33.917 5 115 1.787457181 
Dll 16 2.687 14.633 2 35  
Bgal 16 2.687 27.023 5 115 1.846716326 
Dll 17 3.249 9.789 2 24  
Bgal 17 3.249 19.944 4 76 2.037388906 
Dll 18 5.413 37.182 4 85  
Bgal 18 5.413 31.944 6 115 0.859125383 
Dll 19 4.639 10.504 1 23  
Bgal 19 4.639 27.161 8 115 2.585776847 
Dll 20 5.283 40.954 8 85  
Bgal 20 5.283 24.529 2 115 0.598940274 
Dll 21 5.447 31.652 7 85  
Bgal 21 5.447 23.912 5 115 0.755465689 
Dll 22 3.845 39.887 8 81  
Bgal 22 3.845 11.873 0 72 0.297665906 
Dll 23 4.156 35.81 8 71  
Bgal 23 4.156 12.844 1 60 0.358670762 
rhoEMIN - 6x Dll 
Bgal 1 4.785 16.913 5 37  
Dll 1 4.785 9.787 2 25 0.578667297 
Bgal 2 3.84 17.059 4 41  
Dll 2 3.84 10.177 2 28 0.596576587 
Bgal 3 8.7 13.936 2 34  
Dll 3 8.7 13.978 0 37 1.003013777 
Dll 4 10.851 12.531 1 30  
Bgal 4 10.851 2.048 0 10 0.163434682 
Dll 5 9.226 17.541 3 40  
Bgal 5 9.226 5.135 0 115 0.292742717 
Dll 6 6.277 20.384 4 85  
Bgal 6 6.277 15.273 2 53 0.749264129 
Dll 7 8.418 14.613 3 31  
Bgal 7 8.418 3.449 0 15 0.236022719 
Dll 8 16.015 29.618 5 85  
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Bgal 8 16.015 2.578 0 12 0.087041664 
Dll 9 9.449 40.455 7 85  
Bgal 9 9.449 13.973 0 64 0.345396119 
Dll 10 9.504 23.466 5 62  
Bgal 10 9.504 8.565 2 33 0.364996165 
Dll 11 9.963 24.454 5 61  
Bgal 11 9.963 9.96 2 33 0.40729533 
Dll 12 11.401 38.379 7 85  
Bgal 12 11.401 17.75 0 69 0.462492509 
Dll 13 6.54 11.85 3 27  
Bgal 13 6.54 13.218 3 48 1.115443038 
Dll 14 6.228 14.402 3 31  
Bgal 14 6.228 20.625 5 105 1.432092765 
rhoEMIN - 1x Dll 
Dll 1 5.738 26.887 3 59  
Bgal 1 5.738 5.501 0 111 0.204597017 
Dll 2 5.773 16.353 0 51  
Bgal 2 5.773 13.346 1 96 0.816119366 
Dll 3 5.941 15.365 2 35  
Bgal 3 5.941 7.469 0 32 0.486104784 
Dll 4 6.431 32.697 6 73  
Bgal 4 6.431 14.715 2 115 0.450041288 
Dll 5 6.241 27.41 1 84  
Bgal 5 6.241 11.017 0 41 0.401933601 
Dll 6 5.257 24.596 4 67  
Bgal 6 5.257 13.913 2 61 0.565661083 
Dll 7 4.971 34.05 6 70  
Bgal 7 4.971 11.032 0 106 0.323994126 
Dll 8 4.474 14.428 1 34  
Bgal 8 4.474 5.995 0 89 0.415511505 
Dll 9 4.629 21.91 4 53  
Bgal 9 4.629 8.771 1 37 0.400319489 
Dll 10 6.775 19.378 7 44  
Bgal 10 6.775 5.945 0 98 0.306791207 
Dll 11 5.156 17.798 5 42  
Bgal 11 5.156 0.745 0 21 0.041858636 
Dll 12 7.576 20.289 3 46  
Bgal 12 7.576 6.565 0 23 0.323574351 
Dll 13 5.217 10.405 1 32  
Bgal 13 5.217 3.415 0 96 0.328207593 
Dll 14 7.454 33.256 4 76  
Bgal 14 7.454 6.322 1 23 0.190101034 
Dll 15 9.076 16.034 2 42  
Bgal 15 9.076 5.723 0 111 0.356929026 
Dll 16 7.258 12.331 0 37  
Bgal 16 7.258 1.142 0 18 0.092612116 
Dll 17 8.057 14.911 2 40  
Bgal 17 8.057 8.01 1 50 0.537187311 
Dll 18 8.615 16.217 2 46  
Bgal 18 8.615 5.763 0 115 0.355367824 
rhoEMIN - 5x Dll 
Dll 1 5.993 12.4 3 28  
Bgal 1 5.993 10.519 2 34 0.848306452 
Dll 2 13.466 24.868 2 59  
Bgal 2 13.466 17.783 3 68 0.715095705 
Dll 3 8.866 7.191 0 18  
Bgal 3 8.866 9.111 0 115 1.267000417 
Dll 4 7.099 12.682 3 30  
Bgal 4 7.099 18.125 3 115 1.429190979 
Dll 5 6.819 14.688 2 34  
Bgal 5 6.819 12.762 2 115 0.868872549 
Dll 6 4.604 6.304 1 16  
Bgal 6 4.604 12.617 2 47 2.001427665 
Dll 7 6.509 8.124 1 19  
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Bgal 7 6.509 11.498 2 39 1.415312654 
Dll 8 8.376 11.536 2 27  
Bgal 8 8.376 12.625 3 40 1.094400139 
Dll 9 5.007 20.163 2 43  
Bgal 9 5.007 13.53 4 41 0.671031097 
Dll 10 5.338 13.962 3 33  
Bgal 10 5.338 12.564 4 48 0.899871079 
Dll 11 5.02 18.803 3 42  
Bgal 11 5.02 14.757 4 78 0.784821571 
Dll 12 12.467 39.274 0 85  
Bgal 12 12.467 27.09 0 115 0.689769313 
Dll 13 10.108 30.965 1 85  
Bgal 13 10.108 45.385 9 115 1.465687066 
Dll 14 8.986 13.815 2 30  
Bgal 14 8.986 11.247 2 45 0.814115092 
Dll 15 2.579 8.45 2 22  
Bgal 15 2.579 12.253 3 33 1.450059172 
Dll 16 2.394 7.163 1 18  
Bgal 16 2.394 13.424 4 34 1.874075108 
Dll 17 5.586 8.432 0 21  
Bgal 17 5.586 27.831 4 89 3.300640417 
Dll 18 7.732 8.197 0 19  
Bgal 18 7.732 10.733 0 66 1.309381481 
Dll 19 8.378 4.847 0 15  
Bgal 19 8.378 10.768 0 52 2.221580359 
Dll 20 6.69 7.581 1 18  
Bgal 20 6.69 7.125 0 27 0.939849624 
Dll 21 7.418 9.551 2 21  
Bgal 21 7.418 12.741 2 51 1.33399644 
Dll 22 8.217 8.313 0 21  
Bgal 22 8.217 10.322 1 50 1.241669674 
Dll 23 4.37 10.721 1 26  
Bgal 23 4.37 19.936 5 57 1.859528029 
Dll 24 4.118 11.39 4 22  
Bgal 24 4.118 16.708 6 46 1.46690079 
Dll 25 4.616 10.286 3 21  
Bgal 25 4.616 20.299 6 74 1.973459071 
Dll 26 6.206 9.838 1 24  
Bgal 26 6.206 29.133 6 98 2.961272616 
Dll 27 6.419 9.108 1 20  
Bgal 27 6.419 28.133 5 108 3.088823013 
 
Note: SN collected this data and created the table. 
 
 
Table A6: Fluorescence Quantification Statistics (Figure 2.6) 
vnE 
Number of families 1        
Number of comparisons per family 4        
Alpha 0.05        
Dunnett's multiple comparisons test Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value A-?   
  WT vnE vs. 2x Sp1 0.03702 -0.08077 to 0.1548 No ns 0.8547 B 2x Sp1  
  WT vnE vs. 14x Pan 0.382 0.2396 to 0.5243 Yes **** 0.0001 C 14x Pan  
  WT vnE vs. 12x Mad 0.3697 0.2391 to 0.5004 Yes **** 0.0001 D 12x Mad  
  WT vnE vs. 11x Dll 0.3815 0.2643 to 0.4988 Yes **** 0.0001 E 11x Dll  
         
         
Test details Mean 1 Mean 2 Mean Diff. SE of diff. n1 n2 q DF 
  WT vnE vs. 2x Sp1 0.3845 0.3475 0.03702 0.04783 41 48 0.7739 189 
  WT vnE vs. 14x Pan 0.3845 0.002574 0.382 0.0578 41 24 6.608 189 
  WT vnE vs. 12x Mad 0.3845 0.01479 0.3697 0.05305 41 32 6.969 189 
  WT vnE vs. 11x Dll 0.3845 0.003011 0.3815 0.0476 41 49 8.015 189 
         
rhoE 
Number of families 1        
Number of comparisons per family 4        
Alpha 0.05        
Dunnett's multiple comparisons test Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value B-?   
WT rhoE[MIN] (pST1)  vs. WT rhoE  0.02928 -0.06192 to 0.1205 No ns 0.8456 A WT rhoE   
WT rhoE[MIN] (pST1)  vs. Pan 4x  0.3447 0.265 to 0.4244 Yes **** 0.0001 C PAN 4x   
WT rhoE[MIN] (pST1) vs. Mad 4x  0.4658 0.3756 to 0.5559 Yes **** 0.0001 D Mad 4x   
WT rhoE[MIN] (pST1) vs. Dll 1x  0.2484 0.1275 to 0.3693 Yes **** 0.0001 E Dll 1x   
         
Test details Mean 1 Mean 2 Mean Diff. SE of diff. n1 n2 q DF 
WT rhoE[MIN] (pST1) vs. WT rhoE  0.5987 0.5694 0.02928 0.03705 35 39 0.7902 203 
WT rhoE[MIN] (pST1) vs. Pan 4x  0.5987 0.254 0.3447 0.03237 35 78 10.65 203 
WT rhoE[MIN] (pST1) vs. Mad 4x  0.5987 0.1329 0.4658 0.03662 35 41 12.72 203 
WT rhoE[MIN] (pST1) vs. Dll 1x  0.5987 0.3503 0.2484 0.04911 35 15 5.058 203 
 





Table A7: Fluorescence Quantification Statistics (Figure 2.7) 
rhoE (Dll binding mutants) 
Number of families 1        
Number of comparisons per family 3        
Alpha 0.05        
         
Dunnett's multiple comparisons test Mean Diff. 95.00% CI of diff. Significant? Summary 
Adjusted P 
Value 
A-?   
WT rhoE[MIN] (pST1) vs. 6xDll 0.6366 0.1223 to 1.151 Yes * 0.0111 B 6xDll  
WT rhoE[MIN] (pST1) vs. 1xDll 0.8297 0.3523 to 1.307 Yes *** 0.0002 C 1xDll  
WT rhoE[MIN] (pST1) vs. 5xDll -0.2847 -0.7152 to 0.1458 No ns 0.2708 D 5xDll  
         
Test details Mean 1 Mean 2 Mean Diff. SE of diff. n1 n2 q DF 
WT rhoE[MIN] (pST1) vs. 6xDll 1.196 0.5596 0.6366 0.2147 23 14 2.966 78 
WT rhoE[MIN] (pST1) vs. 1xDll 1.196 0.3665 0.8297 0.1993 23 18 4.163 78 
WT rhoE[MIN] (pST1) vs. 5xDll 1.196 1.481 -0.2847 0.1797 23 27 1.584 78 
 






Table A8: Dll-LT/304 CRM feature and targeting coordinates 
 
Dll locus feature coordinates (dm3) 
Dll-LT  chr2R: 20689377-20690316 
Dll-304  chr2R: 20690306-20691190 
target2 chr2R: 20689221-20689240 
target4 chr2R: 20691813-20691835 
upstream homology arm chr2R: 20687731-20689223 
downstream homology arm chr2R: 20691819-20693331 
 
 
Table A9. FlyLight CRMs surrounding EGFR target genes expressed in the leg 
 



































































The listed FlyLight CRM numbers refer to fragments shown in Figure A1.2 as ordered from left to right in the locus schematics 
 
*These fragments were annotated for their imaginal disc expression by Aurélie Jory. 
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Table A10: EGFR Target Gene CRM coordinates 
 
gene Chromosome start (dm3) end (dm3) Construct name 
al chr2L 365942 366448 alE-pRVV187 
al chr2L 365942 367509 alE-pRVV153 
B-H1 chrX 17273540 17276790 BH1-JaneliaR81D05 
B-H1 chrX 17273540 17275526 BH1-min1-pST188 
B-H1 chrX 17273540 17274551 BH1-min2-pST189 
B-H2 chrX 17201649 17205644 BH2-JaneliaR86B08 
B-H2 chrX 17203985 17204300 BH2-min4-pST190 
C15 chr3R 17338536 17346650 C15-downstream 
C15 chr3R 17338536 17341623 C15-ds1 
C15 chr3R 17341541 17343991 C15-ds2 
C15 chr3R 17343633 17346650 C15-ds3 
C15 chr3R 17313166 17316834 C15-us4 
C15 chr3R 17314410 17315770 C15-us5 





Appendix 4: Genome-wide analysis of leg CRM inputs 
Figure A4.1†: Genome-wide analysis of combinatorial inputs of Dll, Sp1, Wg, and Dpp in leg discs  
 
 
(A) Venn diagram representing the intersection between Dll ChIP-Seq, Sp1 ChIP-Seq and FAIRE data from third instar leg discs.  
(B) Schematic representation of bioinformatic intersection between Dll/Sp1 binding events and FAIRE data together with PWMs for 
Dll, Sp1, Pan and Mad.  
(C-N) Schematic representation of the binding events at selected genomic loci, the intersections and the expression pattern of 
tested intersection fragments for: vnE (C); zfh2_LE (D); rhoLLEMIN (E); E(spl)m3-HLH_LE (F); Dll_LE1 (G); tal_LE (H); spi_LE1 (I); ss_LE 
(J); noc_LE1 (K); fj_LE1 (L); elB_LE (M); fj_LE2 (N). 
 
Note on author contributions: RV planned and executed these experiments. Rebecca Delker performed the bioinformatic analysis. 
RV made the figure. 
 
† indicates figures and data produced by RV, included with permission for the purposes of discussion 
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Figure A4.2†: Additional enhancers identified through genomic analysis of leg CRM inputs  
 
 
Schematic representation of identified genomic loci and the expression patterns they drive in reporter genes from Dll_LE2 (A); 
spi_LE2 (B); noc_LE2 (C); Antp_LE1 (D); Antp_LE2 (E); Ote/fj_LE (F). 
 
Note on author contributions: RV planned and executed these experiments. Rebecca Delker performed the bioinformatic analysis. 
RV made the figure. 
 
† indicates figures and data produced by RV, included with permission for the purposes of discussion 
